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1 Introduction 
1.1 Programmed cell death in neurons 
Programmed cell death (PCD) is a cellular self-destruction mechanism that is essential 
for a variety of physiological processes in the central nervous system (CNS), such as 
developmental sculpturing of the brain, neural tissue homeostasis and the removal of 
dispensable cells. Further, PCD plays a prominent role in neuropathology and causes 
delayed and progressive neuronal loss after ischemic brain damage and in chronic 
neurodegenerative diseases (1-3). Programmed cell death in neurons can be triggered 
by different stress stimuli and may involve very distinct death signaling pathways. 
Depending on the nature and the strength of the insult, PCD is characterized by 
different morphological features, recognized as necrosis or apoptosis.  
1.1.1 Necrosis 
A neuron undergoing necrosis dies rapidly as a result of massive calcium (Ca2+) influx, 
dysregulation of intracellular ion homeostasis, impaired protein function and loss of 
Adenosinetriphosphate (ATP). Later stages of necrosis are associated with 
mitochondrial swelling, cell swelling, and finally, rupture of the cell membrane (4). Such 
cellular disruption by necrosis is associated with inflammatory processes and the 
further release of several substances, such as glutamate, prostaglandins, histamines 
and lysosomal enzymes into the extracellular space, followed by substantial cell 
damage in the surrounding tissue (5;6). 
1.1.2 Apoptosis 
Apoptosis is the best described type of PCD, due to the highly conserved and uniform 
nature of apoptotic cell death. Apoptosis occurs during cell development in proliferating 
tissue and regulates adult cell turnover through replacement of senescent, excessive 
and unneeded cells. For example, during development apoptosis is required to avoid 
the accumulation of cellular debris in the extracellular space and subsequent 
inflammatory response. In contrast to the physiological role of apoptosis, its 
dysregulation has been widely observed to occur as either a cause or consequence of 
distinct pathological disorders ranging from cancer, where inhibition of apoptosis 
promotes cellular survival to malignant proliferation to neurodegenerative diseases, 
where apoptotic mechanisms cause progressive neuronal cell death (7;8). The term 
“apoptosis” was first used to describe a particular form of PCD by Kerr et al. in 1972 
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and was morphologically characterized by nuclear condensation (pyknosis) and DNA 
fragmentation, membrane blebbing and subsequent formation of apoptotic bodies (9). 
The resulting apoptotic cell fragments, which are surrounded by an intact plasma 
membrane, can be absorbed by other cells via phagocytosis. In contrast to necrosis, 
apoptosis does not induce inflammatory processes and is an active form of cell death 
depending on energy supply and apoptosis-inducing factors. For a long time, necrosis 
has been regarded as the passive and uncontrolled form of cell death. However, this 
paradigm has to be redefined based on recent findings, were morphological and 
biochemical features of necrosis and apoptosis were identified in the same cell. This 
newly discovered form of cell death was consequently named necroptosis indicating an 
apoptosis-necrosis continuum within a dying cell. Necroptosis involves tightly controlled 
signaling pathways typical for apoptotic cell death and, concomitantly, features of 
necrotic cell death, such as mitochondrial swelling and plasma membrane lysis (10). 
The role of necroptosis in neurological disorders is an emerging subject of ongoing 
research. 
Apoptosis has been studied in great detail in a large variety of different cell types and 
tissues. As mentioned above, the physiological role of apoptosis in all organisms is the 
removal of damaged, senescent or mutated cells, thereby preserving the function and 
maintenance of various tissues without causing inflammatory responses to this ‘silent’ 
form of cell suicide. Especially in the nervous system, apoptotic mechanisms are 
required to remove dispensable or damaged cells, e.g. during development of the brain 
and the peripheral nerve fibers. In contrast to this important physiological role, 
dysregulation of apoptotic mechanism is the major reason for pathological neural 
demise in neurodegenerative diseases, as for example, Alzheimer’s disease (AD) and 
Parkinson’s disease (PD). Further, deregulated apoptotic pathways are also involved in 
delayed neuronal cell death following acute brain damage, e.g. caused by cerebral 
ischemia or traumatic brain injury (3;8;11-16).  
1.1.2.1 Molecular pathways of apoptosis 
On the biochemical level two apoptotic cascades exist: an extrinsic pathway that 
bypasses the mitochondria and an intrinsic pathway where mitochondria play a pivotal 
role (17). 
The extrinsic pathway is activated by the binding of ligands at different death receptors 
like tumor necrosis factor (TNF), FAS (TNF receptor superfamily, member 6, CD95) or 
tumor necrosis factor related apoptosis inducing ligand (TRAIL), which can activate 
initiator caspases-1, -2, -8 or -10. Activation of caspases is a well-established 
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biochemical hallmark of apoptosis (17). Caspases are cysteine proteases with an 
aspartyl-specificity. Under physiologic conditions, they reside in the cytosol as inactive 
precursors that are activated during apoptosis by autoproteolysis, other caspases or 
other proteases. Pro-caspase-1 or -8 have long pro-domains, such as the death 
effector domain (DED) or the caspase recruitment domain (CARD) which can interact 
with activating proteins containing death domains (DD) or other binding domains. In 
contrast to the initiator caspases, the so-called executing caspases (-3, -6, -7) have 
shorter prodomains with up to now unknown functions and cleave downstream 
substrates such as, for example, inhibitor of caspase-activated deoxyribonuclease 
(ICAD) and inhibitors of apoptosis (IAPs), among others (18). 
Caspase-8 has multiple functions. It transforms the proapoptotic B-cell-lymphoma-2 
(Bcl-2) protein Bcl-2 interacting domain death antagonist (Bid) to a truncated Bid (tBid), 
and, further activates effector caspases, such as caspase-3, which then releases 
nucleases like caspase-activated deoxyribonuclease (CAD) from its inactive form 
(ICAD) (19). Caspase-activated CAD translocates from the cytosol into the nucleus 
where it cleaves the nuclear deoxyribonucleic acid (DNA) into characteristic double-
stranded internucleosomal fragments of 180 base pairs (bp) resulting in the typical 
DNA fragmentation. Such CAD-mediated DNA fragmentation is regarded as a major 
hallmark in late stages of the caspase-dependent signaling pathways, when the 
apoptotic death machinery reaches ‘the point of no return’ and ultimately cell death 
(20;21). Furthermore, caspase-8-mediated cleavage of Bid to tBid links the extrinsic 
caspase-dependent cascade to the intrinsic apoptotic pathways.  
The intrinsic death pathway predominates in neurons and is initiated by trophic factor 
withdrawal, moderate overactivation of glutamate receptors, toxic increases in 
intracellular Ca2+ concentrations, oxidative stress (reactive oxygen species-ROS) and 
DNA-damage (3;22;23). Apoptotic trigger mechanisms involve the activation of kinases 
like c-Jun N-terminal kinases (JNKs) and transcription factors like p53 that 
transactivate the proapoptotic Bcl-2-family proteins Bcl-2-associated x protein (Bax) 
and Bcl-2 antagonist killer 1 (Bak) to the mitochondria where they form pores in the 
outer mitochondrial membrane (OMM). The increased permeability of the outer 
mitochondrial membrane is also involved in the formation of the large permeability 
transition pores (PTP) from the mitochondrial intermembrane space to the cytosol, 
which allows the release of cytochrom c (Cytc), apoptosis-inducing factor (AIF), 
Omi/HtrA2 or Smac/DIABLO. In the cytosol, Cytc binds to the apoptosis-protease 
activating factor (Apaf-1) and ATP to form the apoptosome, which then recruits and 
activates caspase-9. Caspase-9 cleaves and activates caspase-3 which, in turn, 
cleaves numerous protein substrates that execute the cell death process, including the 
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CAD as described before (24). The release of Omi/HtrA2 or Smac/DIABLO from the 
mitochondria are alternative mechanisms of caspase activation by blocking x-
chromosomal linked inhibitor of apoptosis (XIAP) and other inhibitors of apoptosis 
(IAPs) which usually inhibit the activation of caspases (12;14;22;23;25;26). 
In addition to the established caspase-dependent signaling pathways, emerging 
evidence suggests, that caspase-independent pathways mediated by AIF and 
Endonuclease G (EndoG) released from mitochondria play a major role in neuronal 
PCD, in particular in the adult brain. Upon mitochondrial release, AIF and EndoG 
rapidly translocates to the nucleus where they mediate DNA damage in a caspase- and 
ATP-independent manner (27). In neurons, acute brain damage after stroke or 
traumatic brain injury leads to excitotoxic cell death which exhibits apoptotic and 
necrotic features and does not require Bax/Bak activation (28). During acute brain 
injury, such as ischemic stroke, oxygen levels are rapidly reduced resulting in abrupt 
decrease of ATP production and rapid depolarization of the plasma membrane. ATP 
depletion causes the release of abnormally high amounts of glutamate into the 
synapses, which is followed by an overactivation of ionotropic glutamate receptors like 
N-methyl-D-aspartate-(NMDA), 2-amin-3-(3-hydroxy-5-methylisoxazol-4-yl) propionate 
(AMPA) or kainate receptors (29). This causes massive Ca2+-influx, activation of 
neuronal nitric monooxide synthases (nNOS), mitochondrial dysfunction and the 
subsequent release of proapoptotic mitochondrial proteins like Cytc, AIF, EndoG and 
Smac/DIABLO (30-33). All of these mechanisms of excitotoxicity exacerbate the 
formation and accumulation of reactive oxygen species (ROS) and ultimately lead to 
cell death in a combine necrotic and apoptotic fashion. 
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Figure 1  Intrinsic and extrinsic apoptotic pathways in mammalian cells 
Activation of intrinsic, mitochondria-dependent death signaling pathway leads to mitochondrial membrane 
permeabilization and subsequent release of AIF, Cytc, Smac/DIABLO, EndoG, Omi/HtrA2, apoptosome 
formation and caspase activation. Extracellular ligand binding to death receptors (Fas, TNF-R, etc.) 
triggers the extrinsic pathway that involves the activation of caspases. The intrinsic pathway is also 
triggered by caspase-8 which cleaves Bid to tBid. Activated tBid translocates to the mitochondria to induce 
mitochondrial damage and amplification of the death signaling. Both apoptotic signaling pathways 
converge at the level of effector caspases, such as caspase-3. Bcl-2 family members regulate apoptosis 
by modulating the release of proapoptotic mitochondrial proteins, such as Cytc. The proapoptotic proteins 
Bax and Bak interact at the outer mitochondrial membrane where they can form oligomeric pores. Bcl-2 
and Bcl-xl are antiapoptotic Bcl-2 family proteins and can block the function of Bax and Bak. Further, the 
BH3-only Bcl-2 family proteins (Bim, Bid, Bad, Puma, Noxa, etc.) modulate the proapoptotic processes of 
Bax/Bak, e.g. by inhibiting the antiapoptotic Bcl-2 members. Enhanced intracellular Ca2+ concentrations 
promote mitochondrial translocation of the mitochondria-shaping protein Drp1. In the cytosol, Cytc, Apaf-1, 
and procaspase-9 interact to form the apoptosome that drives the activation of caspase-3. Upon release 
from mitochondria, AIF and EndoG translocate to the nucleus where they mediate DNA degradation. 
Smac/DIABLO or Omi/HtrA2 scavenge the inhibitors of apoptosis (IAPs) such as XIAP and, consequently, 
their release from mitochondria indirectly enhances activation of caspase-3 and 9. Caspase-3 cleaves 
many substrate proteins, for example endonucleases including caspase-activated DNAse (CAD) from its 
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1.1.3 Oxidative stress as mediator of neuronal apoptosis 
Production of high levels of ROS as key mediators of oxidative stress has been linked 
to a variety of neurological disorders such as Alzheimer`s, Parkinson`s disease or 
stroke (34;35). Under physiological conditions, low levels of ROS are involved in 
signaling processes and functions as mediators in different processes, such as cellular 
growth and adaption responses (36). ROS include a broad range of diverse molecules 
such as oxygen free radicals (superoxide radicals, hydroxyl radicals), peroxides 
(hydrogen peroxides, lipid hydroperoxides), nitric oxide and peroxynitrite anions, which 
mediate oxidative stress (36). ROS induce damages in cellular membrane and can 
alter DNA and unsaturated lipids as well as membrane lipids. Further, at the 
mitochondrial level, ROS may directly or indirectly mediate the formation of 
mitochondrial membrane permeability (MMP) and consequently the release of 
apoptosis-inducing factors and activation of caspases. Therefore, ROS together with 
excitotoxic increases in intracellular Ca2+, are important triggers of the intrinsic pathway 
in neuronal cell death (22;37;38). Excessive ROS formation in neurons can be caused 
by excessive glutamate, beta-amyloid plaques, oxygen glucose deprivation and 
massive NO formation (2;3;24;37). The mechanism of glutamate-induced oxidative 
stress is not fully understood. It has been shown that high levels of glutamate induce 
Ca2+-dependent ROS formation, but recent findings suggested that glutamate can also 
mediate oxidative stress independently of ionotropic glutamate receptors (39;40). 
Therefore, it is of utmost interest to understand the cellular mechanisms of glutamate-
induced oxidative stress, which is involved in neuronal apoptosis.  
To investigate the mechanism of oxidative stress in neurons, immortalized HT-22 cells 
were used as a glutamate-sensitive neuronal cell line. These cells are derived from 
mouse hippocampus and are responsive to glutamate at millimolar (mM) 
concentrations. Since HT-22 cells do not express ionotropic glutamate receptors, 
glutamate-induced death is mediated by glutathione depletion, not by excitotoxicity. 
High extracellular glutamate concentrations block the glutamate-cystine-antiporter 
system Xc-, which normally mediates the cystine-uptake into the cells. Consequently, 
glutamate reduces the intracellular cystine levels that is a limiting factor for the cells’ 
glutathione (GSH) synthesis (41-44). Glutathione serves as a radical scavenger that 
sequesters free radicals and ROS. Consequently, levels of ROS increase within a few 
hours after glutamate treatment of HT-22 neurons due to the breakdown of the 
glutathione pools in the cells. Later, the excessive ROS levels further increase the 
damage of intracellular structures (lipid membranes, proteins and DNA), mitochondria 
and the subsequent breakdown of the cellular ion homeostasis. Furthermore, an 
elevation of cytosolic Ca2+, despite the absence of NMDA receptors, has been 
1 Introduction  7 
 
observed following ROS formation in glutamate-exposed HT-22 neurons (45). 
Enhanced ROS formation, increased Ca2+ and mitochondrial dysfunction are 
established features of apoptosis. All of these features are detectable in this model 
system of glutamate-induced oxidative stress in HT-22 cells. For this reason, this 
model system of glutamate toxicity serves as a valuable and applicable model to 
investigate molecular mechanisms of neuronal apoptosis induced by detrimental 
oxidative stress.  
In the current thesis, the results obtained in these immortalized hippocampal neurons 
were always compared with similar experiments performed in primary neurons that 
express ionotrophic glutamate receptors (AMPA, NMDA receptors). This strategy 
enabled the comparison of the contribution of the newly identified mechanisms of 
mediating oxidative death pathways in HT-22 cells with paradigms of excitotoxicity that 
are triggered in primary neurons by increases in intracellular calcium and enhanced 
ROS production. 
1.2 The role of Bcl-2 family proteins in neuronal cell 
death 
It is well established that neurons undergo apoptosis via the intrinsic pathway, which 
involves damage of mitochondria (46;47). A critical step of mitochondrial damage is 
reached, when mitochondrial outer membrane permeabilization (MOMP) results in the 
release of mitochondrial proapoptotic factors (Cytc, AIF, Smac/DIABLO, Omi/HtrA2, 
EndoG) into the cytosol. Bcl-2 family proteins are essential regulators of MOMP and 
represent a protein family of pro- and antiapoptotic proteins (48). All members of this 
family share a close homology in characteristic regions named Bcl-2-homology (BH) 
domain. Bcl-2 proteins can be classified into three subtypes based on structural and 
functional features. To date, four BH-domains have been identified, termed BH1, BH2, 
BH3 and BH4 (49). Antiapoptotic Bcl-2 proteins consist of Bcl-2, Bcl-2 related long 
isoform (Bcl-xl), Bcl-w and myeloid cell leukemia 1 (Mcl-1) suppresses apoptosis and 
contains all four Bcl-2-homology domains (BH1-4). For instance, Bcl-2 and Bcl-xl can 
prevent the proapoptotic function of Bax by the formation of heterodimer complexes 
(50).  
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Figure 2  Proteins of the Bcl-2 family 
Bcl-2 proteins can be classified into three subtypes based on structural and functional features. To date, 
four Bcl-2-homolgy (BH)-domains have been identified (BH1-4). The Bcl-2 family is divided into 
antiapoptotic effectors which include Bcl-2, Bcl-xl, Mcl-1. Proapoptotic “multi-domain” proteins include Bax 
and Bak and “BH3-only proteins” as direct activators of MOMP with Bid, Bim, Noxa, Puma, Bik (modified 
from Chipuk et al., 2010). 
Some proapoptotic proteins such as Bax and Bak contain BH1-3-domains and are 
termed “multi-domain proteins”, whereas other proapoptotic members of the Bcl-2 
family, like Bcl-2-interacting mediator of cell death (Bim), Bik, Noxa, Puma, Bid and 
Bcl-2 antagonist of cell death (Bad) share only one BH3-domain with the other 
members of the Bcl-2 protein family and are therefore named “BH3-only proteins”. 
These proteins are exclusively proapoptotic and act as sensors for damage by 
oxidative stress or growth factor deprivation. They are activated by a variety of stimuli 
such as transcriptional upregulation, limited proteolysis or dephosphorylation (51;52). 
How Bcl-2 family members interact to permeabilize the mitochondrial membrane 
remains controversial. 
The multi-domain proapoptotic proteins Bax and Bak are thought to promote MOMP by 
oligomerization to form pores within the outer mitochondrial membrane (OMM). One 
route to Bax/Bak activation involves the displacement of the antiapoptotic Bcl-2 
proteins from Bax/Bak due to binding of BH3-only proteins to the antiapoptotic proteins 
Bcl-xl and Bxl-2 (53). Another possible route to Bax/Bak activation is the direct, but 
possibly transient, interaction of BH3-only proteins, like Bid or Bad that provoke a 
conformational change of Bax/Bak followed by their oligomerization (54). Overall, the 
BH3-only-proteins appear to activate Bax and Bak indirectly by engaging, binding and 
neutralization of pro-survival Bcl-2 family proteins (Bxl-xl, Bcl-2).  
Antiapoptotic 
Proapoptotic 
Bcl-2, Bcl-xl, Mcl-1 
Bax, Bak
Bik, Bim
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1.3 Activation of Bid and the regulation of apoptosis 
In healthy cells, most of the antiapoptotic multi-domain Bcl-2 family members are 
constitutively found in the OMM, like Bak. Bax is mostly localized in the cytosol as well 
as BH3-only proteins like Bid, Bad or Bim. During apoptosis, Bax and Bak undergo 
conformational changes, and at least two of the BH3-only proteins, Bid and Bim are 
capable of direct activation of Bax and Bak. The activated form of Bid (tBid) and Bim 
results in a recruitment, insertion and oligomerization of Bax in the OMM (55;56). The 
translocation of truncated Bid (tBid) to the mitochondria, where it interacts with Bax 
(57;58), has been identified as a major pathway in neuronal cell death triggered by 
death receptor signaling and after cerebral ischemia (59;60). A series of events leading 
to Bid-mediated activation of Bax has been elucidated in in vitro studies with isolated 
mitochondria or large unilamellar vesicles (54;61) and by Förster resonance energy 
transfer (FRET) analysis (55;56). The pivotal role of Bid in the activation of the intrinsic 
pathway of apoptosis was confirmed by several studies, where pharmacological 
inhibition of Bid and genetic Bid depletion exerted pronounced protection against 
apoptotic cell death. In particular, Bid knockout mice show less neuronal cell death 
after trauma compared to wild type mice (62), and Bid-deficient neurons were protected 
against oxygen glucose deprivation and cerebral ischemia (60;63).  
In healthy cells, inactive full-length Bid is highly expressed and located in the cytosol 
where it can be cleaved and activated to tBid by caspase-8 cleavage. Caspase-8 is the 
most prominent activator of Bid, which itself gets activated by Fas or TNF death 
receptors. Several studies found enhanced caspase-8 activation after oxygen glucose 
deprivation (OGD) and cerebral ischemia in rodents (60;63). It is important to note that 
Bid can also be cleaved by caspases-1 and -2 as shown, for example, in models of 
cerebral ischemia and hypoxia for caspase-1. In addition to caspases, granzyme B, 
lysosomal hydrolases and calpains are able to cleave Bid (64;65). For example, 
calcium-triggered activation of calpains may cause Bid activation, and subsequent 
mitochondrial damage and release of proapoptotic mitochondrial proteins (66;67). In 
addition to the proposed direct or indirect activation of Bax and Bak, Bid is also capable 
of (directly) mediating mitochondrial damage, independent of these proapoptotic Bcl-2 
proteins, through pore formation by tBid oligomers in the mitochondrial membrane 
(54;55;68;69).  
Interestingly, truncation of Bid to tBid is only one of various mechanisms to activate the 
full apoptotic activity of BH3-only proteins. In epithelial cells, full-length Bid mediates 
apoptosis associated with loss of mitochondrial membrane potential and DNA damage 
without prior cleavage to tBid (70). Taken together, tBid and also activated full-length 
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Bid are key mediators of mitochondrial demise and subsequent cell death pathways. 
Therefore it is necessary to investigate the exact mechanism of Bid activation and its 
role in regulation of mitochondrial mechanisms during neuronal cell death for further 
understanding of key molecular mechanisms in neurodegenerative disorders. 
1.4 Mitochondria in neurons 
Mitochondria are semi-autonomous organelles present in all aerobic organisms that 
contain their own genome and protein synthesis machinery. The most prominent role of 
mitochondria is to supply the cell with metabolic energy in form of ATP (71). 
Furthermore, mitochondria are involved in many catabolic and anabolic reactions of 
different metabolites, e.g. phospholipids, the regulation of ROS metabolism and 
calcium homeostasis (72;73). In addition to their central role in various biochemical 
pathways, mitochondria are key regulators of development, aging and neuronal 
apoptosis (23). The multitude of different functions of mitochondria is reflected in their 
structure. Mitochondria consist of two membranes, the inner and the outer membrane, 
an intermembrane space and a matrix, which contains the mitochondrial DNA encoding 
proteins essential for the organelle’s replication and energy transduction. 
Live cell microscopy studies showed, that mitochondria are highly dynamic organelles, 
which build large interconnected networks or appear as spherical small rounded 
organelles, depending on physiological conditions (74). The dynamic nature of 
mitochondria provides quality control mechanisms to stabilize mitochondrial function, to 
regulate the organelles size and number, and allows mitochondrial DNA (mtDNA) and 
protein exchange between mitochondria (75-78). Further, continuous movement of the 
organelles along the cytoskeleton throughout the length of axons and dendrites of 
neurons involves constant alterations of mitochondrial morphology and size (75;79;80). 
In fact, energy supply for ATP-dependent processes, like vesicle release, 
neurotransmitter synthesis, calcium buffering in synapses and dendritic spines, 
requires the mitochondria to travel over long distances from the cell body to these 
remote areas (74;81;82). Therefore, neurons are particularly sensitive to changes in 
mitochondrial dynamics and movements. Defects in mitochondrial fusion or division 
lead to an extensively interconnected and collapsed mitochondrial network and a 
complete loss of mtDNA (83). Thus, it is not surprising that alterations in mitochondrial 
dynamics significantly impair/affect neuronal function, and the prevalence of neuronal 
disease associated with mutations in mitochondrial fission/fusion genes underlines the 
important functional relationship between mitochondrial dynamics and neuronal 
function (46;84-86). 
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1.4.1 Mitochondrial dysfunction in neuronal apoptosis and 
neurodegeneration 
Mitochondrial dysfunction is an early event in neurological diseases and defects in 
mitochondrial fission and fusion proteins are associated with a wide array of inherited 
or acquired neurodegenerative diseases, such as Charcot-Marie-Tooth 2A disease 
(CMT2A), dominant optic atrophy (DOA), Alzheimer’s disease or Parkinson`s disease 
(35;87;88). For example, mice lacking the dynamin-related proteins (Drps) that 
comprise the heart of the mitochondrial division and fusion machinery, such as 
dynamin-related protein 1 (Drp1), Mitofusin-1 and -2 (Mfn-1,-2), optic atrophy 1 (Opa1), 
exhibit deleterious developmental defects (88-90). Mutation in human Drp1 causes 
early infant mortality, and mutations in Mfn-2 or Opa1 cause two distinct types of 
neurodegenerative diseases CMT2A and DOA, respectively. Furthermore, the 
mitochondrial network becomes extensively fragmented into smaller, more numerous 
organelles in caspase-independent manner during apoptosis triggered by oxidative 
stress (91-93), or after critical changes in energy demands and fluctuations of 
intracellular calcium levels (94). Fission and fusion defects may limit mitochondrial 
motility, decrease energy production, promote oxidative stress, and lead to 
accumulating mtDNA defects, thereby promoting neuronal dysfunction and cell death.  
It is not clear why the mitochondrial network is disrupted during apoptosis, but it has 
been proposed, that this may be due to neutralization of the function of one or more 
members of the Bcl-2 family that may contribute to the mitochondrial morphogenesis in 
healthy cells (93). Indeed, Youle and colleagues found that Bax/Bak-deficient cells 
have constitutive defects in mitochondrial morphology and contain mitochondria that 
are significantly smaller than mitochondria in wildtype cells (26). In addition, Bax and 
Bak colocalize with mitochondrial fusion and fission GTPases. For example, Drp1 
seems to control the outer mitochondrial membrane permeabilization by interaction 
with Bax. In addition, Bak can interact with mitofusins thereby blocking fusion and 
inducing fragmentation. In neurons, toxic concentrations of nitrogen monoxide (NO) 
display Bax foci on mitochondria undergoing fission. In contrast, inhibition of Drp1 
delays this fission, Bax foci formation and loss of neurons (95;96), which suggests a 
functional link between the progression of apoptosis and Drp1-mediated mitochondrial 
fission. Interestingly, mitochondrial fusion also plays a role in the regulation of 
apoptosis. Loss of Mfn-1 and Mfn-2 has profound effects on mitochondrial structure 
and function, leading to mitochondrial fragmentation and swelling, loss of mtDNA, 
cristae disorganization, and enhanced sensitivity to apoptotic stimuli (97).  
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It has also been suggested that mitochondrial fusion and fission occurs as a 
consequence of apoptosis in association with permeabilization of mitochondrial outer 
membrane and subsequent loss of intermembrane space proteins like Opa1, AIF, and 
Smac/DIABLO (98;99). Some investigators reported that mitochondrial fission 
promoted Cytc release and therefore steered caspase activation during apoptosis 
(85;86). In contrast, however, other findings showed that Bax/Bak-induced 
mitochondrial fission can be uncoupled from Cytc release. Overall, the large majority of 
data suggests, that cell death-associated fragmentation of mitochondria is a 
consequence rather than a cause of apoptosis signaling and reflects potential of yet 
unknown interactions or connections between members of Bcl-2 family and the 
machinery regulating mitochondrial morphology (26;85;93;100).  
Irrespective of the functional role, apoptosis-induced mitochondrial fragmentation is 
widely accepted as an established feature of apoptosis in essentially all cell types and 
in response to most, if not all, apoptotic stimuli (51;85;100). Not only mitochondrial 
networks undergo fragmentation during apoptosis, but these fragmented mitochondria 
also become clustered around the nucleus and the dynamic mitochondrial movement 
appears to cease (92;93). It is not clear exactly how these phenomena are regulated, 
but in apoptotic cells mitochondria likely become uncoupled from their normal 
attachment points on the cytoskeleton, an observation that awaits further investigation. 
Given the importance of mitochondrial dynamics for cellular function, regulation and 
cell death, it is not surprising that aberrant mitochondrial dynamics have been 
associated with prevalent human diseases, including AD, PD, Huntington`s disease, 
amyotrophic lateral sclerosis (ALS) and diabetes. In these cases, fragmentation of the 
mitochondrial network has been observed in patient samples and experimental disease 
models, suggesting a shift in division/fusion balance towards division. The cause of this 
shift is unclear and could be the result of direct activation of mitochondrial division, 
inhibition of mitochondrial fusion or both. In the cases of mitochondrial-fusion linked 
diseases, namely Charcot Marie Tooth 2A or dominant optic atrophy, it is clear, that the 
disease-associated alterations of mitochondrial morphologies are at least in part due to 
a direct shift towards division as a result of attenuated fusion. The link between 
increased mitochondrial division and disease states or apoptosis signaling proposes 
the mitochondrial fission machinery as an attractive target for therapeutics in the 
treatment of an impressive array of diseases from neurodegenerative disorders to more 
acute conditions such as cerebral stroke or myocardial infarction. 
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1.4.2 Regulation of mitochondrial fission and fusion  
The current knowledge of the mechanisms regulating mitochondrial dynamics indicates 
that fission and fusion of mitochondria are under control of highly conserved dynamin-
related GTPases (76). Specifically, in mammalian cells mitochondrial outer and inner 
membrane fusion is mediated by mitofusin-1 and -2 (Mfn-1, -2) and optical atrophy 1 
(Opa1), respectively (97;101).  
Mfn-1 and -2 are localized to mitochondrial outer membranes where they interact with 
each other to promote tethering and fusion of neighboring mitochondria (102). Opa1 is 
localized in the mitochondrial intermembrane space and during fusion, Opa1 
cooperates with mitofusins to reorganize the inner membrane cristae (89;98).  
Mitochondrial fission is mainly mediated by Drp1 and Fis-1 (103-106). Mitochondrial 
fission is a multistep process initiated by the enhanced recruitment of Drp1 protein from 
the cytoplasm to the mitochondrial surface, followed by protein oligomerization around 
the organelle in a punctuated distribution pattern, which become fission sites (107;108).  
 
 
Figure 3  Molecular regulation of mitochondrial dynamics  
Proteins involved in mitochondrial fusion (left panel) and fission (right panel) mechanism. Left panel: 
Mitochondrial outer membrane located Mfn-1 and Mfn-2 in association with Opa1 promote mitochondrial 
fusion of the outer and inner mitochondrial membrane to produce longer mitochondria. Right panel: 
Dynamin-related protein 1 (Drp1) is found in the cytoplasm and forms oligomers and translocates after 
diverse apoptotic stimuli to the mitochondrial outer membrane. The Drp1 oligomers interact with outer 
mitochondrial membrane bound Fis-1 and encircles on specific fission sites on mitochondria to separate 
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Drp1 is mainly distributed in a diffuse manner throughout the cytosol in cultured cells, 
which suggests that it is predominantly unassembled (104). In response to a certain 
apoptotic stimuli, such as increase in Ca2+ levels or initiation of apoptosis, 
mitochondrial targeting and assembly of Drp1 is greatly enhanced and consequently 
fission increased. While the mechanism underlying regulation of Drp1 assembly are 
unclear, it is still evident that regulation of assembly can be used as a means to 
regulate mitochondrial function (85;109).  
In addition, mitochondrial fission is dependent on non-dynamin-related protein factors 
like Fis-1, Endophilin B1, mitochondrial fission factor (Mff), ganglioside-induced 
differentiation associated protein 1 (GDAP) or other outer mitochondrial membrane 
proteins. Fis-1 is distributed evenly at the outer mitochondrial membrane where it may 
act as a mitochondrial Drp1 receptor (103;105). It has been suggested that the 
mitochondrial outer membrane proteins Fis-1 and Mff and the proapoptotic Bcl-2 family 
protein Bax and Bcl-xl (100;110) function as positive regulators of Drp1 to promote 
mitochondrial fission, however, the mechanisms that promote and regulate the 
recruitment of cytosolic Drp1 to mitochondria are largely unknown 
(46;103;105;111;112). In addition to these potential protein regulators of mitochondrial 
division, the function of Drp1 is also influenced by post-translational modifications. 
Phosphorylation, S-nitrosylation, ubiquitination and sumolyation have all been identified 
to regulate Drp1 function (113-124). It is likely known that a distinct combination of 
post-translational modifications and protein effectors regulate the activity of Drp1 in 
different physiological and pathological contexts. 
While the mitochondrial division machinery is influenced by many factors, Drp1 is the 
most obvious target of small molecule modulators as it is the highly conserved, core 
mechanical component of the division protein complex. In addition, Drp1 is a promising 
target for small molecule effectors, in the sense that there are many critical functional 
features of the protein, such as GTP binding, GTP hydrolysis and self-assembly which 
is mediated by conformational changes linked to the GTPase cycle. Therefore, small 
molecule effectors that target the different functional facets of Drp1 and thus either 
positively or negatively affect distinct stages of Drp1-driven mitochondrial division can 
be identified. Finally, given the increasing number of Drp1 interacting proteins that have 
been implicated in division, it may be possible to identify tissue specific or context-
specific inhibitors of mitochondrial division by targeting Drp1 effector interactions. 
These strategies may protect neurons from enhanced mitochondrial fission and from 
irreversible damage and cell death. 
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1.4.2.1 The first inhibitor of mitochondrial Drp1 
The laboratory of Jodi Nunnari, UC Davis, USA identified dynamin-related protein 
(Dnm1, yeast; Drp1, human) as the first small molecule effector of the mitochondrial 
division protein Drp1 in a growth-based assay in yeast (125). Afterwards, Dnm1 was 
also demonstrated to target Drp1 in mammalian cells. This derivative of quinazolinone, 
called mitochondrial division inhibitor 1 (mdivi-1) act as a mixed type inhibitor to 
attenuate the dynamin-related protein (Drp) assembly in the early stages of division by 
preventing the polymerization of higher order structures. Mdivi-1 selectively targets the 
unassembled pool of the mitochondrial division dynamin-related protein, and its binding 
creates and stabilizes an assembly-deficient conformation (Figure 4). Assembly of the 
division dynamin-related protein is critical for its function. Thus, mdivi-1 acts as an 




Figure 4 Modulation of Drp1-mediated mitochondrial division and potentiation of apoptosis by 
negative and positive effectors 
Negative effectors, like mdivi-1, may block Drp1 assembly or Drp1 function and thus attenuate 
mitochondrial division and/or mitochondrial outer membrane permeabilization (MOMP). Positive effectors, 
like phosphorylation, protein interactions with Bax or Fis-1 may stimulate Drp1 assembly and/or function, 
and depending on the distinct set of effectors, which is defined by biological circumstances, mitochondrial 
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Given the conservation of the Drp super family members; it is remarkable that mdivi-1 
also displays a high degree of selectivity for the mitochondrial division dynamins, as it 
has no effect on other Drps, such as the endocytic dynamin or the mitochondrial fusion 
dynamins. This selectivity is encouraging for the division dynamin protein as a 
therapeutic target in different models of neurological diseases (109). This promising 
result makes this compound interesting to investigate the role of Drp1 in more detail. In 
particular, these substances make Drp1 as prime target to prevent mitochondrial 
fragmentation in different models of neurodegenerative diseases and acute brain 
damage by cerebral ischemia. In the present study, different isoforms of mdivi-1 
compound were applied for the first time in neurons to elucidate the role of Drp1-
induced mitochondrial fragmentation in neuronal cell death.  
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1.5 Aims of the thesis 
The relevance of enhanced mitochondrial fragmentation in neuronal cell death 
emerged in the last couple of years, but until now very little is known about the 
regulatory mechanisms, the key mediators upstream and the processing which leads to 
mitochondrial fragmentation in neuronal cell death. 
In particular, it has been established that proapoptotic Bcl-2 protein family members 
such as Bax, Bak and Bid mediate mitochondrial dysfunction and associated death 
signaling pathways in neurons, and a number of recent findings suggested that such 
intrinsic death pathways are associated with extensive mitochondrial fragmentation. 
Therefore, the present thesis investigated the mitochondrial morphology dynamics and 
their regulation in a model of glutamate toxicity in immortalized HT-22 neurons. 
Furthermore, a major aim of this study was to elucidate whether BH3-only protein Bid 
was involved in the regulation of mitochondrial dynamics and associated in 
mitochondrial cell death pathways after glutamate-mediated oxidative stress. In this 
thesis, the established Bid inhibitor BI-6c9 was applied to elucidate the particular role of 
this BH3-only protein in mitochondrial fission in the model of glutamate-induced cell 
death. 
Previous investigations on mechanisms of mitochondrial dynamics highlighted the 
pivotal role of Drp1. The observation that enhanced mitochondrial fission is linked to 
neurodegeneration and apoptotic pathways revealed the possibility that Drp1 is a 
therapeutic target for the prevention of neuronal cell death. For this reason, the present 
thesis emolyed siRNA approaches and novel small molecule inhibitors of Drp1 (125) to 
address whether Drp1 plays a major role in neuronal cell death after glutamate toxicity 
and oxygen-glucose deprivation (OGD) in cultured neurons. In addition, potential 
protein interactions between Drp1 and other regulators of apoptosis and mitochondrial 
damage were addressed, as well as the potential role of Drp1 in other models of 
oxidative stress. Finally, to further substantiate the therapeutic potential of Drp1 
inhibition based on findings in models of neuronal cell death in vitro, the applications of 
the Drp1 inhbitior were expanded to a model of ischemic brain damage in vivo. 
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2 Material and methods 
2.1 Chemicals and reagents 
All standard chemicals were obtained from Sigma-Aldrich (Taufkirchen, Germany) and 
Roth (Karlsruhe, Germany), if not described otherwise. All buffers and solution were 
prepared using demineralized, ultrapure water that was prepared with the SG Ultra 
Clear UV plus pure water system (VWR, Darmstadt, Germany). For media and 
solutions that were used in the cell culture the ultrapure, demineralized water was 
sterilized using a steam autoclave (Systec V-40, Systec GmbH, Wettenberg, 
Germany). All media and solutions that were used in cell culture were sterilized by 
filtration using 0.22 µm filter sets (Sarstedt, Nümbrecht, Germany). 
2.2 Cell culture materials 
Sterile plastic ware was used as follows 
Table 1 Sterile plastic ware 
Plastic ware Ordering number Company 
T75 flasks 658 175 Greiner, Frickenhausen, Germany 
T175 flasks 660 175 Greiner, Frickenhausen, Germany 
6-well plates 657 160 Greiner, Frickenhausen, Germany 
24-well plates 662 160 Greiner, Frickenhausen, Germany 
96-well plates 655 180 Greiner, Frickenhausen, Germany 
12-well plates 655 180 Greiner, Frickenhausen, Germany 
48-well plates 655 180 Greiner, Frickenhausen, Germany 
IbiTreat 8-well 80826 Ibidi, Munich, Germany 
15 ml-tubes 188 271 Greiner, Frickenhausen, Germany 
50 ml-tubes 227 261 Greiner, Frickenhausen, Germany 
Sterile filter 0.22 µm 291-3320 Nalgene, Thermo Fisher Scientific, 
Roskilde, Denmark 
0.5-, 1.5-, 2-ml tubes 72.704, 72.706, 
72.695 
Sarstedt, Nümbrecht, Germany 
Cell scraper 83.1830 Sarstedt, Nümbrecht, Germany 
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The E-plates and the xCELLigence System for the impedance measurements were 
obtained from Roche, Applied Science (Penzberg, Germany). 
2.3 Inducers and inhibitors of apoptosis 
2.3.1 Inducers of apoptosis 
Glutamate stock solution was prepared by solving DL-glutamic acid monohydrate 
(Sigma-Aldrich, Taufkirchen, Germany) to a stock concentration of 100 mM in Earl’s 
balanced salt solution (1x EBSS) or Dulbeccos’s modified eagle medium (DMEM; PAA 
Laboratories GmbH; Cölbe, Germany). The pH was adjusted to 7.2 with concentrated 
sodium hydroxide solution (NaOH). The stock solution was stored at -20 °C and diluted 
with DMEM or 1x EBSS to final concentrations ranging from 1 mM to 5 mM in DMEM 
for HT-22 neurons and at a final concentration of 20 - 30 μM in 1x EBSS for primary rat 
neurons.  
For treatment with hydrogen peroxide (H2O2, Sigma-Aldrich, Taufkirchen Germany), 
H2O2 (stock with a concentration of 30 %) was diluted with DMEM to concentrations of 
500 - 700 µM. The solutions were always freshly prepared. 
Sodium nitropusside (SNP, Sigma-Aldrich, Taufkirchen, Germany) was dissolved in 
DMEM immediately before treatment of the cells and diluted to concentrations of 
20 - 600 µM. 
Glucose oxidase (GO, Sigma-Aldrich, Taufkirchen, Germany) has been used to 
achieve a continuous production of H2O2. Before treatment, glucose oxidase was 
dissolved in sodium acetate solution (50 mM, pH 5.1, Merck, Darmstadt, Germany) and 
diluted to concentrations of 1 - 20 mM. 
4-Hydroxynonenal-dimethylacetat (4-HNE, Sigma-Aldrich, Taufkirchen Germany) was 
dissolved in 1 mM cold HCl according to the manufacture`s protocol and diluted to 
concentrations of 5 - 30 µM with DMEM. 
DEA/NO,2-(N,N-Diethylamino)-diazenolate-2-oxide-diaethylammonium salt (DEANO-
NOate, Enzo Life Science, Lörrach, Germany) was dissolved in 96 % Ethanol to a 
concentration of 100 mM and stored at -20 °C for at most 1 week. This stock solution 
was diluted to concentrations of 500 µM - 2 mM in DMEM immediately before the 
treatment. 
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2.3.2 Inhibitors of apoptosis 
Derivates of mitochondrial division inhibitor 1 (mdivi-1) named A, B, C, E and G (kindly 
provided by Jodi Nunnari, UC Davis, California, USA and from Enzo Life Science, 
Lörrach, Germany) were dissolved in DMSO at stock concentrations of 10 mM 
(Figure 5). Mdivi-1 compounds were applied to the cell culture medium at final 
concentrations of 50 - 75 µM in HT-22 neurons and 25 µM in primary neurons, 
respectively. In order to analyze the toxicity of the solvents of the different chemical 
substances and inhibitors, the vehicle controls were always treated with medium 
containing the highest concentration of the solvent that was present at the highest 







Figure 5  The chemical structure of mdivi-1 representitive compounds A, B, C, E and G 
Mdivi-1 is a derivative of quinazolinone. Compounds A and B have the highest efficacy, compounds C and 
E a moderate and mdiviG no efficacy to block mitochondrial dynamin-related protein GTPase activity. The 
structural differences between each molecule and mdiviA are highlighted in red (adopted from Cassidy-
Stone et al., 2008 (125)).   
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Bid inhibitor BI-6c9 (Sigma-Aldrich, Taufkirchen, Germany) was dissolved in dimethyl 
sulfoxide (DMSO) to a stock concentration of 10 mM (Figure 6). It was used at a final 
concentration of 10 μM in DMEM and 1x EBSS for applications in HT-22 neurons and 
primary rat neurons, respectively. 
 
 
Figure 6  The chemical structure of the Bid inhibitor BI-6c9 
 
2.3.3 Transfection reagents 
Lipofectamine 2000 and Opti-MEM I (both obtained from Invitrogen, Karlsruhe, 
Germany) was used to form DNA- or siRNA transfection complexes. Lipofectamine 
2000 (Invitrogen, Karlsruhe, Germany) was used at a final concentration of 1.5 μl/ml in 
antibiotic-free DMEM medium to complex DNA plasmids or siRNA. 
2.3.3.1 Plasmid vectors 
The mitoGFP (mGFP) vector was a kind gift from Andreas Reichert (Goethe University 
Frankfurt, Frankfurt, Germany). The tBid vector was generated as described previously 
(126). The plasmid pcDNA 3.1+ control vector was obtained from Invitrogen (Karlsruhe, 
Germany). All the plasmids were amplified using a QIAGEN Plasmid Plus Midi 
(Qiagen, Hilden, Germany) according to the manufacturer’s protocol. Prior to use, the 
plasmid DNA-concentrations were determined in a NanoVue Plus Spectrophotometer 
(Implem, GE Healthcare Europe GmbH, Freiburg, Germany), and digestion by 
restriction enzymes with subsequent gel electrophoresis analysis was performed.  
2.3.3.2 SiRNA 
Drp1 siRNA (On-target Plus siRNA Pool) and nonfunctional mutant siRNA (scrambled 
siRNA, 5’-AAG AGA AAA AGC GAA GAG CCA-3’) were purchased from Dharmacon 
(Thermo Scientific, Bonn, Germany). For RT-PCR, Drp1 primers were purchased from 
Eurofins MWG Operon (Ebersberg, Germany). (See also 2.10.3). 
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2.3.4 Primary antibodies 
All primary antibodies were diluted in Tris-buffered saline with Tween 20 (TBST). The 
dilution of the Drp1-antibody (BD Bioscience Laboratories, Heidelberg, Germany) was 
1:500, of AIF-antibody (Santa Cruz, Santa Cruz, California, USA) 1:500, α-tubulin-
antibody (Sigma-Aldrich, Taufkirchen, Germany) was diluted 1:20,000, Tyrosine-
nitrosylation, Bid, Bcl-xl, Bax, Bak-antibodies (Cell Signaling, Danvers, Massachusetts, 
USA and New England Biolabs GmbH, Frankfurt, Germany) were diluted 1:1,000. 
Fis-1-antibody (Enzo Life Science, Lörrach, Germany) was used at a dilution of 
1:1,000, and anti-actin antibodies (Cell Signaling, Danvers, Massachusetts, USA, and 
New England Biolabs GmbH, Frankfurt, Germany) were used at dilution of 1:10,000. 
2.3.5 Secondary antibodies 
All secondary antibodies were purchased from Vector Labs (Burlingame, California, 
USA). Horse radish peroxidase (HRP) labeled anti-mouse IgG (H+L), anti-goat IgG 
(H+L) and anti-rabbit IgG (H+L) secondary antibodies were used for western blot at 
dilutions of 1:2,000 - 1:5,000 in TBST. Biotinylated anti-goat, anti-mouse and anti-rabbit 
IgG (H+L) antibodies were used for immunocytochemistry in a 1:200 dilution in 
phosphate buffered saline (1x PBS) containing 3 % horse serum (Invitrogen, Karlsruhe, 
Germany). 
2.3.6 Kits 
Following kits were used in this work and applied following the manufacturer’s 
instructions: 
Table 2 Kits 
Kit Company  
Annexin-V-FITC Detection Kit Promokine Heidelberg, Germany 
Bodipy (581/591 C11) Invitrogen Karlsruhe, Germany 
JC-1 Invitrogen Karlsruhe, Germany 
Lipofectamine 2000 Invitrogen Karlsruhe, Germany 
NucleoSpin RNA II Kit Machery & Nagel Düren, Germany 
Pierce BCA Kit Perbio Science Bonn, Germany 
QIAGEN Plasmid Plus Midi  Qiagen Hilden, Germany 
ViaLight® HS Kit ATP-detection Lonza Köln, Germany 
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2.4 Cell culture methods 
2.4.1 Cell culture and induction of neuronal cell death 
2.4.1.1 Cell culture media of HT-22 neurons  
Dulbecco’s modified eagle medium with 4.5 g/l glucose and sodium pyruvate (DMEM) 
for culturing HT-22 neurons was prepared as described in Table 3. All reagents were 
obtained from PAA (Cölbe, Germany). 
Table 3 Dulbecco’s modified eagle medium (DMEM)-Medium 
DMEM + 4.5 g/l glucose + sodium pyruvate 500 ml 
10 % FCS Gold 50  ml 
L-alanyl-L-glutamine 200 mM 5  ml 
Penicillin/Streptomycin 100x 5  ml 
 
Table 4 1x Trypsin/EDTA (1x TE) 
0.05 % Trypsin 100 mg 
0.02 % EDTA 40  mg 
1x PBS ad 200  ml 
 
All reagents for 1x TE were obtained from Sigma Aldrich (Taufkirchen, Germany).  
Glutamate (1 - 5 mM) was added to the serum containing medium and cell viability was 
evaluated 12 - 18 h later.  
2.4.1.2 Induction of neuronal cell death in HT-22 neurons 
HT-22 neurons were obtained from Gerald Thiel with kind permission of David 
Schubert (Salk Institute, San Diego, California, USA). The HT-22 line was originally 
selected from HT-4 cells based on glutamate sensitivity. HT-4 cells were immortalized 
from primary hippocampal neurons using a temperature-sensitive SV-40 T antigen 
(127). They were cultured in T75 flasks and split 1:10 - 1:20 every 3 - 4 days. This was 
performed as follows: growth medium was replaced by 2 ml 1x PBS containing 0.05 % 
trypsin and 0.02 % ethylenediaminetetraacetic acid disodium salt (EDTA) (1x TE, 
Invitrogen, Karlsruhe, Germany). Afterwards, cells were incubated 2 - 5 min. at 37 °C. 
After detaching of the cells, trypsin was inhibited by adding serum containing growth 
medium. The cells were centrifuged at 1,000 x g; the cell pellet was resuspended in 
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fresh growth medium. Then cells were seeded in 6-well plates with a density of 
2.5 x 105 cells per well, in 24-well plates with a density of 6 - 8 x 104 cells per well or in 
96-well plates with a density of 7 - 8 x 103 cells per well for further treatment. Induction 
of apoptosis was performed 24 h after seeding of the cells. Growth medium was 
removed and replaced by medium containing inhibitors and inducers of apoptosis. 
Between 3 h and 18 h later, cells were analyzed following standard procedures for flow 
cytometry, epifluorescence microscopy, protein or RNA analysis. To harvest cells for 
flow cytometry, epifluorescence microscopy or protein analysis, 100 μl of 1x TE was 
used per well for a 24-well plates. For analysis by epifluorescence microscopy after 
respective treatments, the cells were fixed with 4 % paraformaldehyde (PFA) and 
stained with the fluorescent DNA-binding dye 4’,6-diamidino-2-phenylindole 
dihydrochloride (DAPI, Sigma-Aldrich, Taufkirchen, Germany).  
2.4.1.3 Cell culture medium of primary embryonic cortical neurons of rat 
For culturing of primary embryonic rat cortical neurons, cell culture dishes were coated 
one day before preparation with 5 % polyethylenimine (PEI). Coating was performed by 
incubation with 5 % PEI for 2 h at room temperature. The dishes were washed twice 
with bidest water and dried under UV-light. Cell dishes were filled up with MEM+ and 
incubated overnight in the cell incubator with 37 °C and 5 % CO2. 
Table 5 5 % PEI 
Boric acid 3.1 mg 
Borax 4.75 mg 
PEI 1 ml 
Bidest H2O ad 1000  ml 
 
Primary rat embryonic cortical neurons were cultured in neurobasal medium with 2 % 
(v/v) B-27 supplement. All mediums were obtained from Invitrogen (Karlsruhe, 
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Table 6 Neurobasal medium (NB) 
Neurobasal 500 ml 
HEPES  
4-(2-hydroxyethyl)-piperazine-1-
ethanesulfonic acid  
0.573 g 
L-glutamine 0.088 g 
Gentamycin sulfate (10 mg/ml) 0.5 ml 
2 % (v/v) B-27 50x  10 ml 
 
Additional following mediums were used: 
Table 7 Eagle’s minimum essential medium (MEM) 
MEM - Phenolrot 4.695 mg 
1 mM HEPES- 4.75 mg 
26 mM NaHCO3 1.1 g 
40 mM Glucose 5 g 
20 mM KCl 0.605 g 
1 mM Na-pyruvate 0.6  g 
1.2 mM L-glutamine 0.088 g 
10 % (v/v) FCS 1000  ml 
10 % (v/v) gentamycin sulfate 0.5 ml 
Bidest H2O  450  ml 
 
Table 8 Hank’s balanced salt solution (1x HBSS) pH 7.2 
10x HBSS 50 Ml 
HEPES 0.573 g 
Gentamycin sulfate (10 mg/ml) 0.5 ml 
2 % (v/v) B-27 50x 10 ml 
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Table 9 1x EBSS pH 7.2, obtained as 10x solution from Invitrogen (Karlsruhe, Germany) 
NaCl 6.8 g 
KCl 0.4 g 
CaCl2 x 2xH2O 0.264 g 
Cl2 x 7 H2O 0.2 g 
NaHCO3 2.2 g 
NaH2PO4 x H2O 0.14 g 
Glucose 1 g 
Bidest H2O ad 1000  ml 
 
In 6 to 10 day-old primary neurons, the culture medium was replaced with Earl’s 
balanced salt solution (1x EBSS) medium immediately before glutamate treatment 
(20 - 30 µM, 18 - 24 h). At 6 - 8 days in vitro (DIV), these neurons express NMDA 
receptors and are therefore susceptible to glutamate-induced excitotoxicity. For oxygen 
glucose deprivation (OGD), glucose-free 1x EBSS medium supplemented with 
gentamycin (5 mg/l) was prepared.  
2.4.1.4 Induction of neuronal cell death in primary rat neurons 
Embryonic hippocampal or cortical cultures: brains were removed from embryonic day 
17 Sprague-Dawley rats (Charles River Laboratories, Sulzfeld, Germany) and 
hippocampi and cortices separated and each dissociated by mild trypsinization and 
trituration as follows. Isolated hippocampi and cortices were separately incubated for 
15 min. in a solution of 1 mg/ml trypsin (Sigma, Taufkirchen, Germany) in 
Ca2+- and Mg2+-free 1x HBSS (made from 10x HBSS, Invitrogen, Karlsruhe, Germany) 
at 37 °C. The separated hippocampi and cortices were then rinsed with fresh 1x HBSS, 
exposed for 2 min. with 1 mg/ml trypsin inhibitor (Sigma, Taufkirchen, Germany), and 
then washed twice with 1x HBSS. Cells were mechanically dissociated by trituration 
using a 10 ml standard glass pipette (VWR International GmbH, Darmstadt, Germany). 
The triturated cells were centrifuged at 1,000 x g for 5 min. at room temperature. The 
supernatant was removed and the cells were again triturated in MEM+ before counting 
in a cell counting chamber (Neubauer Zählkammer). The cells were then seeded onto 
96-well-plates with 8 or 16 x 104/cm2 cells, 35 mm polyethylenimine (PEI)-coated 
culture dishes (for survival analysis) with or without containing glass coverslips (for 
immunocytochemistry) with 4 or 5 x 104/cm2 cells or 60 mm culture dishes (for 
immunoblot analysis) with 8 x 104/cm2 cells containing 1 ml or 2 ml MEM+, 
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respectively. After 4 h of incubation, the MEM+ was replaced with NB+-Medium and 
after five days in culture the medium was exchanged. Since cultures of primary 
neurons develop functional glutamate receptors after 6 - 8 days in culture, experimental 
treatments were performed with 8 - 10-day old cultures in 1x EBSS. Apoptosis was 
induced by glutamate (20 - 30 μM) in 1x EBSS and quantified 18 - 24 h later. Cells 
were treated with mdiviA or mdiviB 25 µM in 1x EBSS. After 18 to 24 hours the neurons 
were fixed with 4 % PFA and stained with the fluorescent DNA-binding dye DAPI 
(Sigma-Aldrich, Taufkirchen, Germany). Living and pyknotic cells were counted using a 
fluorescence microscope (DMI6000B, Leica, Wetzlar, Germany) without knowledge of 
the treatment history. For the quantification of apoptotic cells, five hundred cells from 
five areas per cell culture dish were counted in total and experiments were performed 
at least three times with n=5 per treatment condition. 
2.4.1.5 Oxygen glucose deprivation (OGD) 
Oxygen glucose deprivation (OGD) in neuronal cultures is an in vitro model for cerebral 
ischemia that is based on the application of medium without glucose and the 
deprivation of oxygen by exposure to a mixture of 5 % carbon dioxide (CO2) and 95 % 
nitrogen (N2) in an air-tight chamber. The air-tight chamber is located in an incubator to 
obtain a temperature of 37 °C and linked to a gas bottle containing the mixture of 5 % 
carbon dioxide and 95 % N2. The oxygen concentration is controlled by an oxygen 
sensor (Oxy 3690 MP, Greisinger electronic, Regenstauf, Germany) that also regulates 
the influx of the mixture. To prevent the desiccation of the dishes, a cup filled with 
ultrapure water was placed in the air-tight chamber. All dishes were opened when they 
were placed in the chamber to ensure rapid oxygen deprivation in the samples. 
Validation of the chamber and the protocol was performed by using the NMDA receptor 
antagonist MK-801, because it has been shown that NMDA glutamate receptor 
inhibition by MK-801 significantly reduced OGD-induced neuronal cell death (128). 
Primary cortical or hippocampal neurons were seeded onto 35-mm culture dishes with 
5 x 104/cm2 cells. At day 8 or 9 in culture the dishes were separated into two groups, 
one for the OGD chamber and one control group. First, all dishes were washed twice 
with 1x EBSS without glucose. For OGD the cells were treated with mdiviA or mdiviB 
25 µM in 1x EBSS without glucose and transferred to the chamber containing 5 % 
carbon dioxide (CO2) and 95 % N2 for 4 h. The analogue treatment in 1x EBSS 
containing glucose or neurobasal was applied to the control cells in the regular oxygen-
containing incubator. After four hours of OGD, the 1x EBSS +/- glucose was replaced 
by NB+-medium containing glucose to all dishes and the cells were incubated for 
another 18 - 24 hours. For counting analysis of cell death, cells were fixed with 4 % 
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PFA and stained with the fluorescent DNA-binding dye DAPI (Sigma-Aldrich, 
Taufkirchen, Germany). Living and pyknotic cells were counted using a fluorescence 
microscope (DMI6000B, Leica, Wetzlar, Germany) without knowledge of the treatment 
history. For the quantification of apoptotic cells, five hundred cells from five areas per 
cell culture dish were counted in total and experiments were performed at least three 
times with n=5 per treatment condition. 
2.4.2 Transfection protocols 
HT-22 neurons were transfected in 24-well plates 24 hours after seeding at a density of 
6 - 7 x 104 cells per well. Antibiotic containing growth medium was replaced by 900 μl 
antibiotic free DMEM per well.  
2.4.2.1 DNA-transfection 
Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany) and the respective DNA plasmids 
were dissolved separately in Opti-MEM I (Invitrogen, Karlsruhe, Germany). After 
10 min. of equilibration at room temperature each DNA solution was combined with the 
respective volume of the Lipofectamine 2000 solution, mixed gently, and allowed to 
form plasmid liposomes for further 20 min. at room temperature. The transfection 
mixture was added to the antibiotic-free cell culture medium to a final concentration of 
1 μg DNA and 1.5 μl/ml Lipofectamine 2000 in HT-22 neurons. Controls were treated 
with 100 μl/ml Opti-MEM I only, and vehicle controls with 1.5 μl/ml Lipofectamine 2000. 
Cells were transfected for at least 24 h before further treatment. 
2.4.2.2 SiRNA-transfection 
For siRNA transfections, Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany) and 
Drp1 siRNA or non-functional scrambled siRNA were dissolved separately in Opti-MEM 
I (Invitrogen, Karlsruhe, Germany). After 10 min. of equilibration at RT, each siRNA 
solution was combined with the respective volume of the Lipofectamine 2000 solution, 
mixed gently, and allowed to form siRNA liposome complexes for further 20 min. at 
room temperature. The transfection mixture was added to the antibiotic-free cell culture 
medium to a final concentration 60 - 80 nM siRNA and 1.5 μl/ml or 2 μl/ml 
Lipofectamine 2000 in HT-22 cells. Controls were treated with 100 μl/ml Opti-MEM I 
only, and vehicle controls with 1.5-2 μl/ml Lipofectamine 2000. 
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2.4.3 Morphological cell viability analysis 
For morphological analysis of cell viability, transmission light microscopy of living 
HT-22 neurons or primary neuronal cultures growing as monolayers was performed 
using an Axiovert 200 microscope (Carl Zeiss, Jena, Germany) equipped with a 
Lumenera Infinity 2 digital camera (Lumenera Corporation, Ottawa, Canada). Light was 
collected through a 10 x 0.25 NA objective (Carl Zeiss, Jena, Germany), and images 
were captured using phase contrast. Digital image recording and image analysis were 
performed with the INFINITY ANALYZE software (Lumenera Corporation, Ottawa, 
Canada). Light was collected through 5 x 0.12 NA. 10 x 0.25 NA or 32 x 0.40 NA 
objective (Carl Zeiss, Jena, Germany), and images were captured using phase 
contrast. 
2.5 Cell viability assays 
For cell viability assays, HT-22 neurons were grown in 96-well plates. Primary rat 
hippocampal neurons were grown in 35 mM dish. For the Annexin-V and JC-1 assay, 
HT-22 neurons were cultured in 24-well plates. MitoTracker DeepRed staining was 
performed in cells cultured on Collagen A-coated Ibitreat μ-slide 8-well plates (Ibidi 
GmbH, Munich, Germany) immediately before confocal microscopic analysis. 
2.5.1 MTT-assay 
Metabolic activity of HT-22 neurons was determined by using a 3-(4,5- Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay in 96-well plates: To each 
well 10 μl of a 5 mg/ml MTT solution (Sigma-Aldrich, Taufkirchen, Germany) in sterile 
1x PBS buffer were added (final concentration/well: 0.5 µg/ml). Cells were incubated at 
37 °C for 1 h, medium was removed and the samples were frozen at -80 °C for at least 
one hour. Afterwards, 100 μl of DMSO was added to solve the MTT dye and samples 
were incubated at 37 °C for 30 min. under constant shaking. Absorbance was 
measured at 570 nm (versus the reference wavelength 630 nm) using a microplate 
reader (Fluostar OPTIMA, BMG Labtech, Offenburg, Germany), and cell viability levels 
were expressed as percentage of absorption levels in untreated control cells (100 % 
viability). For statistical analysis the experiments were repeated at least three times. 
2.5.2 ATP-assay 
Adenosinetriphosphate (ATP) can be used to assess the functional integrity of living 
cells since all cells require ATP for survival and their energy-dependent specialized 
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functions. Any form of cell injury results in a rapid decrease of cytoplasmic ATP-levels. 
The detection of ATP is based on a bioluminescent assay. The bioluminescent assay 
utilizes the enzyme luciferase which catalyzes the formation of light from ATP and 
luciferin according to the following reaction: 
 
For endpoint analysis of total ATP levels the ViaLight HS Kit (Lonza,Cologne, 
Germany) was used following the manufacturer’s instructions. HT-22 cells were seeded 
in white 96-well plates (Greiner, Frickenhausen, Germany) for luminescence 
measurements. Twenty four hours after seeding, the cells were damaged with 
glutamate 3 - 5 mM and treated with Drp1-inhibitors (75 µM) or BI-6c9 (10 µM). ATP 
levels were detected 3 - 18 hours after the onset of glutamate exposure by detection of 
luminescence. Briefly, the culture plate was allowed to cool down to room temperature 
for at least 5 minutes. In this time all reagents were prepared following the manual 
instructions. First, 100 µl of “nucleotide releasing reagent” (NRR) was added to each 
well and incubated for 5 minutes. The microplate reader (Fluostar OPTIMA, BMG 
Labtech, Offenburg, Germany) was primed with the “ATP monitoring reagent” (AMR) 
control solution and the software programmed to dispense automatically 20 µl into the 
appropriate wells and immediate measurement of the luminescence. The ATP release 
levels were expressed as percentage of luminescence levels in treated control cells 
(100 % ATP-release). For statistical analysis the experiments were repeated at least 
three times. 
2.5.3 DAPI /Hoechst 33342 staining 
At different time points after the onset of the different treatment conditions, cultured 
primary neurons were fixed for 15 min. in 1 ml of a 1x PBS solution containing 4 % 
PFA. The fixed primary neurons were stained for 15 min. in 35 mm-dishes with the 
fluorescent DNA binding dye 4’, 6-diamidino-2-phenylindole dihydrochloride (DAPI) or 
Hoechst 33342 (1 μg/ml in 1x PBS). After removing the fluorecent dyes, cells were 
washed twice with 1x PBS and kept in 1 ml 1x PBS. Stained nuclei were visualized 
under epifluorescence illumination (DMI6000B, Leica, Wetzlar, Germany with A4 
(340 nm excitation and 510 nm barrier) filter) using a 40x objective. Neurons with 
condensed and fragmented nuclei were considered apoptotic. For the quantification of 
apoptotic cells, five hundred cells from five areas per cell culture dish were counted in 
total and experiments were performed at least three times with n=5 per treatment 
ATP + Luciferin + O2 Oxyluciferin + AMP + PPi + CO2 + LIGHT
Luciferase
Mg 2+
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condition without knowledge of the treatment history. For statistical analysis the 
experiments were repeated at least three times. 
2.5.4 Real-time measurements with xCELLigence System 
The xCELLigence System (Roche, Penzberg, Germany) monitors cellular events in 
real time by measuring the electrical impedance between micro-electrodes integrated 
into the bottom of custom made tissue culture plates (E-plates). Since cells have a very 
high electrical resistance, the detected impedance increases with the area of the E-
plate’s well bottom covered by the cells. HT-22 cells were seeded at a density of 4,500 
cells per well in 96-well E-plates (Roche, Penzberg, Germany). The electrical 
impedance, which is displayed as cell index (CI) as function of the time, was used to 
monitor the kinetics of cellular growth, cell viability and changes of cell morphology in a 
large number of tissue culture wells simultaneously throughout the experiments. It is 
important to note that the system is very sensitive to changes in temperature and 
therefore the medium was never removed completely to prevent a persistent 
breakdown of the impedance (129). At twenty-four hours after seeding of the HT-22 
cells, cells were treated with glutamate or dependent on the experiment, with different 
compounds or siRNA. For statistical analysis the experiments were repeated at least 
three times. 
2.6 Flow cytometric measurements 
2.6.1 Annexin-V-FITC staining 
Apoptotic cells were detected after labeling with Annexin-V and subsequent flow 
cytometry. Annexin-V binds in the presence of calcium to phosphatidylserine, which 
appears on the cell surface in early phases of apoptosis (130). Apoptotic cell death was 
detected by Annexin-V/Propidium iodide staining and subsequent flow cytometry 
analysis. Cells were harvested 14 h after glutamate-treatment by using 1x TE, washed 
once in 1x PBS and stained according to the manufacturer’s protocol (Annexin-V-FITC 
Detection Kit, PromoKine, Promocell, Germany). Apoptotic and necrotic cells were 
determined using FACScan (BD Bioscience, Heidelberg, Germany). Annexin-V-FITC 
was excited at 488 nm and emission was detected through a 530 ± 40 nm band pass 
filter. Propidium iodide was excited at 488 nm and fluorescence emission was detected 
using a 680 ± 30 nm band pass filter. To exclude cell debris and doublets, cells were 
appropriately gated by forward versus side scatter and pulse width, and 1 x 104 gated 
events per sample were collected. Surviving cells did not show any staining whereas 
Annexin-V staining indicated apoptosis and cells positive for both Annexin-V and 
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propidium iodide were regarded necrotic. The experiments were repeated at least three 
times. 
2.6.2 Analysis of mitochondrial membrane potential with JC-1 
Mitochondrial membrane potential of HT-22 neurons was determined by 5, 5', 6, 6'-
tetrachloro-1, 1', 3, 3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) reduction. 
HT-22 neurons were stained with JC-1 (Mitoprobe, Invitrogen, Karlsruhe, Germany) 
according to the manufacturer’s protocol and analyzed by subsequent flow cytometry 
or epifluorescence microscopy. After glutamate treatment (12 h), JC-1 was added to 
each well of the different treatment conditions to a final concentration of 2 μM for 
30 min. Living-control cells received vehicle (DMSO, 0.1 % final concentration) and 
damage-control cells were treated with carbonyl cyanide m-chlorophenylhydrazone 
(CCCP) 15 min. before staining to induce mitochondrial membrane depolarization. 
Detached cells in the medium were collected and combined with the attached cells 
harvested with standard Trypsin/EDTA (1x TE, Sigma-Aldrich, Taufkrichen, Germany) 
in 1x PBS. Trypsin incubation was stopped by adding 1 ml serum containing medium to 
each well. Cells were centrifuged at 1,000 x g for 5 min. at room temperature, washed 
once with 1x PBS, and kept in 0.5 ml 1x PBS on ice until analysis of JC-1 fluorescence 
using a FACScan (BD Bioscience, Heidelberg Germany). JC-1 green fluorescence 
indicating mitochondrial uptake of the dye was excited at 488 nm and emission was 
detected using a 530 ± 40 nm band pass filter. JC-1 red fluorescence indicating intact 
mitochondrial membrane potential was excited at 488 nm and emission was detected 
using a 613 ± 20 nm band pass filter. To exclude cell debris and doublets, cells were 
appropriately gated by forward versus side scatter and pulse width, and 1 x 104 gated 
events per sample were collected from 3 - 4 independent samples per treatment 
condition and the experiments were repeated at least three times. 
2.6.3 Evaluation of oxidative stress/lipid peroxidation with 
Bodipy 
Bodipy is a sensitive fluorescent reporter for lipid peroxidation, undergoing a shift from 
red to green fluorescence emission upon oxidation of the phenylbutadiene segment of 
the fluorophore. This oxidation-dependent emission shift enables fluorescence ratio 
imaging of lipid peroxidation in live cells. For detection of cellular lipid peroxidation, 
HT-22 neurons were seeded out in 24-well plates with 7 x 105 cells per well. After 
respective treatments the cells were loaded with 2 µM BODIPY 581/591 C11 for 
60 min. in 1 ml DMEM per well. Cells were then harvested with standard Trypsin/EDTA 
(1x TE, Sigma-Aldrich, Taufkrichen, Germany) in 1x PBS with 100 µl/well. Trypsin 
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incubation was stopped by adding 1 ml serum containing medium to each well. Cells 
were centrifuged at 1 000 x g for 5 min. at room temperature, washed with 1x PBS and 
resuspended in 1 ml 1x PBS. Detection of lipid peroxidation was performed by flow 
cytometry on a FACScan (BD Bioscience, Heidelberg, Germany) by using 488 nm UV 
line argon laser for excitation and lipid peroxidation emission was recorded on 
channels FL1 at 530 nm (green) and FL2 at 585 nm (red). To exclude cell debris and 
doublets, cells were appropriately gated by forward versus side scatter and pulse 
width, and 2 x 104 gated events per sample were collected from 3 - 4 independent 
samples per treatment condition and the experiments were repeated at least three 
times. 
2.7 Immunocytochemistry  
2.7.1 Mitochondrial staining 
For detection of mitochondrial morphology changes during cell death, HT-22 neurons 
were transfected with the mGFP plasmid, respectively. Twenty-four hours after 
transfection HT-22 cells were seeded in ibidi μ-slide 8-well plates (Ibidi, Munich, 
Germany) at a density of 1.7 x 104 cells per well for endpoint analysis on a 
fluorescence microscope (DMI6000B, Leica, Wetzlar, Germany). Alternatively, 
mitochondria were visualized by MitoTracker Green / DeepRed according to the 
manufacturer’s protocol (Invitrogen, Karlsruhe, Germany). To 50 μg MitoTracker Green 
or DeepRed (Invitrogen, Karlsruhe, Germany) 74.4 μl DMSO were added. The resulting 
1 mM solution was diluted 1:10,000 in DMEM and 300 μl were added to HT-22 neurons 
or primary rat cortical neurons after their respective treatment in Collagen A-coated 
Ibitreat μ-slide 8-well plate. Cells were incubated for 20 min. at 37 °C with the staining 
medium. Afterwards, the staining medium was replaced with DMEM and mitochondria 
were visualized using an epiflourescence (DMI6000B, Leica, Wetzlar, Germany) or 
confocal laser scanning microscope at an excitation wavelength of 488 nm (Axiovert 
200, Carl Zeiss, Jena, Germany). Light was collected through a 40 x 1.3 NA, 
63 x 1.4 NA or 100 x 1.3 NA oil immersion objective. MitoTracker Green fluorescence 
was excited at a wavelength of 488 nm and emission was detected using a 560 nm 
long pass filter. MitoTracker DeepRed fluorescence was excited at a wavelength of 
620 nm band pass filter and emissions were detected using 670 nm long pass filter 
(red). 
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2.7.2 Evaluation of mitochondrial morphology 
HT-22 cells were transfected with mGFP as described before. After 24 h the cells were 
reseeded on ibidi μ-slide 8-well plates (ibidi GmbH, Munich, Germany) and after 
additional 24 hours treated for 18 hours with glutamate (3 or 5 mM) and different mdivi 
compounds (75 µM) or BI-6c9 (10 µM), respectively. Endpoint pictures were taken after 
fixation with 4 % PFA and DAPI counterstaining of the nuclei 18 h after onset of 
treatment. Counting of three different types of mitochondrial states was performed in at 
least four independent experiments with five hundred cells. Three categories of 
mitochondrial morphology states were defined as follows: healthy cells display 
category 1, mitochondria form a tubular network. These mitochondria are equally 
distributed throughout the cytosol. Cells containing large round mitochondria distributed 
throughout the cytosol are defined as category 2. These cells do not show apoptotic 
features, e.g. shrunken nuclei, and are not detached. In contrast, damaged and dying 
cells contain smaller round heterogeneous mitochondria located close to the nucleus. 
These mitochondria are defined as category 3. For the quantification of mitochondrial 
morphology, five hundred cells per well/treatment condition were counted in total and 
experiments were performed at least three times without knowledge of the treatment 
history. For statistical analysis the experiments were repeated at least three times. For 
automated analyses of mitochondrial morphology changes, mitochondrial length was 
also calculated by ImageJ software (NIH, Bethesda, USA) from at least six 
independent pictures per experimental condition (92). 
2.7.3 Immunocytochemistry of Drp1 
For detection of Drp1 localization during apoptosis, HT-22 neurons were seeded in ibidi 
μ-slide 8-well plates (Ibidi GmbH, Munich, Germany) at a density of 1.7 x 104/well. After 
24 hours cells were respectively treated and fixed for endpoint analysis with 4 % PFA. 
Culture medium was removed and cells were washed once with 1x PBS. Afterwards, 
cells were fixed in 1 ml 4 % PFA for 20 min., washed once in 1x PBS and then 
membranes were permeabilized by exposure for 5 min. to 0.4 % Triton X-100 (Sigma-
Aldrich, Taufkirchen, Germany) in 1x PBS, and cells were placed in blocking solution 
(3 % horse serum (Invitrogen, Karlsruhe, Germany) in 1x PBS) for 30 minutes. Cells 
were then exposed to a polyclonal anti-Drp1 antibody (1:100 in block solution, BD 
Bioscience Laboratories, Heidelberg, Germany), overnight at 4 °C and subsequent 
2.5 hours at room temperature, followed by an incubation for 2 hours with biotinylated 
anti-mouse IgG antibody (1:200, Vector Labs, Burlinghame, CA. USA) and 30 min. in 
the presence of streptavidin oregon green 514 conjugate (Invitrogen, Karlsruhe, 
Germany) according to the manufacturers protocol. The specificity of Drp1 immune 
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reactivity was controlled by emission of the primary antibody in parallel staining of 
negative controls. Mitochondria were counterstained with Mitotracker DeepRed as 
described above. Images were acquired using a confocal laser scanning microscope 
(Axiovert 200, Carl Zeiss, Jena, Germany) equipped with an UV and an argon laser 
delivering light at 364 nm and 488 nm, respectively. Light was collected through a 
63 x 1.4 NA oil immersion objective. Mitotracker DeepRed fluorescence was excited at 
620 nm and emission was achieved by using the 690 nm long pass filter. Fluorescence 
of oregon green was excited at a wavelength of 488 nm and emission was detected 
using a 505 nm long pass filter. For digital imaging the software LSM Image Browser 
4.2.0 (Carl Zeiss, Jena, Germany) was used. 
2.8 Epifluorescence and confocal laser scanning 
microscopy (CLSM) 
2.8.1 Epifluorescence microscopy 
Imaging of mitochondrial morphology, JC-1-stained HT-22 neurons or DAPI-stained 
primary rat hippocampal neurons were performed using a DMI6000B fluorescence 
microscope, equipped with a DCF360FX-camera (Leica, Wetzlar, Germany). JC-1 
green fluorescence was excited using a 480 ± 40 nm band pass filter, and emission 
was collected using a 527 ± 30 nm band pass filter (Filter L5, Leica, Wetzlar, 
Germany). JC-1 red fluorescence was excited using a 620 ± 60 nm band pass filter, 
and fluorescence emission was collected using a 700 ± 75 nm band pass filter (Filter 
Cy5, Leica, Wetzlar, Germany). DAPI fluorescence was excited using 360 ± 40 nm 
band pass filter, and emission was collected using a 470 ± 40 nm band pass filter 
(Filter A4, Leica, Wetzlar, Germany). For digital imaging the software LAS AF (Leica, 
Wetzlar, Germany) was used.  
2.8.2 Confocal laser scanning microscopy  
For detection of mitochondrial morphology changes and Drp1 localization during 
apoptosis, HT-22 neurons were immunostained as described before. Endpoint pictures 
were taken after fixation with 4 % PFA and DAPI counterstaining of the nuclei between 
5 h to 17 h after onset of treatment. Images were acquired using a confocal laser 
scanning microscope (Axiovert 200, Carl Zeiss, Jena,Germany) equipped with an UV 
and an argon laser delivering light at 364 nm and 488 nm, respectively. Light was 
collected through a 40 x 1.3 NA, 63 x 1.4 NA or 100 x 1.3 NA oil immersion objective. 
Fluorescence of Mitotracker Green or Mitotracker DeepRed fluorescence was excited 
2 Material and methods  36 
 
at 488 nm and 543 nm and emissions were observed using 505 - 530 nm band pass 
(green) or were excited at 514 nm and emission was achieved by using the 630 nm 
long pass filter (red), respectively. Fluorescence of oregon green was excited at a 
wavelength of 488 nm and emission was detected using a 505 nm long pass filter. 
DAPI fluorescence was excited at 364 nm and emission was achieved by using the 
385 nm. For digital imaging the software LSM Image Browser 4.2.0 (Carl Zeiss, Jena, 
Germany) was used. 
2.9 Protein analysis 
For protein extraction and subsequent analysis, HT-22 neurons were grown at a 
density of 7 x 104 cells per well in 24-well plates or 2 x 105 cells per well in 6-well 
plates. Primary rat neurons were cultured in PEI-coated 60 mm culture dishes at a 
density of 2.5 x 106 cells per dish. Important to note for protein analysis every step was 
performed at 4 °C.  
2.9.1 Protein sample preparation from HT-22 neurons  
For western blot analysis, HT-22 neurons were harvested as described using 1x TE 
solution to detach cells. At least four wells per condition were pooled. Cells were 
washed in 1x PBS and lysed with 50 - 150 μl with protein lysis buffer. Protein extracts 
were kept on ice for 15 min. and then extracts were centrifuged at 15,000 x g for 
15 min. at 4 °C to remove insoluble membrane fragments. The supernatants were 
stored at -80 °C until further use.  
Table 10 Protein lysis buffer pH 7.8 
0.25 M D-Mannitol 4.56 g 
0.05 M Tris-base 0.788 g 
1 mM EDTA 0.038  g 
1 mM EGTA 0.038  g 
Bidest H2O ad 100  ml 
 
The pH 7.8 was adjusted by concentrated HCl. This stock-buffer was stored in 10 ml 
aliquots in -20 °C. For 10 ml of working solution, the stock buffer was supplemented 
with: 
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DTT (100 mM) 0.1  ml 
Triton X-100 0.1 ml 
1 tablet/10 ml Complete mini protease 
inhibitor cocktail  
  
1 tablet/10 ml phosphatases inhibitor   
 
Complete mini protease inhibitor cocktail tablets and phosphatase inhibitor tablets 
contain a cocktail of several reversible and irreversible protease inhibitors and 
phosphatase inhbitors (Roche, Mannheim, Germany).  
2.9.2 Immunoprecipitation of Drp1 
The immunoprecipitation of Drp1 was performed by pull-down of Drp1 from total protein 
lysates according to the manufacturer’s protocol (Invitrogen, Karlsruhe, Germany). 
Briefly, magnetic Dynabeads Protein A were prepared for each condition to effectively 
bind the Drp1-antibody (7.5 µg, BD Biocience Laboratories, Heidelberg, Germany). The 
Drp1-antibody is added to the Dynabeads Protein A for 30 min. to bind the Dynabeads 
via their Fc-region. For all washing steps the tube was placed on a Dynamagnet, where 
the beads migrate to the side of the tube facing the magnet and allow for easy removal 
of the supernatant. To avoid co-elution of the antibody and to increase the binding 
capacity of the antibody on the Dynabeads, crosslinking reaction with BS3 was 
performed according to the manufacturer’s protocol. The bead-bound antibody is now 
ready for immunoprecipitation. For immunoprecipitation of Drp1, 2.5 mg of total protein 
lysate of each treatment condition was incubated for one hour at room temperature 
(RT) followed by a second hour at 4 °C. The elution of Drp1 with its binding partners 
was performed by adding 70 µl of 2.5x sodium dodecyl sulfate (SDS) -sample buffer 
and afterwards boiling of this Dynabead-protein lysat-mix for 10 min. at 95 °C. 
Dynabeads were removed from the solution and the supernatant removed. The 
supernatant was stored at -80 °C. 30 µl of the eluat was loaded on a SDS-gel to detect 
protein-interaction partners of Drp1 by western blotting analysis. The regular protein 
lysate with 30 µg of protein per treatment condition was used as a control in the SDS-
PAGE. 
2.9.3 Determination of protein amount  
Protein determination is one of the most common operations performed in biochemical 
research. The principle of the bicinchoninic acid (BCA)-assay is similar to the Lowry 
procedure, in that both rely on the formation of a Cu2+ protein complex under alkaline 
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conditions, followed by reduction of the Cu2+ to Cu1+ by proteins (Biuret-reaction). The 
amount of reduction is proportional to the protein present. BCA forms a purple blue 
complex with Cu1+ in alkaline solutions. Responsible for this color reaction of the BCA 
are the macromolecular structures of the protein, the amount of peptides and the four 
amino acids cysteine, cystine, tryptophan and tyrosine. This provides a basis to monitor 
the reduction of alkaline Cu2+ by proteins and thus determine the protein concentration 
in biochemical samples and cell extracts (131). 
Protein amounts in extracts were determined with the Pierce BCA kit (Perbio Science, 
Bonn, Germany). To this end, 5 μl of each sample were diluted in 95 μl 1x PBS. A 
standard curve containing 0 - 200 μg bovine serum albumin (Perbio Science, Bonn, 
Germany) per 100 μl, 5 μl of the respective lysis buffer and 1x PBS ad 100 μl was 
prepared. Then, 200 μl of a 1:50 mixture of reagent B : reagent A (Perbio Science, 
Bonn, Germany) was added to each sample. Samples were incubated for 30 min. at 
60 °C; 100 μl of each sample were pipetted into a 96-well plate (Nunc, Wiesbaden, 
Germany). Absorption at 590 nm was determined using a microplate reader (Fluostar 
OPTIMA, BMG Labtech, Offenburg, Germany) and protein amounts of the test samples 
were calculated from the standard curve.  
2.9.4 Polyacrylamid gel electrophoresis and western blot 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a technique 
widely used in biochemistry and molecular biology to separate proteins according to 
their electrophoretic mobility (a function of length of polypeptide chain or molecular 
weight). SDS gel electrophoresis of samples having identical charge per unit mass due 
to binding of SDS results in fractionation by size (132). 
For SDS gel electrophoresis following solutions were used:  
Table 11 0.5 M Tris pH 6.8 
Tris-HCl 7.88  g 
Bidest dH2O ad 100  ml 
 
The pH 6.8 was adjusted by concentrated HCl. 
Table 12 1.5 M Tris pH 8.8 
Tris-HCl 23.6 g 
Bidest dH2O ad 100 ml 
 
2 Material and methods  39 
 
The pH 8.8 was adjusted by concentrated HCl. 
Table 13 10 % Ammoniumpersulfat (APS) 
Ammoniumpersulfat  1  g 
Bidest dH2O ad 10  ml 
 
Table 14 10 % Sodium dodecyl sulfate (SDS) 
Sodium dodecyl sulfate (SDS) 1  g 
Bidest dH2O ad 10  ml 
 
Table 15 Running gel 12.5 % and 15 %  
1.5 M Tris 2.5 ml 
30 % Acrylamid/Bis solution 37,5:1 3.34  
or 5  
ml 
SDS 0.1 ml 
10 % APS 0.05 ml 
TEMED 0.01 ml 
Bidest dH2O ad 10 ml 
 
Table 16 Stacking gel 3.5 % 
0.5 M Tris 2.5 ml 
30 % Acrylamid/Bis solution 37,5:1 1.2  ml 
SDS 0.1 ml 
10 % APS 0.05 ml 
TEMED 0.01 ml 
Bidest dH2O ad 10 ml 
 
Table 17 1x Electrophoresis buffer 
Tris base 3 g 
Glycine 14.4  g 
SDS 1 g 
Bidest dH2O ad 1000 ml 
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Table 18 5x SDS-loading buffer 
1 M Tris-HCl pH 6.8 7  ml 
Glyerol 3  ml 
SDS 1 g 
D,L-dithiotreitol (DTT) 0.93 g 
β-Mercaptoethanol 0,1 ml 
Bromophenol blue sodium salt 1.2 mg 
 
For Western Blot analyses following buffers were used:  
Table 19 1x Transfer buffer 
Tris base 3 g 
Glycine 14.4  g 
Methanol 100 ml 
Bidest dH2O ad 1000 ml 
 
Table 20 1x TBS/Tween 20 
Tris base 2,42 g 
Sodium chloride 29,2  g 
Methanol 100 ml 
Tween 20 0,5 ml 
Bidest dH2O ad 1000 ml 
 
Table 21 5 % Blocking buffer 
non-fatty milk powder 5  g 
TBST ad 100 ml 
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Table 22 Stripping buffer 
Glycine 15 g 
SDS 1 g 
Tween 20 10 ml 
Bidest dH2O ad 1000 ml 
 
The pH was adjusted to 2.2 by concentrated HCl. 
An amount of 20 - 30 μg protein of each sample was filled up to 40 μl with bidest water. 
Afterwards, 8 μl of 5x SDS-loading buffer were added and boiled at 95 °C for 
5 minutes. Then samples were loaded onto the gel and 10 μl of PageRuler™ Plus 
Prestained Ladder (Fermentas, St. Leon-Rot, Germany) were used on each gel as 
molecular weight marker. The electrophoresis was performed at 60 V for 20 min. and 
subsequent 125 V for one hour per 2 gels in electrophoresis buffer. After 
electrophoresis, proteins were blotted onto a polyvinylidenfluorid membrane (PVDF, 
Bio-Rad, Munich, Germany) according to the Bio-Rad protocol at 15 V for 90 minutes.  
PVDF-Membrane was activated in methanol 2 min. and afterwards incubated for 
10 min. in 1 x transfer buffer before blotting. In addition the two thick filter paper and 
the gels were also pre-incubated in 1x transfer buffer before blotting. The blotting was 
performed in a Trans-Blot SD semi-dry transfer cell (Bio-Rad, Munich, Germany) using 
extra thick filter paper (Bio-Rad, Munich, Germany) and 1x transfer buffer containing 
methanol. The blots were washed with TBST and blocked for 1 h in 5 % blocking 
buffer. Then blots were probed with an appropriate primary antibody in 5 % blocking 
solution at 4 °C overnight. Membranes were then exposed to the appropriate HRP-
conjugated secondary antibody in 5 % blocking solution for one hour followed by 
washing three times with TBST for 15 min. binding was detected by 
chemiluminescence using HRP-Juice (PJK GmbH, Kleinblittersdorf, Germany).  
Detection was performed using the Chemidoc-XRS System (Bio-Rad, Munich, 
Germany). Equal protein loading and quality was controlled by re-probing the 
membrane with the monoclonal anti-α-tubulin or anti-actin antibodies (Sigma-Aldrich, 
Taufkirchen, Germany) and the respective secondary antibodies. Chemidoc software 
(Bio-Rad, Munich, Germany) was used for quantification of western blot signals. 
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2.10 RNA analysis 
For RNA extraction and subsequent analysis HT-22 neurons were grown at a density 
of 7 x 104 cells per well in 24-well plates.  
2.10.1 RNA sample preparation 
For RT-PCR analysis, HT-22 neurons were harvested in 1x PBS and then centrifuged 
at 1,000 x g at 4 °C for 10 min., the pellet was washed once in 1x PBS, and afterwards 
centrifuged again. NucleoSpin RNA II Kit was used for total RNA extraction according 
to the manufacturer’s protocol (Macherey und Nagel, Düren, Germany). Briefly, 
samples were dissolved in Nucleospin SDS-containing cell lysis buffer RA1 and β-
mercaptoethanol (Merck, Darmstadt, Germany). To separate insoluble cell fragments, 
samples were filtered through Nucleospin Filter units. Ethanol was added to the filtrate 
and the sample was loaded onto a Nucleospin RNA II column. Salt and DNA were 
removed by membrane desalting buffer and a subsequent DNAse reaction, 
respectively. The membrane was washed with Nucleospin buffer RA2 and RA3. Finally, 
the purified RNA was eluted from the column with RNAse-free water. The RNA 
samples were stored at -80 °C until further use.  
2.10.2 Determination of RNA amount 
To determine the RNA amount in the samples, 4 μl were diluted in 156 μl RNAse-free 
water (Sigma-Aldrich, Taufkirchen, Germany). The RNA concentration was determined 
by UV absorption measurements, using NanoVue Plus Spectrophotometer (Implem, 
GE Healthcare Europe GmbH, Freiburg, Germany) at a wavelength of 260 nm. The 
quality of the purified RNA was determined at the reference wavelength of 280 nm. An 
OD of 1 at 260 nm represents a concentration of 40 μg/ml RNA.  
2.10.3 One Step reverse transcriptase polymerase chain 
reaction (RT-PCR) 
One-step RT-PCR was performed with SuperscriptIII One Step RT-PCR (Invitrogen, 
Karlsruhe, Germany). Primers for Drp1 and GAPDH were used as follows:  
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Table 23 Forward and reverse Primer sequence for Drp1 and GAPDH 
Primer Sequence 
Drp1 forward 5`-ACAGGAGAAGAAAATGGAGTTTGAAGCAG-3` 
Drp1 reverse 5`-AACAAATCCTAGCACCACGCAT-3` 
GAPDH forward 5`-CGTCTTCACCACCATGGAGAAGGC-3` 
GAPDH reverse 5`-AAGGCCATGCCAGTGAGCTTCCC-3 
 
PCR for GAPDH and Drp1 was performed as follows: cDNA-synthesis at 60 °C for 
30 min.; initial denaturation 95 °C for 2 min., amplification by 26 cycles of 30 s at 95 °C, 
1 min. at 57 °C and 2 min. at 70 °C. The final extension was performed at 70 °C for 
10 min. RT-PCR products were visualized under UV illumination after electrophoresis 
on a 1.5 % agarose gel containing ethidium bromide or SybrGold (Invitrogen Karlsruhe, 
Germany). 
2.10.4 Agarose gel electrophoresis 
Analysis of PCR amplification products was performed by fluorescence detection after 
agarose gel electrophoresis. To this end, 10 μl of each sample were mixed with 6x 
bromphenol blue containing loading buffer and were loaded onto a 1.5 % agarose gel 
containing ethidium bromide or SybrGold. The gel was prepared by dissolving 0.6 g 
agarose (Sigma-Aldrich, Taufkirchen, Germany) in 40 ml 1x TBE boiling everything up 
to 100 °C and adding 2 μl of a 0.5 mg/ml SybrGold or 5 μl of stock solution ethidium 
bromide (1 % in water) (Invitrogen, Karlsruhe, Germany) solution after cooling down to 
about 70 °C. The electrophoresis was performed for 70 min. at 80 V. 10 μl of 1,000 bp 
DNA-ladder (Fermentas, St. Leon-Roth, Germany) were used as a size marker. PCR 
amplification products were detected under UV light (excitation 260 nm) by 
photographing the emission light (560 nm) of ethidium bromide in the Chemidoc 
System (Bio-Rad, Munich, Germany). 
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Table 24 6x DNA loading buffer 
0.5 M EDTA 2.4 ml 
Glycine 12 ml 
Bromphenol blue 0.04 g 
Bidest dH2O  5.6 ml 
 
Table 25 1x TBE buffer 
Tris-base 10.8 g 
Boric acid 5.5 g 
Disodium EDTA 0.75 g 
Bidest dH2O ad 1000 ml 
 
Table 26 1.5 % Agarose gel 
Agarose 0.6 g 
1x TBE buffer 40 ml 
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2.11 Cerebral ischemia in mice 
The middle cerebral artery occlusion (MCAo) experiments were performed in a blinded 
and randomized manner by Uta Mamrak (Ludwig-Maximillians-University, Munich, 
Germany). Male C57BL/6 mice (body weight, 18 - 22 g; Charles River, Wilmington, MA, 
USA) were subjected to transient MCAo as described previously (60;133). The Drp1 
inhibitors mdiviA and B were injected i.p. at doses of 1 and 3 mg/kg body weight prior 
to the induction of MCAo. Surgery was performed in isoflurane/N2O anesthesia (1.5 % 
isoflurane, 68.5 % N2O, 30 % O2). A silicone coated nylon monofilament was inserted 
into the internal carotid artery and gently pushed forward until blood flow in the MCA 
territory decreased to less than 20 % of baseline as determined by laser Doppler 
fluxmetry. Twenty four hours after MCAo animals were perfusion fixed with 4 % PFA. 
Thereafter brains were removed, post fixed in 4 % PFA over night, dehydrated, and 
embedded in paraffin. Twelve-fifteen sections (10 µm, 500 µm apart), including the 
middle cerebral artery territory, were stained with cresyl violet for quantification of 
infarct area. For each experimental group, 8 - 11 animals were used. Statistical 
analysis was performed using the Mann-Whitney-U-test. For determination of neuronal 
function mice were examined at one and 24 hours after reperfusion. The neuroscore 
was determined by the following criteria: 0: no deficit; 1: paralysis of the contralateral 
forepaw; 2: circling to the contralateral side; 3: loss of righting reflex; 4: no spontaneous 
motor activity. 
2.12 Statistical analysis  
All data are given as means ± standard deviation (SD) and means ± standard deviation 
of the mean (SEM) as indicated. For statistical comparison between two groups Mann-
Whitney-U-test was used. Multiple comparisons were performed by analysis of 
variance (ANOVA) followed by Scheffé's post hoc test or Bonferroni test, as indicated. 
Calculations were performed with the Winstat standard statistical software package 
(R. Fitch Software, Bad Krozingen, Germany). 
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3 Results 
3.1 Glutamate sensitivity of HT-22 cells 
HT-22 neurons are immortalized hippocampal mouse neurons. This is an adhesive cell 
line with spindle shaped morphology that does not exhibit dendrites or axons. In these 
cells, glutamate (1 - 5 mM) induces toxicity by inhibition of the Xc-transporter and the 
subsequent glutathione (GSH) depletion mediates lethal oxidative stress and cell death 
in dose- and time-dependent manner (Figure 7A, B). After exposure to glutamate, 
HT-22 neurons round up and detach from the well bottom (Figure 7A). The glutamate 
toxicity was confirmed by endpoint measurements using the MTT assay and real-time 
analysis of the electrical impedance using the xCELLigence System (Figure 7A, B, C).  
 
Figure 7  Glutamate-induced toxicity leads to loss of cell viability in HT-22 cells 
HT-22 cells were seeded in 96-well plates with a density of 7,000 cells per well. A, Glutamate (1 - 5 mM) 
reduced cell viability of HT-22 neurons in a concentration-dependent manner as evaluated by MTT assay 
18 h after onset of glutamate treatment (n=8). B, MTT assay evaluated glutamate-toxicity in a time-
dependent manner with 3 and 5 mM in HT-22 cells for 6 - 18 h (n=8). C, HT-22 cells were seeded in 96-
well E-plates with a density of 4,500 cells per well. Attaching and proliferation of the cells were observed 
over 48 h. After 24 h, cells were treated with glutamate 3 and 5 mM and real time detection of cellular 
impedance was done with xCELLigence System (Roche, Penzberg, Germany). HT-22 cells showed 
reduction of cell viability after 8 - 10.5 h glutamate treatment. After initiation of cell death, HT-22 cells died 
within 3 - 5 h (n=8). The experiments were repeated three times and the results presented as mean ± S.D. 
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Treatment of HT-22 cells with glutamate at concentrations of 3 mM and 5 mM resulted 
in a decrease of the Normalized Cell Index (NCI) between 8 and 10.5 h later, indicating 
progressive cell death (Figure 7B, blue and red graphs, glutamate 3 mM and 5 mM, 
respectively). It is interesting to note that, once started, the loss of cellular impedance 
was observed within a relatively small and constant time window of 3 - 5 h, suggested 
that cell death and detaching of the cells occurred rapidly and in a highly synchronized 
manner. In contrast, the control groups showed an increase of NCI, which was the 
cause of their normal growth (Figure 7B, green graph). It is important to note that 
sensitivity to glutamate toxicity varies in HT-22 neurons depending on their density and 
passage number. Therefore, experiments were always performed at different glutamate 
concentrations between 1 - 5 mM, and representative results are mostly shown from 
individual experiments where the respective glutamate concentration induced at least 
50 % cell death as detected with the MTT assay. Glutamate-induced cell death was 
accompanied by a decrease of total ATP levels in the HT-22 cells. Glutamate (5 mM) 
led to a decrease of approximately 50 % of total ATP levels 6 h after induction of cell 
death (Figure 8A). The supposed increase of lipid peroxidation/ROS afer glutamate 
challenge was measured at different time points after onset of glutamate treatment 
using the fluorescent dye Bodipy (BODIPY® 581/591 C11 Invitrogen, Karlsruhe, 
Germany) followed by FACS analyses. The results obtained from cells exposed to 
glutamate for 6 h, 8 h and 17 h showed a time-dependent increase of lipid 
peroxidation/ROS formation. Glutamate induced a first increase of lipid peroxidation 
within 6 - 8 h after glutamate exposure, followed by a more pronounced, secondary 
accumulation at 17 h after glutamate treatment (Figure 8B). 
 
Figure 8  Glutamate-induced toxicity leads to ATP depletion and lipid peroxidation in HT-22 cells 
A, HT-22 cells were seeded in 96-well plates with a density of 7,000 cells per well. ATP levels were 
determined by luminescence measurements. Total ATP levels are decreased after 6 h with glutamate 
(5 mM) in HT-22 cells (n=8). B, Glutamate induced the production of lipid peroxides. Glutamate treatment 
(5 mM) was performed for 6 - 17 h. After the addition of 2 µM Bodipy for 60 min., fluorescence was 
quantified by FACS analysis. Lipid peroxidation increased two fold 6 h after glutamate treatment with 
5 mM. A second increase of lipid peroxidation was observed after 17 h (n=3). The experiments were 
repeated three times and the results presented as mean ± S.D. 
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3.2 Oxidative stress results in pronounced 
mitochondrial fragmentation 
As described before, exposure of HT-22 neurons to glutamate resulted in enhanced 
lipid peroxidation and ROS formation in a time-dependent manner (Figure 8B). This 
ROS formation was associated with a significant change in mitochondrial morphology. 
For further quantification of mitochondrial fission in HT-22 cells, three categories of 
mitochondrial morphology were defined (Figure 9A). Healthy HT-22 cells predominantly 
expose category 1 mitochondria that form a tubular network. These mitochondria are 
equally distributed throughout the cytosol. Cells containing large round mitochondria 
distributed throughout the cytosol are defined as category 2 and these cells are still 
viable and do not show apoptotic features, such as, for example, pyknotic nuclei, and 
they are adherent to the well bottom. In contrast, damaged and dying cells show small 
rounded mitochondria of different sizes that are predominantly accumulated close to 
the nucleus. Cells containing such fragmented mitochondria are defined as category 3. 
To quantify mitochondrial morphology, cells were transfected with mGFP as described 
before and used for experiments 24 h after they were seeded out in 8-well ibidi slides. 
Mitochondrial categories were evaluated with five hundred cells per well without 
knowledge of the treatment history. In addition, mitochondrial length was quantified in 
six photomicrographs using the ImageJ image analysis software (Figure 9B). 
 
Figure 9  Classification of different morphology categories of mitochondria in HT-22 cells 
A, Fluorescence photomicrographs (63x objective) showed mitochondria-targeting (mGFP)-transfected 
HT-22 cells which have different mitochondrial morphology structures. Category 1: elongated, tubulin-like, 
category 2: intermediate, category 3: fragmented. Magnifications for each category show mitochondrial 
morphology for each category in detail. B, Photomicrographs of analyzed mitochondria of categories 1 and 




Category 2 Category 3
Category 1 Category 3
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As mentioned before mitochondria were organized as a tubular network under control 
conditions, however, after exposure to glutamate the mitochondrial network broke up in 
short tubules and small round fragments (Figure 10A). These changes resulted in a 
significant shortage of mitochondrial length (Figure 10B) and in an evident shift of 
mitochondrial morphology three hours after glutamate treatment from category 1 into 
categories 2 and 3 (Figure 10C). These changes, which are well in line with the 
definition of mitochondrial fission, were associated with a decrease of cell viability from 
100 % to 20 % (Figure 7). The evaluation of the kinetics of this process of the 
organelle`s fragmentation showed that mitochondrial fragmentation started 3 - 4 h after 
glutamate exposure (Figure 10C) and was associated with increased ROS formation 
and lipid peroxidation (Figure 8B). The following decline of cell viability occurred 
8 - 12 h after onset of the glutamate challenge, i.e. several hours after mitochondrial 
fission and at time points where mitochondrial depolarization became evident. 
 
 
Figure 10  Oxidative stress induces pronounced fragmentation of mitochondria in HT-22 neurons 
A, Fluorescence photomicrographs (63x objective) showed changes of mitochondrial morphology in HT-22 
cells transfected with mGFP (green) and DAPI-stained nucleus (blue) treated with glutamate (5 mM) for 
18 h. B, Mitochondrial length measurements of control and glutamate-treated HT-22 cells. Six Pictures 
were quantified as absolute values (AU) by the ImageJ program. C, Time-dependent shifting of 
mitochondria category 1 (tubulin-like) over 12 h to mitochondria category 3 (fragmented) in culture of 
HT-22 neurons. The increase of fragmented mitochondria of category 2 and 3 started 3 - 4 h after 
glutamate treatment (3 mM). The experiments were repeated three times and the results presented as 
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3.3 The BH3-only protein Bid is a mediator of 
glutamate-induced mitochondrial fission 
3.3.1 Bid inhibition prevents fission of mitochondria in 
glutamate-induced cell death 
It has been established that proapoptotic Bcl-2 protein family members such as Bax, 
Bak and Bid mediated mitochondrial dysfunction and associated death signaling in 
neurons (99;134;135), and a number of recent findings suggested that such intrinsic 
death pathways are associated with extensive mitochondrial fragmentation 
(3;13;51;57;136;137). The present study investigated, whether Bid is involved in the 
regulation of mitochondrial dynamics and associated with mitochondrial cell death 
pathways after induction of oxidative stress in HT-22 cells. Translocation of the 
proapoptotic Bcl-2 family member Bid to mitochondria results in AIF translocation to the 
nucleus and cell death, as previously evaluated in HT-22 cells expressing Bid-red 
fusion protein and AIF-GFP (39). To confirm the essential role of Bid in the regulation 
of mitochondrial dynamics, the specific Bid inhibitor BI-6c9 was applied in glutamate-
induced neuronal death.  
In the current experiments, the highly specific Bid inhibitor BI-6c9 blocked fission of 
mitochondria in glutamate-exposed HT-22 cells and prevented the shift of 
mitochondrial morphology from tubular, network-like structures (category 1) to small, 
round shaped and highly fragmented organelles (categories 2 and 3). Thus, in BI-6c9 
treated cells, mitochondrial morphology was restored almost to control levels 
(Figure 11A and B). The preservation of mitochondrial morphology by BI-6c9 was 
associated with a normalization of mitochondrial membrane potential (Figure 14), 
suggesting that mitochondrial morphology is closely linked to mitochondrial function 
and that ROS-induced mitochondrial damage and loss of function are not the result of 
unspecific membrane damage, but of specific Bid-mediated cell death signaling.  
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Figure 11  Bid inhibitor BI-6c9 prevents Bid translocation to mitochondria and mitochondrial 
fission  
A, Fluorescence photomicrographs (63x objective) of mGFP-transfected and DAPI-stained HT-22 cells 
showed that Bid inhibitor BI-6c9 (10 µM) prevented fission of mitochondria in glutamate-exposed (5 mM, 
18 h) HT-22 cells. B, Quantification of mitochondrial morphology of five hundred cells per condition. 
Category 1: elongated, tubulin-like, category 2: intermediate, category 3: fragmented. 
***p<0.001 compared with glutamate 3 and 5 mM-treated cells (ANOVA, Scheffé’s-test). The experiments 
were repeated three times and the results presented as mean ± S.D. 
3.3.2 Mechanism of mitochondrial damage downstream of Bid 
3.3.2.1 Restoration of mitochondrial morphology and function – effect on 
cell viability 
Inhibition of Bid did not only result in the preservation of mitochondrial morphology and 
function, but also preserved cell viability in glutamate-treated HT-22 cells as 
demonstrated by the MTT assay and the novel xCELLigence System (Figure 12). 
While exposure to glutamate resulted in a reduction of cell viability from 100 % to 20 %, 
inhibition of Bid by Bl-6c9 restored cell viability at almost baseline levels (Figure 12A). 
The protective effect of Bid inhibition could be confirmed by the real-time analysis of 
the electrical impedance using the xCELLigence System (Figure 12B). The NCI started 
to decrease after the treatment of HT-22 cells with glutamate at concentrations of 3 mM 
between 5.5 h and 7 h later, which indicated a progressive cell death (Figure 12B, red 
graph, glutamate 3 mM). The loss of cellular impedance in glutamate treated cells was 
observed within a relatively small and constant time window of 2 - 3 h, suggesting that 
cell death and detaching of the cells occurred rapidly and in a highly synchronized 
manner. Inhibition of Bid by BI-6c9 resulted in a complete protection of this delayed, 
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glutamate-induced loss of the NCI and, hence, inhibition of cell death as also confirmed 
by the MTT assay. These data indicate that glutamate-induced ROS production 
induced specific, Bid-mediated cell death signaling, which result in a delayed loss of 
mitochondrial morphology and function, and ultimately cell death.  
Photomicrographs confirmed the essential role of Bid in glutamate-induced neuronal 
death. HT-22 neurons exposed to glutamate for 17 h showed typical morphology of 
dying cells: the neuronal cells appear shrunken, rounded and detach from the culture 
dish (Figure 13A). HT-22 cells treated with the Bid inhibitor BI-6c9 retained their normal 
spindle-shaped morphology and were completely rescued from glutamate-induced cell 
death as determined by the MTT assay (Figure 12A). Cells treated with the Bid inhibitor 
alone, showed enhanced metabolic activity. In addition to the protective effect of BI-6c9 
on cell viability, the Bid inhibitor also prevented significantly HT-22 cells from ATP 
depletion (Figure 13B).  
Overall, these results reveal a major upstream role for Bid in mitochondrial damage, 







Figure 12  Bid inhibitor BI-6c9 protects HT-22 cells against glutamate-induced cell death 
A, Quantification of glutamate-induced (3 and 5 mM, 17 h) sever cell damage and the protective effect of 
BI-6c9 (10 μM) by the MTT assay. HT-22 cells were seeded in 96-well plates with a density of 7,000 cells 
per well (n=8). ***p<0.001 compared to glutamate (3 and 5 mM)-treated cells (n=8) (ANOVA, Scheffé’s-
test). B, HT-22 cells were seeded in 96-well E-plates with a density of 4,500 cells per well and treated 24 h 
later with 3 mM glutamate for 20 h. Real time detection of cellular impedance was done with xCELLigence 
System (Roche, Penzberg, Germany). BI-6c9 showed an exerted persistent protective effect. All 
experiments were repeated three times and the results presented as mean ± S.D. 
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Figure 13  Bid inhibitor BI-6C9 protects HT-22 cells against glutamate-induced cell death and ATP 
depletion 
A, Photomicrographs (10x objective) showed morphological evidence for severe damage of HT-22 cells 
17 h after glutamate (3 mM) exposure. Glutamate-treated cells lose their spindle-like morphology, shrink 
and detach from the culture well bottom; in contrast, cells pretreated with the Bid inhibitor BI-6c9 (10 μM) 
are fully protected against glutamate-induced death and are not different from the controls. B, HT-22 cells 
were seeded in 96-well plates with a density of 7,000 cells per well. ATP levels were determined by 
luminescence measurements after glutamate (3 and 5 mM, 15 h) challenge. Bid inhibitor BI-6c9 (10 μM) 
prevents the glutamate-induced loss of ATP (n=8). ***p< 0.001 compared to glutamate 3 and 5 mM-treated 
cells (ANOVA, Scheffé’s-test). All experiments were repeated three times and the results presented as 
mean ± S.D. 
3.3.2.2 Mitochondrial membrane potential 
Since Bid is supposed to act upstream of mitochondrial damage, the involvement of Bid 
in the breakdown of mitochondrial membrane potential was examined. Staining with 
JC-1 was used to evaluate the effect of Bid inhibition on glutamate-induced breakdown 
of the mitochondrial membrane potential. Glutamate treatment caused a significant loss 
of JC-1 red fluorescence, i.e. loss of mitochondrial membrane potential after glutamate 
treatment within 12 h (Figure 14A, B).  
In the HT-22 neurons, glutamate was as effective as carbonyl cyanide 
chlorophenylhydrazone (CCCP) inducing mitochondrial membrane depolarization 
(Figure 14B). Treatment with the Bid inhibitor BI-6c9 prevented glutamate-induced 
breakdown of the mitochondrial membrane potential after 12 h. Further, the results 
presented here confirmed that depolarization of the mitochondrial outer membrane is 
an important key event of mitochondrial apoptosis induced by oxidative stress. 
Pharmacological inhibition of Bid prevented mitochondrial outer membrane 
depolarization, mitochondrial membrane integrity which was associated with preserved 
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mitochondrial fission in HT-22 neurons is associated with depolarization of the 






Figure 14  Bid inhibitor BI-6c9 prevents glutamate-induced mitochondrial depolarization 
A, Mitochondrial membrane potential was analyzed by JC-1 fluorescence: upper panels showed 
epifluorescence photomicrographs (40x objective) indicating equal cellular uptake of JC-1 by green 
fluorescence, lower panels depicted mitochondria exposing red fluorescence. Glutamate-treated (5 mM, 
12 h) HT-22 cells showed significantly reduced red fluorescence compared to controls whereas BI-6c9 
(10 μM) prevented the breakdown of the mitochondrial membrane potential as indicated by preservation of 
the red JC-1 fluorescence. B, FACS analyses of n=3 per group revealed a decrease of the red JC-1 
fluorescence to 30 % of control levels 12 h after glutamate treatment (5 mM) which is prevented by BI-6c9. 
Glutamate treatment was as effective as the positive damage-control CCCP, which causes a fast 
breakdown of the mitochondrial membrane potential. **p<0.01 compared to glutamate-treated cells 
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3.3.3 Specificity of the Bid inhibitor 
The presented data demonstrated a role for the proapoptotic BH3-only protein Bid in 
enhanced mitochondrial fragmentation in the oxytosis model systems of HT-22 cell. 
Oxytosis, or oxidative glutamate toxicity, is a particular type of oxidative stress caused 
by exposure of neurons to glutamate. This happens most commonly in vivo due to 
stroke, which leads to the release of glutamate from dead and dying neurons. Oxytosis 
leads to a distinct mode of cell death separate from that caused by excitotoxicity. When 
neurons are exposed to high levels of extracellular glutamate, the normal function of 
the cystine/glutamate antiporter Xct is inhibited. In recent studies it was additionally 
demonstrated, that Bid is involved in the loss of MOMP and release of mitochondrial 
AIF, thereby mediating delayed neuronal death after cerebral ischemia (60;134). The 
specificity of BI-6c9 in the presently used culture system was confirmed in HT-22 
neurons transfected with a tBid expression vector. Overexpression of tBid reduced cell 
viability by approximately 70 %, whereas cells pretreated with the Bid inhibitor BI-6c9 




Figure 15  Inhibition of Bid by BI-6c9 prevents tBid-induced cell death  
A, HT-22 neurons were pretreated with BI-6c9 (10 μM, 1 h) before transfection with a tBid expressing 
plasmid (pIRES-tBid) with the Lipofectamine 2000 protocol. MTT assay was used to determine the cell 
viability 14 h after tBid toxicity. Bid inhibitor BI-6c9 (10 μM, 1 h pretreatment) attenuated tBid toxicity. 
***p<0.001 compared to tBid-transfected cells (n=8) (ANOVA, Scheffé’s-test). B, Photomicrographs 
(10x objective) showed morphological evidence for severe damage of HT-22 cells 14 h after tBid toxicity. 
Similar to the glutamtate-treated cells, tBid toxicity induced loss of their spindle-like morphology, shrink 
and detach from the culture well bottom; in contrast, cells pretreated with the Bid inhibitor BI-6c9 (10 μM, 
1 h pretreatment) are fully protected against tBid-induced death and are not different from the controls. 
The experiments were repeated three times and the results presented as mean ± S.D. 
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Photomicrographs confirmed the essential role of Bid in tBid-induced neuronal death. 
HT-22 neurons exposed to tBid for 14 h showed typical morphology of dying cells: the 
neuronal cells appear shrunken, rounded and detach from the culture dish (Figure 
15B). HT-22 cells pretreated with the Bid inhibitor BI-6c9 retained their normal spindle-
shaped morphology and were completely rescued from tBid-induced cell death as 
determined by the MTT assay (Figure 15A, B). 
Additionally, this study revealed that glutamate-induced mitochondrial fragmentation 
also depended on tBid, since Bid inhibition by BI-6c9 prevented tBid-induced 
mitochondrial fission and preserved cell viability (Figure 16A, B). HT-22 cells 
transfected with tBid induced mitochondrial fragmentation, while treatment of BI-6c9 in 
combination with tBid preserved the tubulin-shaped mitochondrial morphology 
(Figure 16A). Quantification of mitochondrial morphology confirmed that BI-6c9 
reduced the number of fragmented, shorter mitochondria of categories 2 and 3 in 
tBid-transfected HT-22 cells (Figure 16B).  
 
 
Figure 16  Inhibition of Bid by BI-6c9 prevents tBid-induced mitochondrial fragmentation in 
neuronal cell death  
A, HT-22 neurons were pretreated with BI-6c9 (10 μM, 1 h) before cotransfection with an mGFP and a tBid 
expressing plasmid (pIRES-tBid) with the Lipofectamine 2000 protocol. Fluorescence photomicrographs 
(63x objective) of HT-22 cells showed tBid-induced mitochondrial fission and the Bid inhibitor BI-6c9 
(10 µM) prevented fission of mitochondria in tBid-induced toxicity after 14 h in HT-22 cells (nucleus - in 
blue (DAPI)). B, Quantification of mitochondrial morphology of five hundred cells per condition. Category 1: 
elongated tubulin-like, category 2: intermediate, category 3: fragmented. **p<0.01 compared to glutamate 
(5 mM)-treated cells (ANOVA, Bonferroni-test). The experiments were repeated three times and the results 























3 Results  57 
 
It is important to note that overexpression of tBid may only partly reflect the mechanism 
of Bid-mediated death signaling, since Bid cleavage could not be detected in significant 
amounts in HT-22 cells after the glutamate challenge. However, BI-6c9 prevents 
translocation of full-length Bid to mitochondria, tBid-induced mitochondrial fission, tBid-
mediated AIF release and cell death, suggesting that this model system is appropriate 
to mimic mechanisms mediating Bid-dependent neurotoxicity. 
3.4 BI-6c9 prevents Drp1 translocation to the 
mitochondria in glutamate-induced cell death 
There are a lot of speculations as to how Bcl-2 proteins are capable of regulating 
fission and fusion mechanisms of mitochondria. There is evidence that Bax, Bcl-xl and 
Bid are interact with Drp1, the main regulator of mitochondrial fission. Drp1 
translocates after an apoptotic stimuli to the mitochondria, oligomerize and interacts on 
specific fission sites with the mitochondrial outer membrane to induce fragmentation of 
mitochondria (26;55;96;100;112;122;137). The initial data in this presented study upon 
the role of Bid in glutamate-induced neurotoxicity, suggested that Bid is a key regulator 
of glutamate-induced mitochondrial fission in HT-22 cells. But the exact mechanism, 
how Bid is involved and interacts with the mitochondrial fragmentation machinery in 
neuronal cell death is currently under consideration. Though, these data raised the 
questions, firstly, does Drp1 translocation occur in this model system of oxidative stress 
and secondly, can Bid influence the Drp1 translocation to induce enhanced fission after 
glutamate-induced toxicity in HT-22 cells. Experiments addressing these questions 
were performed by immunocytochemistry. 
 
 
Figure 17  BI-6c9 inhibits glutamate-induced translocation of Drp1 to the mitochondria and 
prevents mitochondrial fission in HT-22 cells  
HT-22 cells were cultured for 24 h in 8-well-ibidi-plates and treated with 3 mM glutamate and BI-6c9 
(10 µM) for 17 h. Immunostaining of Drp1 revealed that Drp1 (green) translocation to the mitochondria 
(red) occured after glutamate stimulus. This is shown by overlapping of the fluorescence in yellow. 
Interestingly, BI-6c9 inhibited the translocation of Drp1 to the mitochondria and therefore mitochondrial 
fragmention.  
Control BI-6c9 BI-6c9 + GlutamateGlutamate
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This immunocytochemistry analysis revealed, that Drp1 (green) translocated to the 
mitochondria (red), where Drp1 formed clusters associated with mitochondria after 
glutamate treatment, concomitant with changes of mitochondrial shapes from tubulin-
like structures to round fragmented bodies with perinuclear distribution (Figure 17). In 
control cells, mitochondria (red) are distributed as tubulin-like structures and Drp1 
(green) is diffusely distributed in the cytosol. Treatment with the Bid inhibitor BI-6c9 
prevented Drp1 translocation to the mitochondria and Drp1 clustering and the 
mitochondrial morphology was protected after glutamate toxicity, respectively.  
In conclusion, glutamate toxicity induces a Drp1-dependent fragmentation, 
mitochondrial depolarization, accompanied with the movement of the mitochondria in 
the vicinity of the nucleus and decrease of cell viability in HT-22 cells. Bid inhibition can 
prevent these events and seems to interact with Drp1 in a direct or indirect manner. To 
reveal the direct interaction of Bid and Drp1, immunoprecipitation analysis was 
performed in this thesis (Figure 39). The analysis showed no direct interaction of Drp1 
with Bid which suggests, that they interact indirectly with each other via other proteins, 
such as Bax or until now unknown mechanisms. This has to be investigated in greater 
detail in future studies. 
3.5 Drp1 as a mediator of glutamate-induced 
mitochondrial fission 
3.5.1 SiRNA silencing of Drp1 attenuates glutamate-induced 
cell death and mitochondrial fragmentation in HT-22 cells 
The current knowledge on mechanisms regulating mitochondrial dynamics indicates 
that fission and fusion of mitochondria are under control of highly conserved dynamin-
related GTPases (76). Specifically, in mammalian cells, mitochondrial outer and inner 
membrane fusion is mediated by mitofusin-1 and -2 (Mfn-1, -2) and optical atrophy 1 
(OPA1), respectively (97;101). Mitochondrial fission is mediated by dynamin-related 
protein 1 (Drp1) (103-106). It has been suggested that the outer membrane proteins 
Fis-1 and Mfn-2 and the proapoptotic Bcl-2 family protein Bax (100) function directly or 
indirectly as Drp1 receptors to promote mitochondrial fission, however, the 
mechanisms that promote and regulate the recruitment of cytosolic Drp1 to 
mitochondria are largely unknown (46;103;105;111;112).  
The observation, that enhanced mitochondrial fission is linked to neuronal apoptotic 
cell death raises the possibility that Drp1 may serve as a target to get more insight into 
the whole mechanism of mitochondrial fission. Further, Drp1 may exert as a novel 
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therapeutic target for the prevention of neuronal cell death. In the present thesis, siRNA 
and novel small molecule inhibitors of Drp1 (125) were used to address, whether Drp1 
plays a major role in neuronal cell death after glutamate toxicity and oxygen-glucose 
deprivation (OGD) in vitro.  
The approach of Drp1 siRNA significantly reduced the expression of Drp1 mRNA and 
protein in cells as assessed by RT-PCR and western blot analysis, respectively. These 
analyses indicated that the Drp1-targeting siRNA significantly reduced the expression 
of Drp1 by >60 % in the HT-22 cells (Figure 18A). 
 
 
Figure 18  SiRNA silencing of Drp1 attenuates glutamate-induced neuronal cell death in HT-22 cells 
A, RT-PCR analysis of Drp1 mRNA (upper panels) and western blot analysis of Drp1 protein (lower 
panels) in HT-22 cells pretreated with 60 nM and 80 nM Drp1 siRNA for 48 h. RT-PCR with primers 
specific for glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) and anti-β-Actin-Antibody used as 
controls for respective analyses is shown. Quantification of the relative protein expression showed a 
reduction of 60 % and 70 %. B, After 24 h Drp1 siRNA transfected HT-22 cells were seeded out for 
additional 24 h in 96-well E-plates with 4,500 cells per well and treated with 3 mM glutamate for 20 h. Real 
time detection of cellular impedance was done with xCELLigence System (Roche, Penzberg, Germany). 
Glutamate-induced death did not differ in vehicle- or srambled siRNA treated cells, whereas Drp1 siRNA 
exerted a persistent protective effect. ***p<0.001 compared to glutamate 5 mM-treated cells (n=8) 
(ANOVA, Scheffé’s-test). C, FACS analysis of HT-22 cells after FITC-Annexin-V labeling to detect 
apoptotic cells. Exposure to glutamate (3 mM, 14 h) results in enhanced Annexin-V binding of apoptotic 
HT-22 cells compared to controls. Silencing of Drp1 by siRNA (80 nM) significantly reduced glutamate-
induced apoptosis. ***p<0.001 compared to glutamate 3 mM-treated cells (n=3) (ANOVA, Scheffé’s-test). 
The experiments were repeated three times and the results presented as mean ± S.D. 
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In addition, silencing of Drp1 enhanced cell viability in glutamate-treated HT-22 cells as 
detected by real time measurements of cellular impedance (Figure 18B) and FACS 
analysis of apoptotic cells after FITC-Annexin-V-staining (Figure 18C). Specifically, 
both assays indicated that glutamate treatment significantly reduced cell viability and 
that a similar decrease in cell survival was observed in cell populations treated with 
glutamate or scrambled siRNA. In contrast, cell viability was comparable to control 
cells, when cells were treated with both, glutamate and Drp1 siRNA (Figure 18B, C).  
These results indicate that Drp1 is a suitable target of therapeutic strategies for 
neuroprotection against glutamate toxicity.  
As shown before, glutamate-toxicity involved enhanced mitochondrial fragmentation in 
the model of HT-22 cells (92). Under control conditions, mitochondria were primarily 
organized in an evenly distributed tubular network in HT-22 cells, indicating a balance 




Figure 19  SiRNA silencing of Drp1 attenuates glutamate-induced mitochondrial fragmentation in 
HT-22 cells  
A, Fluorescence photomicrographs (63x objective) of mGFP-transfected and DAPI-stained HT-22 cells 
showed that Drp1 siRNA (80 nM, 48 h) prevented fission of mitochondria in glutamate-exposed (5 mM, 
18 h) HT-22 cells. B, Quantification of mitochondrial morphology of five hundred cells per condition: 
category 1: elongated tubulin-like, category 2: intermediate, category 3: fragmented mitochondria. *p<0.05 
compared to glutamate 5 mM-treated cells (ANOVA, Bonferroni-test). C, HT-22 cells were seeded out in 
96-well plates with 7,000 cells per well. Silencing of Drp1 attenuated glutamate (5 mM, 17 h)-induced cell 
death as determined by MTT assay (n=8). ***p<0.001 compared to glutamate 5 mM-treated cells (ANOVA, 
Scheffé’s-test). The experiments were repeated three times and the results presented as mean ± S.D. 
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In contrast, after exposure to glutamate, mitochondria were presented in cells as short 
tubules and round fragments with a perinuclear located phenotype of mitochondria, as 
indicated in the quantification analysis by the number of cells that contained long 
tubular structures (category 1) versus fragmented mitochondria (category 3) 
(Figure 19A, B). The approach of Drp1 siRNA, but not the control scrambled siRNA, 
attenuated mitochondrial fragmentation and preserved mitochondrial length in 
glutamate-treated cultures (Figure 19A, B, Figure 20A, B), indicated that glutamate-
induced fragmentation of mitochondria is Drp1 dependent (Figure 19B). In addition, 
silencing of Drp1 enhanced cell viability in glutamate-treated HT-22 cells as detected 
by the MTT assay (Figure 19C). In contrast, control scrambled siRNA could not 
attenuate cell viability after glutamate-induced damage in HT-22 cells (Figure 18B, C, 
Figure 19C).  
Overall, all shown cell viability assays and the quantification of mitochondrial 
morphology confirmed the protective effect of silencing of Drp1. The presented data 
indicate that glutamate-induced mitochondrial fragmentation is Drp1 dependent and 
accentuate Drp1 as a suitable target for therapeutic strategies of neuroprotection 







Figure 20  Scrambled siRNA has no effect on mitochondrial morphology 
A, Quantification of mitochondrial morphology of five hundred cells per condition. HT-22 cells transfected 
with scrambled siRNA (80 nM, 48 h) and treated with glutamate (3, 5 mM) for 18 h. Category 1: elongated 
tubulin-like, category 2: intermediate, category 3: fragmented. N.s. (ANOVA, Bonferroni-test). B, 
Mitochondrial length measurements of treated HT-22 cells by ImageJ. Six Pictures were quantified as 
absolute values (AU) by the ImageJ program. The experiments were repeated three times and the results 
presented as mean ± S.D. 
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3.5.2 Novel pharmacological inhibitors of Drp1 provide 
protective effects in HT-22 cells 
3.5.2.1 MdiviA rescues HT-22 cells from glutamate-induced mitochondrial 
fragmentation and neuronal cell death 
On the basis of the promising results from the siRNA approach, the next step was 
applying the specific Drp1 inhibitor mdivi-1 (derivative A: mdiviA, Figure 5), which 
based on previously published work target Drp1 (125) to test the therapeutic potential 
of Drp1 inhibition in the model of glutamate-induced neuronal cell death. MdiviA 
preserved the tubular mitochondrial morphology and completely rescued HT-22 cells 
from glutamate-induced mitochondrial fragmentation (Figure 21A, B). Quantification of 
mitochondrial morphology confirmed the effect of mdiviA, showing that the Drp1 
inhibitor increased the overall mitochondrial length and thus shifted the majority of 
mitochondria into category 1 in the cells (Figure 22D, Figure 21B).  
 
Figure 21  The novel pharmacological inhibitor of Drp1, mdiviA, protects HT-22 cells against 
glutamate toxicity 
A, Fluorescence photomicrographs (63x objective) of mGFP-transfected and DAPI-stained HT-22-cells 
showed that Drp1 inhibitor mdiviA (75 µM) prevented fission of mitochondria in glutamate-exposed (5 mM, 
18 h) HT-22 cells. B, Quantification of mitochondrial morphology of five hundred cells per condition. 
Category 1: elongated tubulin-like, category 2: intermediate, category 3: fragmented. **p<0.01 category 1 
mdiviA + glutamate compared to glutamate 5 mM-treated cells (ANOVA, Bonferroni-test). C, HT-22 cells 
were cultured for 48 h in 96-well E-plates with 4,500 cells per well and treated 24 h after seeding with 
3 mM and 5 mM glutamate and mdiviA (75 µM) for 18 h (n=8). Real time detection of cellular impedance 
was performed with xCELLigence System (Roche, Penzberg, Germany). The experiments were repeated 
three times and the results presented as mean ± S.D. 
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Inhibition of Drp1 by mdiviA did not only preserve mitochondrial morphology, but also 
enhanced cell viability of glutamate-treated HT-22 cells as detected by the MTT assay 
and real time measurements of cellular impedance. While glutamate significantly 
reduced cell viability to 50 - 20 % of control levels, inhibition of Drp1 by mdiviA 
preserved cell survival almost to baseline levels in MTT analysis (Figure 22A). 
Measurements of cellular impedance revealed that adding of glutamate at 
concentrations of 3 mM and 5 mM resulted in an immediate decline of normalized cell 
index (NCI) as a result of the temperature drop during the handling of the cells.  
 
 
Figure 22  MdiviA prevents mitochondrial length and neuronal cell death  
A, HT-22 cells were cultured in 96-well plates with 7,000 cells per well and MTT assay was used to 
determine the cell viability 18 h after glutamate (3 and 5 mM) treatment. Drp1 inhibitor mdiviA (75 µM) 
attenuated glutamate-induced cell death in HT-22 cells (n=8). B, FACS analysis of HT-22 cells after FITC-
Annexin-V labeling to detect apoptotic cells (n=3). Exposure to glutamate (5 mM, 14 h) resulted in 
enhanced Annexin-V binding of apoptotic HT-22 cells compared to controls. MdiviA (75 μM) significantly 
reduced glutamate-induced apoptosis. C, Photomicrographs (10x objective) showed morphological 
evidence for severe damage of HT-22 cells 17 h after glutamate-toxicity. Glutamate-treated cells lost of 
their spindle-like morphology, shrink and detach from the culture well bottom; in contrast, cells pretreated 
with the Drp1 inhibitor mdiviA (75 μM, 17 h) are fully protected against glutamate-induced death and are 
not different from the controls. D, Mitochondrial length measurements of treated HT-22 cells by ImageJ. 
Six pictures were quantified as absolute values (AU) by the ImageJ program. ***p<0.001, *p<0.05 
compared to glutamate (5 mM)-treated cells (ANOVA, Scheffé’s-test). The experiments were repeated 
three times and the results presented as mean ± S.D. 
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The NCI returned to baseline levels over the following 7 h of incubation in all control 
cultures and mdivi-treatment groups, whereas only the glutamate-treated cells showed 
a decrease of the NCI indicating progressive cell death in these cultures that became 
detectable between 8 h and 10 h after onset of 5 mM and 3 mM glutamate exposure, 
respectively (Figure 21C). Inhibition of Drp1 by mdiviA resulted in a complete protection 
of this delayed glutamate-induced loss of the NCI, and this protective effect against 
glutamate toxicity was also confirmed by FACS analysis of apoptotic cells after FITC-
Annexin-V-staining (Figure 22B).  
Photomicrographs confirmed the essential role of Drp1 in the glutamate-induced 
neuronal death. HT-22 neurons exposed to glutamate for 17 h showed typical 
morphology of dying cells: the neuronal cells appear shrunken, rounded and detach 
from the culture dish (Figure 22C). HT-22 cells pretreated with the Drp1 inhibitor mdiviA 
retained their normal spindle-shaped morphology and were completely rescued from 
glutamate-induced cell death as determined by the MTT assay and FACS analysis 
(Figure 22A, B).  
Here, these data confirm that glutamate-induced mitochondrial fragmentation depends 
on Drp1, since Drp1 inhibition by mdiviA prevented glutamate-induced mitochondrial 
fission and preserved cell viability. 
3.5.2.2 MdiviA inhibits glutamate-induced translocation of Drp1 to the 
mitochondria, and prevents lipid peroxidation and energy 
depletion 
It has been observed that Drp1 assembly and recruitment to mitochondria is stimulated 
during apoptosis (85;138;139). To gain further insight into Drp1-mediated mitochondrial 
division in HT-22 cells, the alterations of Drp1 distribution in the cells after glutamate 
exposure were examined. Consistent with the observations on mitochondrial 
morphology changes, glutamate treatment caused an increase in Drp1 clusters 
associated with mitochondria (Figure 23A). In contrast, in cells treated with mdiviA, the 
majority of Drp1 remained diffusely distributed in the cytoplasm despite the glutamate 
challenge similar to control cells. Consistent with the previous results, mitochondria in 
cells treated with mdiviA appeared as a tubular network, in sharp contrast to 
mitochondrial fragmentation present in cells undergoing glutamate-induced cell death 
(Figure 21A, Figure 22A).  
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Figure 23  MdiviA inhibits glutamate-induced translocation of Drp1 to the mitochondria, prevents 
energy depletion and lipid peroxidation 
A, HT-22 cells were cultured for 24 h in 8-well-ibidi-plates and treated with 3 mM glutamate and mdiviA 
(75 µM) for 14 h. Immunostaining of Drp1 revealed that Drp1 (green) translocation to the mitochondria 
(red) occured after glutamate stimulus. This is shown by overlapping of the fluorescence in yellow. MdiviA 
inhibited the translocation of Drp1 to the mitochondria. B, HT-22 cells were cultured in white 96-well plates 
with 7,000 cells per well and ATP-luminescence measurements treated with 3 mM and 5 mM glutamate 
and mdiviA (75 µM) at 14 h (n=8). C, Fluorecence detection of lipid peroxidation by Bodipy assay, 
quantified by FACS analysis (n=3). ***p<0.001 compared to glutamate (3, 5 mM)-treated cells (ANOVA, 
Scheffé’s-test). The experiments were repeated three times and the results presented as mean ± S.D. 
These results suggest, that mdiviA attenuated mitochondrial division during glutamate-
induced oxytosis by blocking Drp1 recruitment to mitochondria, consistent with 
previously published work indicating that this compound inhibits Drp1 translocation 
during STS-induced cell death (85;125). In addition to the protection against cell death, 
mdiviA also prevented HT-22 cells from ATP depletion (Figure 23B) and reduced 
significantly lipid peroxidation after glutamate toxicity (Figure 23C). 
3.5.2.3 The second isoform of the specific inhibitor of Drp1, mdiviB, also 
preserves cell viability 
Another novel specific Drp1 inhibitor and mdivi-1 derivative, mdiviB (125), was applied 
to confirm the essential role of Drp1 in glutamate-induced neuronal death. The 
structure of mdiviB is modified by two additional methyl groups to the mdiviA structure 
(Figure 5).  
In line with the previous results, HT-22 cells treated with mdiviB also preserved the 
tubulin-shaped mitochondrial morphology, while mitochondrial fragmentation 
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associated with glutamate toxicity was completely blocked by the Drp1 inhibitor (Figure 
24A). Quantification of mitochondrial morphology confirmed that mdiviB mediated an 
increase of tubulin-like mitochondria representing category 1 compared to glutamate-
treated HT-22 cells, which mainly showed fragmented, shorter mitochondria of 
categories 2 and 3 (Figure 24B, C). Moreover, mdiviB restored the cell viability 
assessed by the MTT assay. Glutamate-reduced cell viability to 20 % of control levels, 
whereas inhibition of Drp1 by mdiviB significantly preserved the viability in glutamate-
treated cells (Figure 25A, C). Analysis of Annexin-positive cells by FACS analysis 
confirmed the protective effect of mdiviB (Figure 25B).  
Overall, these results reveal a major upstream role for Drp1 in mitochondrial damage, 
energy depletion and subsequent execution of cell death in glutamate-induced oxytosis 




Figure 24  The second isoform of the specific inhibitor of Drp1, mdiviB prevents mitochondrial 
fission 
A, Fluorescence photomicrographs (63x objective) of mGFP-transfected and DAPI-stained HT-22 cells 
showed that Drp1 inhibitor mdiviB (75 µM) prevented fission of mitochondria in glutamate exposed (5 mM, 
18 h) HT-22 cells. B, Quantification of mitochondrial morphology of five hundred cells per condition. 
Category 1: elongated tubulin-like, category 2: intermediate, category 3: fragmented. **p<0.01 compared 
to glutamate (5 mM)-treated cells (ANOVA, Bonferroni-test). C, Mitochondrial length measurements of 
treated HT-22 cells by ImageJ. Six Pictures were quantified as absolute values (AU) by the ImageJ 
program. **p<0.01 compared to glutamate (5 mM)-treated cells (ANOVA, Scheffé’s -test). The experiments 
were repeated three times and the results presented as mean ± S.D. 
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Figure 25  The second isoform of the specific inhibitor of Drp1, mdiviB preserves cell viability 
A, HT-22 cells were cultured in 96-well plates with 7,000 cells per well and MTT assay was used to 
determine the cell viability 18 h after glutamate treatment (5 mM). Drp1 inhibitor mdiviB (50, 75 µM) 
attenuated glutamate-induced cell death in a concentration-dependent manner (n=8). B, FACS analysis of 
HT-22 cells after FITC-Annexin-V labeling to detect apoptotic cells. Exposure to glutamate (5 mM, 14 h) 
resulted in enhanced Annexin-V binding of apoptotic HT-22 cells compared to controls (n=3). MdiviB 
(75 μM) significantly reduced glutamate-induced apoptosis. ***p<0.001, **p<0.01 compared to glutamate 
(5 mM)-treated cells (ANOVA, Scheffé’s-test). C, Photomicrographs (10x objective) showed morphological 
evidence for severe damage of HT-22 cells 17 h after glutamate-toxicity. Glutamate-treated cells loose of 
their spindle-like morphology, shrink and detach from the culture well bottom; in contrast, cells pretreated 
with the Drp1 inhibitor mdiviB (75 μM, 17 h) are fully protected against glutamate-induced death and are 
not different from the controls. The experiments were repeated three times and the results presented as 
mean ± S.D. 
3.5.3 Drp1 gene silencing and pharmacological Drp1 inhibition 
prevent mitochondrial depolarization 
Loss of mitochondrial membrane potential (MMP) is a major feature of glutamate-
induced cell death that is associated with mitochondrial fragmentation and precedes 
the fatal release of AIF and execution of caspase-independent cell death (39;92).  
In line with previous experiments in HT-22 cells, JC-1 fluorescence, which measures 
MMP, showed significant loss of red fluorescence signal, indicated that there was a 
decrease in MMP within 12 h after glutamate treatment, similar to that observed after 
treatment with the mitochondrial uncoupler CCCP (Figure 26 and Figure 27). In 
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contrast, Drp1 siRNA significantly attenuated the glutamate-induced breakdown of the 
mitochondrial membrane potential and similar effects were detected after using the 





Figure 26  Inhibition of Drp1 prevents glutamate-induced mitochondrial depolarization 
A, Mitochondrial membrane potential was analyzed by JC-1 fluorescence: upper panels showed 
epifluorescence photomicrographs indicating equal cellular uptake of JC-1 by green fluorescence; lower 
panels depicted intact mitochondria exposing red fluorescence. Glutamate treated (5 mM, 12 h) HT-22 
cells show significantly reduced red fluorescence compared to controls whereas siRNA of Drp1 (80 nM) 
prevented the breakdown of the mitochondrial membrane potential as indicated by preservation of the red 
JC-1 fluorescence. B, FACS analyses of n=3 per group revealed a decrease of the red JC-1 fluorescence 
to 30 % of control levels 12 h after glutamate-treatment (5 mM) which is prevented by siRNA of Drp1 
(80 nM). Glutamate treatment was as effective as the positive damage-control CCCP which causes a fast 
breakdown of the mitochondrial membrane potential. ***p<0.001 compared to glutamate-treated controls 
(ANOVA, Scheffé’s-test). The experiments were repeated three times and the results presented as mean 
± S.D. 
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Figure 27  Inhibition of Drp1 prevents glutamate-induced mitochondrial depolarization 
A, Mitochondrial membrane potential was analyzed by JC-1 fluorescence: upper panels showed 
epifluorescence photomicrographs indicating equal cellular uptake of JC-1 by green fluorescence; lower 
panels depicted intact mitochondria exposing red fluorescence. Glutamate treated (5 mM, 12 h) HT-22 
cells show significantly reduced red fluorescence compared to controls whereas mdiviA and B (75 μM) 
prevented the breakdown of the mitochondrial membrane potential as indicated by preservation of the red 
JC-1 fluorescence. B, FACS analyses of n=3 per group revealed a decrease of the red JC-1 fluorescence 
to 30 % of control levels 12 h after glutamate-treatment (5 mM) which is prevented by mdiviA and B. 
Glutamate treatment was as effective as the positive damage-control CCCP which causes a fast 
breakdown of the mitochondrial membrane potential. ***p<0.001 compared to glutamate-treated controls 
(ANOVA, Scheffé’s-test). The experiments were repeated three times and the results presented as mean 
± S.D. 
Drp1-dependent mitochondrial fission is essential for the maintenance of mitochondrial 
integrity in neurons. Any impairment in the Drp1-mediated fission process in healthy 
cells can promote changes in mitochondrial morphology with loss of neuronal viability. 
To observe the effect of totally blocking Drp1 activity in healthy HT-22 neurons, mdiviA 
was added in increased concentrations of 75 - 500 µM.  
The approach of high concentrations of Drp1 inhibitor mdiviA showed a massive 
decrease of cell viability as evaluated by the MTT assay (Figure 28A). In the HT-22 
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the fission of mitochondria and drastically reduced mitochondria with tubulin-structure 
and enhanced the amount of rounded, fragmented mitochondria (category 3) 
(Figure 28B). This has been shown impressively in fluorescence photomicrographs of 
mGFP-transfected HT-22 cells treated with increased concentrations of mdiviA (Figure 
28C). Chemical or genetic interference with the mitochondrial fission machinery is 
reported to inhibit apoptotic mitochondrial fragmentation and delays cell death, which 
has to been considered beneficial for diseases, where mitochondrial fusion proteins are 
mutated and mitochondrial fission is enhanced.  
The findings of this experiment clearly indicate that a deregulation by inhibition of Drp1 
leads to a significant shift of the balance of fusion/fission protein activities towards 
fission. This deregulation of outbalanced fusion and fission mechanism has deleterious 
effects on mitochondrial homeostasis and consequently on neuronal survival. Thus, the 
regulation of mitochondrial dynamics must be tightly regulated in neurons, which 
suggests that Drp1 function is important for mitochondrial integrity and cellular 
homeostasis which cannot be sustained when Drp1 is totally blocked.  
 
 
Figure 28  Higher concentrations of Drp1 inhibitor mdiviA leads to enhanced mitochondrial 
fragmentation and neuronal cell death 
A, HT-22 cells were cultured in 96-well plates with 7,000 cells per well and MTT assay was used to 
determine the cell viability 18 h after treatment with Drp1 inhibitor mdiviA (75 - 500 µM) (n=8). ***p<0.001 
compared to control cells (ANOVA, Scheffé’s-test). B, Quantification of mitochondrial morphology of five 
hundred cells per condition. Category 1: elongated tubulin-like, category 2: intermediate, category 3: 
fragmented. C, Fluorescence photomicrographs (63x objective) of mGFP-transfected HT-22 cells showed 
that Drp1 inhibitor mdiviA (75 - 500 µM) enhanced mitochondrial fission in concentration-dependent 
manner after 18 h. HT-22 cells. ***p<0.001 compared control cells (ANOVA, Bonferroni-test). The 
experiments were repeated three times and the results presented as mean ± S.D. 
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3.5.4 Mdivi compounds mdiviC and E show protective effects 
on mitochondrial fragmentation in HT-22 cells 
Further mdivi-1 derivates, named mdiviC and E, were used in this model of glutamate-
induced oxytosis in HT-22 cells and showed similar effects on restoration of 
mitochondrial morphology and cell viability as detected before with mdiviA and B 
(Figure 29). MdiviC structure is modified by an additional chloride and mdiviE is 




Figure 29  Further mdivi compounds, mdiviC and E show similar protective effect on mitochondrial 
fragmentation in HT-22 cells 
A, Photomicrographs (10x objective) showed after glutamate treatment typically round HT-22 cell shape. 
Addition of Drp1 inhibitors mdiviC and E (50 µM, 18 h) showed spindle-like shapes as control. B, HT-22 
cells were cultured in 96-well plates with 7,000 cells per well and MTT assay was used to determine the 
cell viability 18 h after glutamate treatment (5 mM). Drp1 inhibitor mdiviC and E (50 µM) attenuated 
glutamate-induced cell death (n=8). ***p<0.001 compared to glutamate (5 mM)-treated cells (ANOVA, 
Scheffé’s-test). C, Quantification of mitochondrial morphology of five hundred cells per condtition. Mito-
GFP-transfected HT-22 cells were cotreated with mdiviC and E (50 µM) and glutamate (5 mM) for 18 h. 
Category 1: tubulin-like, category 2: intermediate, category 3: fragmented. **p<0.01 compared to 
glutamate (5 mM)-treated cells (ANOVA, Bonferroni-test). The experiments were repeated three times and 
the results presented as mean ± S.D. 
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3.5.5 The negative isoform of Drp1 inhibitor mdiviG cannot 
prevent mitochondrial fission in HT-22 cells 
In contrast, a closely related compound mdiviG (Figure 5), which previously was 
observed to have no efficacy in Drp1-dependent mitochondrial division, failed to inhibit 
glutamate-induced fragmentation and reverse glutamate-induced cell death, indicating 
that the effects of the active mdivi compounds are selective for Drp1 inhibition 
(Figure 30). 
 
Figure 30  The negative isoform of Drp1 inhibitor mdiviG cannot prevent mitochondrial fission in 
HT-22 cells  
A, Photomicrographs (10x objective) show no morphology differences after mdiviG (75 µM, 18 h) 
treatment compared to glutamte treatment. B, Fluorescence photomicrographs (63x objective) of mGFP-
transfected and DAPI-stained HT-22 cells showed that negative isoform of Drp1 inhibitor mdiviG 
(50, 75 µM) could not prevent fission of mitochondria in glutamate-exposed (5 mM, 18 h) HT-22 cells. C, 
Quantification of mitochondrial morphology of five hundred cells per condition. Cells treated with mdiviG 
(50, 75 µM) + glutamate (3 and 5 mM) showed similar amount of fragmented mitochondria in counted cells 
compared to glutamate-treated cells. Category 1: elongated tubulin-like, category 2: intermediate, category 
3: fragmented. N.s. non-significant (ANOVA, Bonferroni-test). D, HT-22 cells were cultured in 96-well 
plates with 7,000 cells per well and MTT assay was used to determine the cell viability 18 h after glutamate 
treatment (3 and 5 mM). Drp1 inhibitor mdiviG didn`t attenuate glutamate-induced cell death (n=8). N.s. 
non-significant (ANOVA, Scheffé’s-test). The experiments were repeated three times and the results 
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3.5.6 Inhibition of Drp1 prevents tBid-induced mitochondrial 
fragmentation and neuronal cell death 
The recent data demonstrated a role for the proapoptotic BH3-only protein Bid in the 
regulation of enhanced mitochondrial fission and in the loss of MMP in the present 
model system of HT-22 oxytosis. Therefore, the present study examined the role of 
Drp1 in Bid-mediated neuronal cell death. HT-22 cells were transfected with the toxic 
tBid-expressing vector to induce tBid-toxicity accompanied by enhanced mitochondrial 
fragmentation. Notably, the cotreatment with mdiviA and B with tBid-vector prevented 
tBid-induced cell damage and morphologic shape changes (Figure 31A, B). Moreover, 
treatment with mdiviA or B restored the cell viability assessed by the MTT assay. 
Vector-induced expression of tBid reduced cell viability to 30 % of control levels, 
whereas cell viability was restored to control levels when the Drp1 inhibitors were 
applied to tBid expressing cells (Figure 31B).  
 
 
Figure 31  Inhibition of Drp1 prevents tBid-induced neuronal cell death 
A, Photomicrographs (10x objective) of tBid-transfected and mdiviA and B treated HT-22 cells showed 
protective effect of cellular shape with mdiviA and B (75 µM, 12 h) treatment compared to tBid-induced 
toxicity. B, MTT assay was used to determine the cell viability 12 h after tBid toxicity. Drp1 inhibitors 
mdiviA and B (75 µM) attenuated tBid toxicity (n=8). ***p<0.001 compared to tBid toxicity (ANOVA, 






























3 Results  74 
 
Specifically, mitochondrial fragmentation associated with tBid-toxicity was significantly 
attenuated by Drp1 inhibitors mdiviA and B (Figure 32A). Quantification of 
mitochondrial morphology confirmed that mdiviA and B (75 µM) reduced fragmented, 
shorter mitochondria of category 3 in tBid-transfected HT-22 cells compared to tBid 
transfection alone (Figure 32A, B). This protective effect of mdiviA and B against tBid-
induced cell death was confirmed by FACS analysis of apoptotic cells after FITC-
Annexin-V-staining (Figure 32C), where inhibition of Drp1 by mdiviA and B resulted in a 
complete protection of this tBid-induced cell death. 
 
Figure 32  Inhibition of Drp1 prevents tBid-induced mitochondrial fragmentation and neuronal cell 
death  
A, Fluorescence photomicrographs (63x objective) showed that the Drp1 inhibitors mdiviA and mdiviB 
(75 µM) prevented fission of mitochondria in tBid-induced toxicity after 12 h in HT-22 cells. B, 
Quantification of mitochondrial morphology of five hundred cells per condition. Category 1: elongated 
tubulin-like, category 2: intermediate, category 3: fragmented. *p<0.05 compared to glutamate (5 mM)-
treated cells (ANOVA, Bonferroni-test). C, FACS analysis of HT-22 cells after FITC-Annexin-V labeling to 
detect apoptotic cells. Transfection of pIRES-tBid resulted in enhanced Annexin-V binding of apoptotic HT-
22 cells compared to controls. MdiviA and B (75 μM) significantly reduced tBid-induced cell death (n=3). 
***p<0.001 compared to tBid-toxicity (ANOVA, Scheffé’s-test). The experiments were repeated three times 











































3 Results  75 
 
In summery, these data demonstrate that Bid/tBid-mediated mitochondrial 
fragmentation and MOMP is dependent on Drp1 activity, since the Drp1 inhibition 
prevented tBid-induced fission and preserved cell viability. These findings were 
confimed by immunocytochemistry analysis of Drp1 translocation which is inhibited by 
the Bid inhibitor BI-6c9 (Figure 17). This sustain the detrimential interaction of Bid and 
Drp1 that occured upstream of mitochondrial pathways that involved mitochondrial 
fission. 
3.6 The Role of Drp1 in primary neurons in vitro and in 
vivo 
3.6.1 Mdivi compounds protect primary neurons against 
glutamate-induced excitotoxicity 
So far, the protective effects of Drp1 inhibition have been shown in immortalized HT-22 
hippocampal neurons, which die because of glutathione depletion after glutamate-
induced inhibition of the glutamate-cystine antiporter (40). HT-22 cells lack NMDA and 
AMPA/kainate receptors, and consequently, the HT-22 model of oxytosis only partly 
reflects the mechanisms of neuronal death after acute brain injury, which involves 
glutamate-induced immediate increase in the intracellular Ca2+-concentration through 
activation of the ion channel coupled glutamate receptors. Nevertheless, formation of 
ROS is also a major feature involved in glutamate toxicity in primary neurons 
downstream of initial calcium overload of the cells. Therefore, the study revealed the 
effects of the mdivi compounds in a model of glutamate-induced excitotoxicity in 
primary cortical neurons, which express NMDA and AMPA/kainate receptors. Primary 
rat cortical cultures were treated on day 9 after the preparation. At this time point the 
neurons express ionotropic glutamate receptors and are highly sensitive to glutamate-
induced excitotoxicity. MdiviA and B (25 µM) were added together with glutamate at 
concentrations of 30 µM. Cell viability was evaluated 18 h after glutamate treatment by 
DAPI staining of the nuclei and subsequent quantification of pyknotic nuclei. Similar to 
the results obtained in HT-22 cells, treatment of primary neurons with mdiviA or B 
significantly attenuated glutamate neurotoxicity (Figure 33). 
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Figure 33 Mdivi compounds protect primary neurons against glutamate-induced excitotoxicity  
Quantification of pyknotic nuclei in % of four independent experiments. Primary rat cortical neurons were 
treated on day 9 for 18 h with glutamate 30 µM and mdiviA and B (25 µM). After 18 h, cells were fixed in 
4 % PFA. After fixation cells were stained with DAPI and approximately five hundred nuclei were counted 
per treatment condition. MdiviA and B significantly reduced glutamate-induced cell death (n=5). ***p<0.001 
compared to glutamate-treated control cells (ANOVA, Scheffé’s-test). The experiments were repeated four 
times and the results presented as mean ± S.D. 
3.6.2 Mdivi compounds protect primary neurons against 
oxygen glucose deprivation (OGD) in vitro 
Cerebral ischemia causes severe and persistent brain damage is accompanied with a 
high mortality rate. To date, tissue plasminogen activator (tPa) is the only available 
therapy in patients suffering from ischemic stroke. However the number of stroke 
patients eligible for tPA treatment is very limited for safety reasons and, thus, the vast 
majority of patients do not receive any therapy targeting the cause of ischemia or 
mechanisms of the following delayed infarct development (140). 
Here, oxygen glucose deprivation (OGD) was used as an in vitro model for cerebral 
ischemia to investigate the protective effect and the role of Drp1 in delayed neuronal 
cell death. Similar protective effects of the mdivi compounds were also detected in 
primary neurons exposed to OGD (Figure 34A, B).  
Primary rat cortical neurons were treated with mdiviA and B (25 µM) one hour prior to 
OGD and were exposed to OGD for four hours. After 18 h of reoxygenation the cell 
viability was analyzed by DAPI staining and quantification of pyknotic nuclei. In this in 
vitro model system of ischemic conditions in a culture dish, control neurons displayed 
condensed, pyknotic nuclei 18 h after OGD with 75 %, whereas the neurons receiving 
the mdivi compounds A and B maintained healthy nuclear morphology to control levels 
(Figure 34A). Quantification of four independent experiments revealed that mdivi 
compounds A or B reduced OGD-induced cell death by approximately 55 % 
(Figure 34B).  
These results indicate that Drp1 activity is involved in ischemic neuronal cell death 
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Figure 34  Mdivi compounds protect primary neurons against OGD in vitro 
Primary rat cortical neurons (day 9) were exposed 4 h to OGD. A, Fluorescence microscope images 
(40x objective) of DAPI-stained embryonic cortical neurons were obtained after 18 h of exposure to OGD. 
B, Counting of DAPI-stained neurons displaying pyknotic nuclei after 4 h of OGD revealed that 25 µM Drp1 
inhibitor mdiviA and B significantly protect neurons from hypoxic-hypoglycemic cell death (n=5). 
***p<0.001 vs. untreated neurons subjected to OGD (ANOVA, Scheffé’s-test). Cultures treated with 25 µM 
mdiviA or B contained >60 % healthy nuclei, whereas all other OGD-treated groups showed 75 % pyknotic 
and/or fragmented nuclei, indicating apoptotic damage (OGD, right white column). The respective control 
cultures with 1x EBSS medium + glucose contained only very few apoptotic nuclei (Control, left white 
column). The experiments were repeated three times and the results presented as mean ± S.D. 
3.6.3 Mdivi compounds attenuate ischemic brain damage in 
vivo 
The findings on the efficacy of mdivi compounds in the in vitro models encouraged to 
expand the work for further investigations of their protective potential in vivo, in a model 
of ischemic stroke (Figure 35). The model of transient middle artery occlusion (MCAo) 
was performed by Uta Mamrak at the Ludwig-Maximilians-University in Munich, 
Germany.  
The C57BL/6 mice obtained intraperitoneal injections of two different doses of mdiviA 
(3 mg/kg) and mdiviB (1 and 3 mg/kg) one hour before the induction of MCAo. 
Transient focal ischemia was induced for 45 min. by a silicon-coated nylon filament that 
was introduced into the internal carotid artery to occlude the middle cerebral artery 
(MCA). The infarct volume was analyzed 24 h after reperfusion. Pretreatment of mdiviA 
(3 mg/kg) and mdiviB (1 and 3 mg/kg) significantly reduced the mean infarct volume by 
34 % and 30 % compared to vehicle (DMSO) controls, respectively, suggesting that 
Drp1 is a mediator of acute brain damage after MCAo (Figure 35A, B). In addition the 
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neuroscore was evaluated in the mice at 1 and 24 hours after reperfusion. The 
neuroscore is used to judge the motor activity of the animals. In contrast to the 
protective effects determined by histology, functional analysis by the neuroscore 
showed no difference between control and treated mice after one hour. Mice pretreated 
with mdiviA and B slightly improved the neuroscore at 24 h after reperfusion 
(Figure 35C, D).  
These results indicate that Drp1 participate in ischemic brain damage, whereas further 
analyses are required to evaluate the potential functional recovery that may be 






Figure 35  Mdivi compounds attenuate ischemic brain damage in vivo 
A and B, Transient focal ischemia was induced for 45 min. by a silicon-coated nylon filament that was 
introduced into the internal carotid artery to occlude the middle cerebral artery (MCA). Surgery was 
performed in deep isoflurane/N2O anesthesia with controlled ventilation, and ischemia and reperfusion 
were verified by laser Doppler fluxmetry. The infarct volume was calculated on the basis of the 
histomorphometric data from twelve-fifteen consecutive sections (every 500 µM) obtained 24 h after onset 
of ischemia. MdiviA (3 mg/kg) and mdiviB (1 and 3 mg/kg) reduced the mean infarct volume by 34 % and 
30 % compared to vehicle (DMSO) controls, respectively. C and D, The neuroscore was determined at 1 
and 24 hours after reperfusion in order to analyze the motor activitiy of the animals. Data in this figure are 
represented as mean +/- SEM. n=5 for mdiviA and n=10 for mdiviB (Mann-Whitney-U-test). 
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3.7 Mitochondrial distribution and mobility 
3.7.1 Tubulin structures are destroyed after glutamate toxicity 
in HT-22 cells 
It is known that tubulin filaments are involved in the transport of mitochondria in 
neurons and interact with dyneins and kinesins for mitochondrial transport into 
dendrites and axons to the places of high energy demand. It is commonly observed 
that mitochondria are often located around the nucleus after oxidative stress (92;93). 
To examine the reason for perinuclear location of mitochondria, the current thesis 
further investigated tubulin structures and their conformational changes associated with 
glutamate-induced cell death.  
In immunocytochemistry analysis of HT-22 cells, tubulin was stained by antibody in 
green and mitochondria by Mitotracker DeepRed in red. In control cells, tubulin 
displayed as long filaments and mitochondrial structures showed a tubular network, 
distributed in the whole cytosol. In contrast, glutamate-treated HT-22 cells displayed 
destroyed, punctuated tubulin structures after 14 h of the onset of glutamate exposure. 
This observation was highly consistent with the previous findings that mitochondria 
appeared in punctuated, fragmented organelles and accumulating around the nucleus 
with very similar kinetics as the tubulin destruction after the glutamate challenge 
(Figure 36A). Treatment with mdiviA or B (75 µM) and even BI-6c9 (10 µM) prevented 
this fragmentation of tubulin structures as well as mitochondrial fission, respectively. 
Quantification of percentages of cells with fragmented tubulin structures confirmed the 
observation that mdiviA or B, and even BI-6c9 acted as an upstream regulator to 
prevent tubulin destruction (Figure 36B). Measurements of the cytosolic area covered 
by mitochondria in HT-22 cells revealed that mitochondria move in the vicinity of the 
nucleus and the cytosolic area size remained more or less stable. Glutamate led to 
mitochondrial movement, where mitochondria covered an area from only 48 % of the 
cell. Small molecule inhibitors, like mdiviA and BI-6c9 could significantly avoid this 
movement of mitochondria to the nucleus and recovered the distribution of 
mitochondria to nearly control levels (Figure 36C).  
These findings strongly suggest the influence of Drp1 and Bid on tubulin structures and 
mitochondrial location around the nucleus in a so far unknown manner and kinetic.  
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Figure 36  Tubulin structures are destroyed after glutamate toxicity in HT-22 cells 
MdiviA, B and BI-6c9 interact with tubulin and influence the mitochondrial movement and distribution in 
HT-22 cells. A, HT-22 cells were cultured for 24 h in 8-well-ibidi plates and treated with 3 mM glutamate 
and mdiviA and B (75 µM) and BI-6c9 (10 µM) for 14 h. Immunocytochemistry analysis revealed that 
tubulin structures (green) were destroyed, mitochondria (red) fragmented and moved into the vicinity of the 
nucleus after glutamate (3 mM) stimulus. MdiviA and BI-6c9 inhibited the destruction of tubulin filaments 
and prevented mitochondiral fission. B, Quantification of tubulin morphology of five hundred cells per 
condition in at least four independent experiments. ***p<0.001 compared to glutamate (3 mM)-treated cells 
(ANOVA, Scheffé’s-test). C, Determination of mitochondrial localisation in the HT-22 cells. HT-22 cells 
were stained with Mitotracker DeepRed and treated with mdiviA, B (75 µM) and glutamate (3 mM) for 16 h. 
The area of cytosol and the area of mitochondria were quantified with LASAF sofware (Leica, Wetzlar, 
Germany). The quotient: area covered by mitochondria/area cytosol in percantage represented in low 
values fragmented, perinuclear located mitochondria, which are less distributed in the cytosol. Control cells 
or mdiviA or BI-6c9 treated cells represented a high value of the quotient, mitochondria are distributed in 
the whole cytosol. ***p<0.001 compared to glutamate (3 mM)-treated cells (n=20, ANOVA, Scheffé’s-test). 
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3.7.2 Cyclosporine A prevents mitochondrial fragmentation 
after glutamate-toxicity in HT-22 cells 
Mitochondrial membrane permeabilization (MMP) can derive from two distinct, but 
partially overlapping, molecular mechanisms. On the one hand, large channels formed 
by “multi-domain” proapoptotic proteins of the Bcl-2 family (Bax and Bak) might 
selectively promote mitochondrial outer membrane permeabilization (MOMP). On the 
other hand, cell death inducers such as Ca2+ or oxidative stress can trigger MMP at the 
inner mitochondrial membrane (IMM), by favoring the opening of the permeability 
transition pore complex (PTPC) for the release of proapoptotic proteins, such as Cytc 
and AIF (38). Further is known, that Ca2+-dependent phosphatase calcineurin regulates 
the subcellular localization of Drp1 by dephosphorylation. Dephosphorylation of Drp1 
by calcineurin promotes translocation of Drp1 to the mitochondria causing their fission 
in apoptotic cell death (113).  
 
Figure 37  Cyclosporine A prevents mitochondrial fragmentation after glutamate toxicity in HT-22 
cells 
A, Fluorescence photomicrographs (63x objective) showed mGFP-transfected and DAPI-stained HT-22 
cells. The pore blocker cyclosporine A (CysA 5 and 10 µM, 18 h) prevented fission of mitochondria after 
glutamate (3 mM, 18 h). B, HT-22 cells were cultured in 96-well plates with 7,000 cells per well and MTT 
assay was used to determine the cell viability 18 h after glutamate toxicity (3 mM). Cyclosporine A (5, 
10 µM) showed significantly protective effects compared to glutamate-treated cells (n=8). ***p<0.001 
compared to glutamate-treated cells (ANOVA, Scheffé’s-test). C, Quantification of mitochondrial 
morphology of five hundred cells per condition. Category 1: tubulin-like, category 2: intermediate, 
category 3: fragmented. Cyclosporine A (10 µM, 18 h) significantly prevented mitochondrial fragmentation 
after glutamate treatment (3 mM, 18 h) (n=3). *p<0.05 compared to glutamate (3 mM)-treated cells 
(ANOVA, Bonferroni-test). The experiments were repeated three times and the results presented as mean 
± S.D. 
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To address the question, if glutamate-induced Ca2+-increase induces the activity of 
calcineurin thereby influencing Drp1 localization, cyclosporine A (CysA), as a specific 
inhibitor of calcineurin was used. It is interesting to note, that CysA binds additionally to 
cyclophilin D (CypD), one part in the PTPC and thereby inhibiting PTPC opening, 
respectively (141). 
CysA prevented cell death in the glutamate toxicity model in HT-22 cells as evaluated 
by MTT assay (Figure 37B). In addition glutamate-induced mitochondrial fragmentation 
was also prevented by CysA 18 h after the onset of glutamate treatment 
(Figure 37A, C). The significant protective effect of CysA is due the inhibition of the 
activity of Ca2+-dependent calcineurin, which dephosphorylated Drp1 and thereby 
induced the increased translocation of Drp1 to the mitochondria and subsequently 
mitochondrial fragmention after glutamate toxicity. In addition, CysA inhibited the 
opening of MPT pores after glutamate challange. Both events seemed to be active in 
this model system of oxidative stress and were prevented by CysA (5, 10 µM) 
(Figure 37A, B).  
Based on the fact that the HT-22 model of oxytosis only partly reflects the mechanisms 
of neuronal death, cyclosporine A was also tested in a model of glutamate-induced 
excitotoxicity in primary cortical neurons. Similar to the previous findings in HT-22 cells, 
treatment with CysA (5, 10 µM) of primary rat cortical neurons significantly attenuated 
glutamate-toxicity as quantified by the MTT assay (Figure 38).  
The mitochondrial transition pore and the role of Ca2+-dependent calcineurin in the 
regulation of Drp1 activity presented further mechanisms in the complex regulation of 
mitochondrial fission in glutamate-induced cell death. Both mechanisms can be 
specifically blocked by CysA.  
 
Figure 38  Cyclosporine A prevents mitochondrial fragmentation after glutamate toxicity in primary 
cortical neurons 
MTT assay was used to determine the cell viability 18 h after glutamate toxicity. Primary rat cortical 
neurons were treated on day 9 for 18 h with glutamate (30 µM) and mdiviA and B (25 µM). Cyclosporine A 
(5, 10 µM) showed significantly protective effects compared to glutamate-treated cells (n=8). ***p<0.001 
compared to glutamate-treated cells (ANOVA, Scheffé’s-test). The experiments were repeated three times 
and the results presented as mean ± S.D.  
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These experiments assumed that calcineurin could be activated by glutamate and 
cause dephosphorylation of Drp1, followed by Drp1 translocation to the mitochondria. 
Furthermore, these experiments give evidences that the opening of the PTPC occur in 
parallel to mitochondrial fission in glutamate-induced cell death. However, further 
studies are necessary to clarify, if the opening of the transition pore is a consequence 
or epiphenomena during mitochondrial fission in these model systems of glutamate 
neurotoxicity in HT-22 cells and primary cortical neurons. Further, the regulation of 
Drp1 by calcineurin could provide a target to manipulate apoptotic mitochondrial fission 
and a helpful tool to clarify the mechanism of Drp1-dependent mitochondrial 
fragmentation in neuronal cell death. Therefore, future studies have to elucidate, which 
exact role calcineurin has in the glutamate toxicity model in HT-22 cells.  
3.7.3 Protein interacting partners of Drp1 in HT-22 cells after 
glutamate-toxicity  
Mitochondrial fission is a complex process, which is mainly regulated by the Drp1 
protein. It has been suggested that the mitochondrial outer membrane protein Fis-1 
and the proapoptotic Bcl-2 family proteins Bax and Bcl-xl (100;110) operate directly as 
positive regulators of Drp1 to promote mitochondrial fission in apoptosis 
(46;103;105;111;112). The potential interacting partners of Drp1 in the glutamate 
oxytosis model are unknown, yet. Thus, protein lysates were analyzed by 
immunoprecipitation of Drp1 to identify potential protein interaction partners and further 
regulator proteins of mitochondrial fission in HT-22 cells. HT-22 cells were treated with 
glutamate (3 mM) and cells were harvested at defined times, ranging from 8 h to 12 h 
after the onset of glutamate exposure. The following immunoprecipitation experiment 
revealed two Bcl-2 family proteins which interacted with Drp1. Enhanced binding of 
Bcl-xl and Bax was detected 10 - 12 h after the onset of the glutamate treatment 
(Figure 39).  
These findings fit well to recently published data, indicating that Drp1 and Bax 
interacted to enhance mitochondrial dysfunction by opening the membrane pore and 
inducing fragmentation of this organelle (112). No interaction of Drp1 was detected with 
BH3-only protein Bid. This suggest that Bid and Drp1 do not interact directly to induce 
mitochondrial fragmentation and further studies are required to find the exact 
mechanism, on which both proteins regulate mitochondrial fission and dysfunction in 
glutamate-induced cell death. Further, the experiment in HT-22 cells reveals that Bax 
could be a key regulator and the link between Drp1 and Bid in the regulation of MOMP 
and fission in HT-22 cells after glutamate-toxicity. This theory is confirmed by current 
literature, where is describing that both proteins are able to interact directly with Bax. 
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Figure 39  Western blot analysis of Drp1 and interacting partners in HT-22 cells after glutamate-
toxicity in HT-22 cells 
Immunoprecipitation analysis of Drp1 protein was prepared from 2.5 mg total protein lysat of HT-22 cells 
which are treated with 3 mM glutamate for 8, 10 and 12 hours. Western blot analysis showed on the left 
side the pulldown of Drp1 and on the right side total protein lysat with 30 µg. 10 hours after glutamate 
treatment in HT-22, Drp1 interacts with Bcl-2 family proteins Bax and Bcl-xl. No interaction was detectable 
with BH3-only protein Bid. 
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3.8 The Role of Drp1 and Bid in different models of 
oxidative stress 
The previous results suggested that Drp1 and also Bid are key mediators of glutamate-
induced mitochondrial fission and cell death in HT-22 cells as well as in primary 
neurons. In order to elucidate, whether Drp1 activation or Bid activation is also involved 
in neuronal cell death induced by different oxidative stress stimuli, several prominent 
models of oxidative stress were analyzed in HT-22 cells, to address the involvement of 
Drp1 and Bid. To this end, HT-22 neurons were exposed to radical donors such as 
glucose oxidase (GO) and H2O2, 4-HNE (4-Hydroxynonenal) as well as to nitrogen 
monoxide (NO)-donors, such as DEANONOate and sodium nitropusside (SNP).  
3.8.1 Bid inhibition does not prevent neuronal cell death by 
radical donors 
The radical donors glucose oxidase and H2O2 induced cell death in HT-22 cells in a 
concentration- and time-dependent manner (Figure 40A, B). Both model substances 
are common radical donors and were applied in several studies on mechanisms of 
neurodegenerative diseases (142;143). It is important to note, that treatment with H2O2 
leads to rapid production of high ROS levels, whereas glucose oxidase serves as a 
more continuous source for the release of H2O2. 
To determine the potent role of the BH3-only protein Bid in GO- and H2O2-induced cell 
death, HT-22 cells were pretreated with BI-6c9 (10 µM) for one hour before incubation 
with H2O2 (600 - 700 µM) and GO (10 - 20 mU/ml). Cell viability was evaluated by MTT 
assay at 16 h. Inhibition of Bid could not prevent cell death induced by radical donors 
(Figure 40C, D). In contrast, studies with radical scavenger, like NAC showed 
protective effects HT-22 cells against H2O2-induced cell death (144). 
In conclusion these data show that cell damage induced by radical donors is not 
comparable with glutamate-induced cell death and the associated oxytosis. Bid 
apparently plays no role in cell death in HT-22 cells exposed to radical donors. 
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Figure 40  Bid inhibitor BI-6c9 does not prevent radical donor induced cell death 
HT-22 cells were cultured in 96-well plates with 7,000 cells per well and treated with A, glucose oxidase 
(GO) (1 - 20 mU/ml) and B, H2O2 (500 - 700 µM). Cell death was evaluated by MTT assay 14 - 16 h after 
the onset of the treatment (n=8). Cells died in a concetration- and time-dependent manner. HT-22 cells 
were treated with C, glucose oxidase (GO) (10 - 20 mU/ml) and D, H2O2 (500 - 700 µM). H2O2 and glucose 
oxidase were added 1 h after pretreatment with BI-6c9 (10 µM). After 16 h cell death was evaluated using 
the MTT assay (n=8). The experiments were repeated three times and the results presented as mean ± 
S.D. 
3.8.2 4-HNE-induced cell death is not prevented by BI-6c9 
Peroxidation of cellular membrane lipids or circulating lipoprotein molecules generates 
highly reactive aldehydes. Among these, the most important reactive aldehyde is the 
toxic second messenger of free radical formation, 4-Hydroxynonenal (4-HNE), which is 
often detected in brain tissues of patients suffering from neurodegenerative diseases, 
e.g. in the brain of AD patients. Application of 4-HNE in neuronal cultures is a widely 
used model system in vitro to investigate mechanisms of neurodegeneration (145-147). 
To elucidate the question, if Bid is activated in 4-HNE-induced neuronal cell death, 
BI-6c9 (10 µM) was added one hour before treatment with 4-HNE. 4-HNE induced 
concentration- and time-dependent cell death in HT-22 neurons (Figure 41A), which 
could not be prevented by the Bid inhibitor BI-6c9 (10 µM) 16 h after the exposure to 
4-HNE as quantified by the MTT assay (Figure 41B). These data suggest that Bid was 
not involved in the death signaling pathway of 4-HNE induced cell death in HT-22 
neurons. Further, these data indicated that glutamate toxicity does not involve 
formation of large amounts of 4-HNE and 4-HNE triggers different apoptotic pathways 
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Figure 41  4-Hydroxynonenal (4-HNE) causes cell death independent on Bid activation in HT-22 
cells 
HT-22 cells were cultured in 96-well plates with 7,000 cells per well. A, HT-22 cells are treated with 4-HNE 
(2 - 10 µM) for 16 h. Time- and concentration-dependent cell death was induced by 4-HNE and evaluated 
by MTT assay (n=8). B, The inhibition of Bid by one hour preincubation with the Bid inhibitor BI-6c9 
(10 µM) failed to prevent 4-HNE-induced damage atfer 16 h. Cell viability was detected using the MTT 
assay (n=8). The experiments were repeated three times and the results presented as mean ± S.D. 
3.8.3 NO toxicity and subsequent nitrosylation of Drp1 does not 
occur in glutamate-treated HT-22 cells 
In recent studies it has been shown, that NO-mediated neuronal cell death occur 
amongst others by nitrosylation of proteins, like Drp1 (116;120;148-150) after induction 
of oxidative stress or disruption of the calcium homeostasis (32;116;151). To address 
the question, whether Drp1 was regulated in the NO-induced cell death in HT-22 cells 
and if NO-mediated post-translationally modification of Drp1 played a role in this kind of 
cell death, the NO-donor DEANONOate was applied. DEANONOate was added at final 
concentrations of 2 - 10 mM to induce cellular toxicity by a fast release of NO. 
DEANONOate is a very unstable chemical substance, which induced high NO-levels 
immediately after the onset of the treatment.  
In HT-22 cells, DEANONOate (2 - 10 mM) induced a concentration-dependent damage 
which was evaluated by MTT assay (Figure 42A) after 14 - 16 h after the onset of the 
treatment. Application of Drp1 inhibitor mdiviA (75 µM) and Bid inhibitor BI-6c9 (10 µM) 
one hour prior to DEANONOate (2 mM) failed to prevent NO-mediated neuronal cell 
death in HT-22 cells (Figure 42B, C). These results suggest that Bid and Drp1 
activation is not involved in the NO-induced cell death in HT-22 cells. 
A B








































3 Results  88 
 
 
Figure 42  NO toxicity does not involve Drp1 and Bid activity 
HT-22 cells were seeded out in 96-well plates with 7,000 cells per well. 24 h after seeding of the cells 
treatments starts with the pretreatment of the inhibitors. A, NO donor DEANONOate (2 - 10 mM) reduced 
cell viability in HT-22 cells in a concentration-dependent manner. B and C, mdiviA (75 µM) was added 1 h 
prior to DEANONOate (2 mM) and Drp1 and Bid inhibition did not prevent DEANONOate-induced cell 
death. Cell viability was analyzed by MTT assay 14 - 16 h after the onset of the treatment (n=8). The 
experiments were repeated three times and the results presented as mean ± S.D. 
In order to examine the role of potential NO-release in detail, the HT-22 cells were also 
treated with sodium nitropusside (SNP, 20 µM - 20 mM) to induce the formation of NO, 
CN- and Fe2+. It is important to note, that SNP leads to a continuous release of Fe2+ and 
CN- and persistent low levels of NO overtime in the cell, in contrast to the application of 
DEANONOate, where toxic NO levels are immediately achieved. SNP reduced the cell 
viability in the HT-22 cells in a concentration- and time-dependent manner after 
16 hours of exposure (Figure 43A). Adding the Bid inhibitor BI-6c9 (10 µM) one hour 
prior to SNP significantly reduced cell death as detected by the MTT assay after 16 h 
(Figure 43B). In contrast, the Drp1 inhibitor mdiviA (75 µM) added one hour prior the 
SNP treatment failed to prevent SNP toxicity (Figure 43B). Real time measurements of 
cell viability by the xCELLigence System showed that inhibition of Bid by BI-6c9 clearly 
prevented the SNP-induced neuronal cell death which is confirmed by the MTT assay 
(Figure 43C). In summary, neuronal cell death induced by different NO-donors, such as 
DEANONOate or SNP activate different apoptotic pathways compared to glutamate. 
Apparently, Drp1 was not involved in this NO-mediated cell death in neuronal HT-22 
cells. In contrast, Bid seems somehow to be involved in the SNP-induced neuronal cell 
death in HT-22 cells, which has to be studied in greater detail in the future. 
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Figure 43  Bid inhibtion prevents SNP-induced neuronal cell death, but not Drp1-inhibiton 
HT-22 cells were seeded in 96-well plates with 7,000 cells per well. Twenty-four after seeding of the cells 
treatment started with the pretreatment of the inhibitors BI-6c9 (10 µM) and mdiviA (75 µM). A, The SNP 
(20 µM - 5 mM) reduces cell viability in HT-22 cells in a concentration-dependent manner. B and C, mdiviA 
(75 µM) and BI-6c9 (10 µM) were added 1 h prior to SNP (200 and 400 µM) and Bid inhibition prevents 
SNP-induced cell death in HT-22 cells. Cell viability was analyzed by MTT assay 14 - 16 h after the onset 
of the treatment (n=8). ***p<0.001 compared to SNP (200 and 400 µM)-treated cells (Anova, Scheffé’s-
test). C, HT-22 cells were cultured for 48 h in 96-well E-plates and treated with 200 and 400 µM SNP and 
BI-6c9 (10 µM) for 18 h. Real time detection of cellular impedance was performed with xCELLigence 
System (n=8) (Roche, Penzberg, Germany). The experiments were repeated three times and the results 
presented as mean ± S.D. 
In order to examine the mechanism of SNP toxicity in further detail and with regard to 
post-translational modification by nitrosylation of Drp1 in this model system of oxidative 
stress, total protein lysates of HT-22 cells were analyzed by western blotting to 
evaluate the tyrosine nitrosylation after exposure to SNP. The NO-donor DEANONOate 
was used as a positive control to confirm the function of the antibody. Tyrosine 
nitrosylation was not detectable in cells exposed to SNP suggesting that the formation 
of NO and subsequent tyrosine nitrosylation was not the dominant trigger in neuronal 
cell death and did not modify the Drp1 protein in HT-22 cells (Figure 44). 
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Figure 44  SNP does not induce detectable tyrosine nitrosylation 
Total protein lysate was obtained from damaged HT-22 cells after 16 h exposure to SNP (400 and 600 µM) 
± mdiviA (75 µM) and DEANONOate (2 mM) and analyzed by western blotting. Nitrosylation of tyrosine 
residues were detected using an anti-nitro-tyrosine antibody (New England Biolabs-Cell Signaling, 
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4 Discussion 
The major aim of this thesis was to analyze the mitochondrial dynamics and their 
regulation by the proteins Drp1 and Bid in models of glutamate-induced neuronal cell 
death. The involvement of Bid and Drp1 was mainly characterized in immortalized 
mouse hippocampal HT-22 neurons and in primary neuronal cultures exposed to toxic 
glutamate concentrations. In addition, the roles of Bid and Drp1 in other models of 
oxidative stress induced by H2O2, 4-HNE and NO-donors like SNP and DEANONOate 
were addressed. 
The first part of this study revealed the critical involvement of enhanced mitochondrial 
fission in glutamate-induced cell death. The results showed that glutamate-induced 
apoptosis was associated with enhanced mitochondrial fission, loss of mitochondrial 
membrane potential and relocation of fragmented mitochondria to the nucleus. Further, 
the results obtained here provided evidence for an essential role of the BH3-only 
protein Bid in mitochondrial fragmentation of neuronal apoptosis caused by oxidative 
stress. The mitochondrial fragmentation, the associated loss of the mitochondrial 
membrane potential and cell death were prevented by BI-6c9, a highly specific Bid 
inhibitor, indicating a major role of Bid in death signaling upstream of mitochondrial 
fission, and the altered cellular distribution and integrity of these organelles in neuronal 
cells.  
The second part of this study explored whether Drp1 played a major role in neuronal 
cell death after glutamate-toxicity in HT-22 cells and primary cortical neurons. To 
investigate the role of Drp1, highly specific small molecule inhibitors of Drp1 and siRNA 
approach were used for the first time in this model system of oxidative stress in 
neuronal cells. The data demonstrated a significant neuroprotective effect through 
inhibition of Drp1, suggesting that this regulator of mitochondrial fission is involved in 
delayed neuronal cell death. This conclusion is based on findings showing that down-
regulation of Drp1 by siRNA or by small molecule inhibitors significantly preserved 
mitochondrial morphology and mitochondrial membrane potential, and reduced 
glutamate toxicity in neuronal cells. In addition, the Drp1 inhibitors protected primary 
cortical neurons against oxygen glucose deprivation in vitro, and preserved brain tissue 
after cerebral ischemia in vivo. These results exposed Drp1 as a key factor in ischemic 
and glutamate-induced neuronal cell death and identified Drp1-dependent 
mitochondrial fission as a potential therapeutic target in acute cerebrovascular 
diseases.  
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Overall, data obtained from the present study demonstrated for the first time that Bid 
and Drp1 are key regulators of mitochondrial cell death pathways associated with 
glutamate toxicity and enhanced oxidative stress in neurons. Bid-mediated neuronal 
cell death involved Drp1-dependent mitochondrial fission, mitochondrial relocation to 
the nucleus, mitochondrial membrane permeabilization, and release of mitochondrial 
cell death regulators such as AIF. Therefore, the presented data exposed the inhibition 
of Bid and inhibition of Drp1 as a promising therapeutic strategy to prevent 
mitochondrial fragmentation and dysfunction, hallmarks of neuronal cell death in many 
acute and chronic neurodegenerative diseases. 
4.1 Enhanced mitochondrial fission induced by 
glutamate in HT-22 cells 
Mitochondria routinely divide and fuse through the actions of conserved large 
GTPases. Under physiological conditions the rate of such mitochondrial dynamics is 
balanced by the rate of fusion and fission events. Especially in neurons, mitochondrial 
dynamics appear to play an even more critical role because of complex energy 
requirements for maintaining and restoring neuronal membrane potential and particular 
synaptic functions, such as neurotransmitter synthesis and release. Dysregulation of 
mitochondrial dynamic proteins enhance fragmentation, loss of mitochondria in 
dendritic spines and increase synapse formation and dysfunction. In the present study, 
the mitochondria network in neuronal cells underwent dramatic rearrangement after the 
apoptotic damage induced by glutamate, resulting in fragmented mitochondrial 
phenotype associated with enhanced mitochondrial fission, loss of mitochondrial 
potential and relocation of fragmented mitochondria to the vicinity of the nucleus.  
Exposure of HT-22 cells to glutamate resulted in enhanced, ROS formation in a time-
dependent manner and this ROS formation was associated with a significant change in 
mitochondrial morphology. Mitochondria were organized as a tubular network under 
control conditions, however, after exposure to glutamate the network broke up in short 
tubules and round fragments. In HT-22 cells, mitochondrial fragmentation and the 
organelle`s relocation to the nucleus started 3 - 4 hours after exposure to glutamate 
and was associated with the increased ROS formation, lipid peroxidation and the 
decreased cell viability. It is interesting to note that the recruitment of the mitochondria 
was detectable by the accumulation and agglomeration of the highly fragmented 
mitochondria in the vicinity of the nucleus, suggesting that in dying neurons enhanced 
mitochondrial fission was permissive for an enhanced transport of these organelles 
towards the nucleus. This was further confirmed by the measurements showing that 
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the cytososolic area covered by mitochondria in the cell after glutamate was 
significantly reduced and a breakdown of the tubulin network at later time points. These 
kinetics of mitochondrial changes fitted well with the kinetics of cell death execution 
that has been established in the applied model of glutamate-induced oxidative cell 
death. In particular, multiple lines of evidence proposed a prelude of several hours for 
the glutamate-induced glutathione depletion and Bid-mediated disruption of 
mitochondrial function. Previous studies defined a therapeutic time window of 8 - 10 h 
after the onset of the glutamate challenge that allowed delayed application of 
antioxidants or e.g. the Bid inhibitor to rescue mitochondrial function and to prevent 
neuronal cell death (39).  
The impedance measurements correlated very well with established measurements of 
cell viability by the standard MTT assay and clearly demonstrated that oxidative cell 
death occurred not before 8 – 10 h after onset of the glutamate challenge. In this time 
frame, enhanced mitochondrial fission and peri-nuclear accumulation of the organelles 
precede the final execution of cell death that is featured by mitochondrial membrane 
permeabilization and release of mitochondrial AIF to the nucleus. Further, the observed 
agglomeration of fragmented mitochondria in close vicinity to the nucleus further 
explains the relatively fast kinetics of the following death execution that occurs within 
1 - 3 h after the preluding events and involves rapid translocation of AIF to the nucleus 
as shown by video-microscopy in earlier work (39). The high number of fragmented 
and permeabilized mitochondria is likely to be a prerequisite for the observed rapid 
transfer of the deadly mitochondrial protein over the short distance to the nuclei of 
lethally stressed cells.  
In conclusion, enhanced mitochondrial fission is a key feature for programmed cell 
death execution, since fragmented mitochondria can easily accumulate around the 
nucleus where they release their deadly message after reaching the “point of no return” 
marked by mitochondrial membrane permeabilization. 
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4.2 The Bcl-2 family proteins modulate mitochondrial 
dynamics 
4.2.1 The Bcl-2 family proteins control mitochondrial dynamics 
in nonapoptotic cells 
Accumulating evidence suggests that members of the Bcl-2 family influence 
mitochondrial network-dynamics in healthy neuronal cells. The proapoptotic proteins 
Bax and Bak were the first Bcl-2 family members discovered to play a role in 
mitochondrial dynamics in nonapoptotic cells by interacting with components of the 
machinery regulating mitochondrial dynamics. It has been reported that Bax and Bak, 
can directly interact with mitofusins. Both proteins promote mitochondrial fragmentation 
by regulating the localisation of Mfn-1, its mobility in the outer mitochondrial membrane 
(OMM) as well as its ability to oligomerize (152;153). Further, antiapoptotic Bcl-xl has 
been shown to interact with Drp1 in neurons and Bcl-xl may regulate mitochondrial 
fusion and fission in a Drp1-dependent manner with impact on synapse formation and -
activity, biomass and mitochondrial localization in the synapses (110).  
4.2.2 The Bcl-2 proteins control mitochondrial dynamics in 
apoptotic cells 
The control of mitochondrial dynamics in apoptotic cells is a matter of intense ongoing 
research. Apoptosis-associated mitochondrial outer membrane permeabilization 
(MOMP) leads to increased ROS formation, reduced ATP levels and the release of 
proapoptotic proteins such as AIF, Cytc, EndoG and among others. In apoptotic cells, 
mitochondrial MOMP, is tightly regulated by Bcl-2 family proteins (48;154), and is 
functionally associated with mitochondrial fission and fusion proteins. For example, 
during apoptosis, Bax and Bak promote Drp1-dependent mitochondrial fragmentation 
by colocalization of Bax with Drp1 and Mfn-2 at sites of the mitochondria outer 
membrane which then become fission sites. These protein interactions stabilize the 
association of Drp1 with the mitochondrial membrane and are prerequisite to inducing 
fragmentation of the organelles (153). In turn, Drp1 stimulates Bax oligomerization by 
triggering hemifusion of the mitochondrial membrane (112). Such Drp1 facilitated Bax 
oligomerization is likely an essential step towards enhanced membrane permeability, 
and the Bax-dependent release of proapoptotic factors from the mitochondria into the 
cytosol. Such Bax translocation to the mitochondria correlates with a reduction of 
mitochondria fusion (155). Furthermore, Bak regulates mitochondrial dynamics by 
interaction with mitofusins to decrease mitochondrial fusion (112;156;157). 
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Interestingly, overexpression of Bcl-xl inhibited Bax-induced Cytc release, but not Bax-
induced fragmentation (93;158). Bcl-xl increases the rates of both, fusion and fission in 
a Drp1-dependent manner. Bcl-xl appear to maintain proper dendritic spine and 
synaptic structures in neurons via regulation of Drp1-dependent mitochondrial 
morphology and biomass (84;110;159). The present thesis now revealed an impact of 
Bid in the regulation of mitochondrial dynamics during apoptosis. Hence, Bcl-2 family 
proteins cause mitochondrial fragmentation by activation of fission and/or blocking 
fusion.  
4.2.3 Bid is a key regulator of mitochondrial fission in 
glutamate-induced cell death in HT-22 cells 
The present study provides evidence for a key role of the BH3-only protein Bid in 
mitochondrial pathways of neuronal apoptosis caused by oxidative stress. The data 
suggested that glutamate significantly disturbed the delicate balance between 
mitochondrial fission and fusion in neuronal cells and that fission of mitochondria-
accompanied cell death. In the currently used model system, glutamate induced 
oxidative cell death through glutathione depletion and accelerated formation of reactive 
oxygen species (ROS), which was associated with enhanced mitochondrial fission, the 
depolarization of the mitochondrial outer membrane, relocation of fragmented 
mitochondria to the nucleus, and the release of mitochondrial AIF to the nucleus 
(39;92;160-162). All the latter mitochondrial features of apoptosis were prevented by 
Bid siRNA and the Bid inhibitor BI-6c9. 
These data demonstrated that depolarization of the mitochondrial outer membrane and 
mitochondrial fragmentation are both important key events of mitochondrial apoptosis 
induced by oxidative stress, and both events were apparently Bid-dependent. The 
conclusion of the pivotal role for Bid upstream of such mitochondrial dysfunction is 
substantiated by experiments demonstrating pronounced neuroprotective effects of the 
Bid inhibitor BI-6c9 in models of glutamate-induced excitotoxicity and oxygen glucose 
deprivation in primary cultured neurons, and similar studies in HT-22 neurons using Bid 
siRNA (39;160;163). Further, genetic deletion of Bid attenuated neuronal death in a 
model of oxygen glucose deprivation in vitro and reduced brain damage in models of 
cerebral ischemia and brain trauma in vivo (60;62). These findings supported the 
conclusion, that Bid activation and subsequent mitochondrial translocation are early 
key events recruiting mitochondria to the death machinery in neurodegenerative 
pathologies associated with glutamate toxicity and oxidative stress. The precise 
mechanism of Bid/tBid-dependent mitochondrial fragmentation, loss of mitochondrial 
membrane potential and release of proapoptotic mitochondrial proteins is the subject of 
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current studies. However, data obtained from this thesis demonstrated an essential 
interaction of Bid with Drp1, the main regulator of mitochondrial fission. The process of 
Bid/tBid-dependent mitochondrial fission may involve interactions of Bid with other Bcl-
2 family proteins, like Bax and Bak, which also be regulated by factors of the fission 
and fusion machinery, like Drp1.  
Previous studies showed, that tBid and full-length Bid exert similar effects on 
mitochondria and AIF-dependent cell death in neurons (39;164). Further studies 
confirmed that full-length Bid was sufficient to induce mitochondrial dysfunction in 
neurons (164). One study identified two separate apoptotic pathways where Bid 
translocation to the mitochondria played a significant role. On the one hand, activated 
tBid is capable of inducing mitochondrial demise in caspase-dependent death receptor 
mediated pathways, and, on the other hand, full-length Bid mediated glutamate-
induced caspase-independent cell death pathways in different time frames/kinetics; 
while tBid induced rapid mitochondrial damage, detrimental effects of activated full-
length Bid occurred much slower (70).  
Glutamate-induced apoptosis in cerebellar granule and hippocampal neurons in a 
caspase-independent manner, involving the translocation of full-length Bid to the 
mitochondria 6 h after glutamate challenge. Further, translocation of full-length Bid and 
a collapse of the mitochondrial outer membrane permeabilization accompanied with a 
rapid increase of cytosolic Ca2+ occured prior to a cleavage of the Bid protein, indicated 
that Bid cleavage was a secondary event to translocation and mitochondrial 
depolarization in this model system. This suggested the potential for activation of 
calpains to cleave full-length Bid following the translocation and the collapse of the 
mitochondrial depolarization within these neurons (70). Addtionally, alterations in 
phospholipids have been shown to be a hallmark of excitotoxic, Ca2+-dependent cell 
death. It has been presented that change in the cellular phospholipid content such as 
increased phosphatidic acid and phosphatidylglycerol levels enhanced the ability of full-
length Bid to translocate and to permeabilize mitochondria (165). Further, it has been 
demonstrated that full-length Bid is able to oligomerize and trigger the insertion of Bax 
in isolated mitochondria (58). These data indicate that Bid can mediate mitochondrial 
damage and cell death as a full-length protein, which fits to the observation that tBid 
was hardly detectable in cytosolic or mitochondrial extracts from HT-22 cells or primary 
neurons after the glutamate challenge. This suggested that either full-length Bid was 
activated and then able to translocate to the mitochondria or only a small part of Bid 
was cleaved to tBid (39;162). 
These findings are in contrast to reported findings in non-neuronal MCF-7 cells, where 
TRAIL-death receptor-mediated Bid cleavage, tBid translocation and mitochondrial 
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deplorization occured in less than 2 min. time frame suggesting that very little Bid 
translocation/cleavage was sufficient to trigger mitochondrial outer membrane 
permeabilization during death receptor-induced apoptosis (70). 
In this study, transfection with a toxic tBid-vector was used to induce tBid-mediated 
mitochondrial toxicity in HT-22 cells. The fast kinetics of tBid-induced cell death within 
12 h in HT-22 cells showed that tBid was able to mediate mitochondrial dysfunction. It 
is important to note, that the Bid inhibitor BI-6c9 prevented the translocation of both, 
full-length Bid and tBid to the mitochondria and the detrimental effects on mitochondria, 
suggesting that the effects of both forms of activated Bid are comparable and may 
occur concomittantly in HT-22 neurons.  
Currently, there are several hypotheses which propose to explain why tBid specifically 
translocates to mitochondria during apoptosis. One of the hypothesis, suggests that 
tBid acts as a ligand for other proteins of the Bcl-2 family such as Bax and Bak to 
induce mitochondrial outer membrane pore formation (7;56;166). Another hypothesis 
postulates, that tBid is post-transcriptionally myristinylated, which enhances targeting of 
tBid to the mitochondria (167). A third hypothesis proposed that tBid is able to remodel 
the intermembrane cristae which led to a release of Cytc to promote apoptosis 
independent of Bax/Bak activities (13;168). A fourth hypothesis postulated that tBid 
binds to cardiolipin at mitochondrial contact sites. In this context, it has been 
suggested, that full-length Bid and caspase-8 docked at the OMM via cardiolipin and 
formed an activating platform that enhanced the production of tBid (169;170). The latter 
finding is in line with reports that suggest that full-length Bid translocates to the 
mitochondria where it oligomerized directly with Bax or full-length Bid occurs prior to 
the interaction with the mitochondria cleaved to tBid to activate mitochondrial death 
pathways (171).  
Overall, mitochondrial transactivation of full-length Bid or tBid may mark the execution 
phase of apoptotic death signaling. Therefore, activated Bid is regarded as a key 
mediator of mitochondrial neuronal cell death pathways associated with enhanced 
oxidative stress. The current study demonstrated for the first time, that Bid is a key 
regulator of mitochondrial fission, mitochondrial relocation to the nucleus, and 
mitochondrial integrity in neuronal cells exposed to oxidative stress. Therefore, Bid is a 
promising therapeutic target to prevent mitochondrial fragmentation and dysfunction 
which are hallmarks of neuronal cell death in most neurodegenerative diseases. 
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4.3 The role of Drp1 in the oxidative stress model of 
HT-22 cells 
4.3.1 Mitochondrial fission is Drp1-dependent after glutamate 
The present study demonstrated a significant neuroprotective effect by inhibition of 
Drp1, suggesting that this regulator of mitochondrial fission plays a major role in 
delayed neuronal cell death. This conclusion is based on findings showing that down-
regulation of Drp1 by siRNA or by new small molecule inhibitors significantly preserved 
mitochondrial morphology and mitochondrial membrane potential and reduced 
glutamate toxicity in neuronal cells. These results showed that glutamate-induced 
mitochondrial fission was associated with depolarization of the mitochondrial 
membrane, and both events were Drp1 dependent. These data let suppose the theory 
that mitochondrial fission could happen in parallel to mitochondrial membrane 
permeabilization. In fact, pharmacological inhibition of Drp1 and Drp1 siRNA prevented 
mitochondrial membrane depolarization, and the rescue of mitochondrial membrane 
integrity was associated with preserved mitochondrial morphology and neuronal 
survival. These data clearly put Drp1 upstream of the detrimental loss of mitochondrial 
integrity, indicating that mitochondrial fragmentation is not only associated with features 
of mitochondrial cell death pathways and involved regulators of mitochondrial fission 
play a central role in these processes.  
4.3.2 Drp1 and Bcl-2 family proteins control mitochondrial 
fission in HT-22 cells 
The presented data demonstrated a role for the proapoptotic BH3-only protein Bid in 
Drp1-mediated mitochondrial fragmentation (39;92). As reported before, Bid was 
involved in the loss of MOMP and release of mitochondrial AIF in apoptotic neurons 
and played a key role in mechanisms of delayed neuronal death after cerebral 
ischemia (60;133;160). The present thesis now demonstrated that tBid-induced loss of 
MOMP and mitochondrial fragmentation depends on Drp1 activity since Drp1 inhibition 
prevented tBid-induced mitochondrial fission and preserved cell viability. In addition, 
the Bid inhibitor BI-6c9 prevented Drp1 translocation to the mitochondria. These data 
indicated a detrimental interplay between Bid and Drp1 that occurs upstream of 
mitochondrial death pathways that involve mitochondrial fission, MOMP and AIF 
release to the nucleus. Further, Drp1-dependent mitochondrial fission is closely linked 
to death signaling pathways triggered by proapoptotic Bcl-2 proteins. Consistent with 
the current literature (153), the present study was able to show, that Bax and Bcl-xl 
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colocalized with Drp1 after glutamate toxicity what substantiated that Bax could be the 
connection of Bid- and Drp1-dependent mitochondrial fission. In addition, recent data 
suggested a role for tBid in enhancing Drp1-induced polymerization of Bax at 
mitochondrial fission sites, which further supporting the important role of Bid in these 
pathways of mitochondrial cell death (112).  
In damaged neurons, inhibition of Drp1 may serve to shift the observed mitochondrial 
fission back to an outbalanced ratio of fusion and fission thereby preventing neuronal 
dysfunction and death. Alternatively, the role of Drp1 in neuronal cell death may be 
independent of its role in mitochondrial fission. Recently, Martinou and co-workers 
suggested Drp1 recruitment to cardiolipin-rich membrane sites as a prerequisite for 
membrane hemifusion and Bax oligomerization at mitochondria (112). Bax 
oligomerization, subsequent MMP, and release of proapoptotic factors to the cytosol 
were significantly delayed with Drp1 mutants lacking membrane recruitment and 
hemifusion activity. This observation is in line with these present findings of Drp1 
recruitment to mitochondria prior to the demise of these organelles. Notably, Drp1-
induced Bax oligomerization also required the presence of tBid which further supports 
the conclusion that both, Drp1 and Bid interact at the mitochondrial membrane for 
execution of mitochondrial death pathways in neurons. These findings suggest that Bid 
and oligomerized Bax accumulate at Drp1 recruiting sites which then become 
mitochondrial fission sites. Further, Drp1 activation is critical for mitochondrial 
fragmentation in apoptotic cell death. Thus, in dying neurons mitochondrial fission may 
be regarded as a morphological hallmark indicating the process of mitochondrial 
membrane permeabilization and mitochondrial death pathways. In the underlying 
mechanisms contrast the physiological fission of mitochondria, where fragmentation of 
these organelles permanently occurs without fatal damage to the organelles. Whether 
physiological fission in neurons also requires Bid and Bax has not been elucidated. 
However, earlier studies indicated that mitochondrial fusion dominated over fission in 
neurons exposed to pharmacological inhibitors of Bid and after siRNA-mediated Bid 
silencing (92). Further studies are required, to define the mechanisms that link 
oxidative stress, detrimental Bid activation and Drp1 activities at the sites of 
mitochondria in neurons.  
A recent study showed that tBid can directly trigger christae remodeling by disassembly 
of Opa1 oligomeres in the inner mitochondiral membrane. This leads to a loss of 
christae structure with the release of Cytc and mitochondrial fission (168). To identifiy 
the regulating mechanisms of Bid/tBid it would be necessary to investigate if this tBid-
induced christae remodeling happened during glutamate-induced cell death. Further, 
several reports showed that post-translational modifications like phosphorylation, 
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sumoylation or ubiquitination on specific protein sites of Drp1 influenced its activity and 
localization in the cell. In line with previous studies, this thesis confirmed indirectly, that 
phosphorylation influenced the Drp1 activity in glutamate-induced apoptosis. Glutamate 
enhanced Ca2+ levels thereby stimulating the dephosphorylation of Drp1 by calcineurin, 
which, in turn, caused the translocation of Drp1 to the mitochondria and subsequent 
mitochondrial fragmentation. This was prevented by using the calcineurin inhibitor 
CspA, which revealed that dephosphorylation of Drp1, is an important post-translational 
modification to regulate Drp activity in glutamate-induced cell death. In addition, as 
shown in this thesis, NO and therefore nitrosylation of Drp1 did not play a significant 
role in glutamate-induced cell death. However, based on the finding that 
phosphorylation influenced the Drp1 activity, further investigations are warranted to 
define the potential roles of protein kinase A or Ca2+/calmodulin-dependent protein 
kinase I alpha mediated mechanisms of Drp-1 activation and their relevance in the 
glutamate-induced cell death. The importance of post-translational modifications of 
Drp1 is underlined by recent findings indicating that phosphorylation and S-nitrosylation 
may significantly influence the Drp1 activity towards the direction of enhanced fission 
(116-118;141). 
4.4 Two major structural changes in mitochondria 
correlate with glutamate-induced apoptosis  
4.4.1 Mitochondrial fission and mitochondrial membrane 
permeabilization 
Two major classes of structural changes in mitochondria are correlated with apoptosis: 
the opening of the mitochondrial outer membrane permeabilization (MOMP) and 
mitochondrial fission and fusion. These events have been studied independently in the 
past. Mitochondrial outer membrane permeabilization is defined as the “point of no 
return”, which promotes apoptosis by permitting proapoptotic proteins such as Cytc and 
AIF to promote downstream events of apoptosis. However, the mechanism underlying 
MOMP is still elusive. Recently, mitochondrial fission has been proposed to be closely 
related with MOMP in the execution of cell death. This hypothesis is based on the 
observations that apoptosis-associated mitochondrial fragmentation via Bax/Bak 
occured concomitantly with the Cytc-release (172). MOMP is believed to result from 
Bcl-2 protein conformation changes, protein-protein and protein-membrane-
interactions. In particular, Bax seems to play a pivotal role to connect these two 
processes, because Bax is involved in the formation of the membrane permeabilization 
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pore together with Bak and interacts with fusion and fission proteins like Drp1, and Mfn-
1 and -2. This thesis demonstrated that Bid is additionally one pivotal regulator of 
MOMP and Drp1-dependent fission in glutamate-induced apoptosis.  
However, several independent observations suggested that these events are merely 
coincident and can be functionally uncoupled. Different scenarios have been proposed 
on how mitochondrial dynamics are involved in the execution of apoptosis (99;173): 
1. Both Bax and Drp1-dependent mitochondrial fission are responsible for 
apoptosis but these two regulation machineries work independently, in parallel. 
Apoptotic stimuli induce Bax translocation, oligomerization and Bax/Bak 
interactions on the OMM resulting in MOMP and Drp1-dependent fission of the 
mitochondria (85;106;174). 
2. Drp1-dependent mitochondrial fission is promoted by Bax translocation and 
responsible for MOMP (86;106;175). 
3. Mitochondrial fission is an essential step before MOMP. Apoptotic signals 
induce the release of calcium from the Endoplasmatic reticulum (ER) at first. 
This triggers the Drp1 translocation to mitochondria and induction of 
fragmentation. Mitochondrial fission induces Bax translocation, which is 
followed by MOMP (96;106). 
4. Mitochondrial fission lies downstream of MOMP but is not necessary for MOMP. 
Apoptotic stimuli trigger the translocation of Bax to the mitochondria. This 
results in the release of intermembrane space proteins like Cytc or Opa1, which 
could explain the inhibition of mitochondrial fusion occurring during apoptosis 
(96;106;175-177).  
5. Uncoupling of Bax/Bak-associated fragmentation and MOMP is based on 
studies in which Bax and Bak were transiently expressed along with 
antiapoptotic members of the Bcl-2 family, such as Bcl-xl or Bcl-2. In these 
studies, Bcl-2 and Bcl-xl failed to suppress Bax-induced fission but clearly 
suppressed MOMP and downstream apoptosis signaling (93;158). 
These scenarios suggest that mitochondrial fission may participate in apoptosis 
through different pathways depending on the cell type, and/or apoptotic signal 
characteristics. Which scenario is relevant for the execution of neuronal cell death in 
the present model system of oxidative stress was one of the major questions 
addressed by this thesis. The data strongly suggest that mitochondrial fission occurs in 
parallel to mitochondrial membrane permeabilization and thus imply that Drp1 
possesses multiple functions in mammalian cells.  
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4.4.2 The role of Drp1 in MOMP 
Further, the data of the present thesis suggest that Drp1 acts upstream of 
mitochondrial membrane permeabilization and together with Bcl-2 proteins to directly 
modulate MOMP. Earlier data revealed that Drp1 self-assembly during apoptosis is 
relevant to trigger Drp1 functions at mitochondria. Such Drp1 self-assembly is blocked 
by mdiviA and therefore critical in MOMP. Here in this thesis, Drp1 inhibition by mdiviA 
clearly prevented mitochondrial depolarization in HT-22 cells. One possible explanation 
is that Drp1 directly interacts and co-assembles with Bid-activated Bax/Bak, creating a 
complex that is more active for both MOMP and mitochondrial division (125). In 
addition, enhanced fission exhibited by Drp1 clusters on mitochondria is dramatically 
lost after Bax recruitment to mitochondria during apoptosis, indicating that the 
biochemical properties of Drp1 are altered in a Bax-dependent manner (122). Evidence 
for this explanation is now shown by results of this thesis, indicating that Bax and Drp1 
interact 10 - 12 h after glutamate challenge. This fits well with the established kinetics 
of glutamate-induced cell death, where MOMP was detected 10 - 12 h after the 
glutamate challenge. Thus, Drp1 may have a positive regulatory role in MOMP that is 
independent of its role in mitochondrial division, further demonstrating that Drp1 
possesses multiple roles in mammalian cells depending on physiological or 
pathological settings. 
Another possible mechanism for Drp1 during apoptosis is that it exerts its effects on 
MOMP by regulating the mitochondrial fusion machinery (125). Recent studies have 
shown that in healthy cells, Bax and Bak are required to maintain normal levels of 
mitochondrial fusion activity and alter the behavior of the mitochondrial outer 
membrane fusion protein, Mfn-2 (26). This contrasts the role of Bak and Bax during 
apoptosis, where, activated Bax and Mfn-2, are co-localized in clusters on the outer 
membrane to attenuate mitochondrial fusion (153). Thus, it is possible that Drp1 
recruitment to an activated Bax/Bak complex alters their activities, causing inhibition of 
Mfn-2-dependent fusion activity. This in turn, may facilitates MOMP, likely via the 
control of cristae structures (178). Indeed, it has been reported that RNAi depletion of 
Drp1 in HeLa cells does not affect the release of Smac/DIABLO from mitochondria 
during apoptosis, but attenuates cytochrome c release, which is sequestered in the 
mitochondrial cristae (100;177). That mdiviA has a general influence on MOMP and 
likely does not exert its effects through changes in cristae structure was also shown by 
experiments, where mdiviA blocked Bax/Bak-dependent release of Smac/DIABLO from 
mitochondria in vitro (125). In consideration of this theory it is relevant to elucidate the 
role of mitochondrial fusion regulators, like Mfn-2, in glutamate-induced cell death.  
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4.5 The role of Drp1 in primary neurons 
So far, the proposed detrimental role of Drp1 in neurons is based in large parts on the 
presented findings in HT-22 cells and is now also extended to postmitotic neurons, 
since Drp1 inhibitors also prevented glutamate excitotoxicity and OGD-induced death 
in primary cultured neurons, and in a model of cerebral ischemia in vivo. In these 
model systems, it is well established that the underlying death program also includes 
Bid-mediated mitochondrial damage and AIF release to the nucleus (60;133;134). The 
Drp1 inhibitors mdiviA and mdiviB also significantly protected primary cultured neurons 
from glutamate- and OGD-induced cell death in vitro. Further, in a model of ischemic 
stroke in mice, the small molecule inhibitors of Drp1 resulted in a significant reduction 
of the mean infarct volume compared to vehicle-treated controls. These data exposed 
Drp1 as a key factor in ischemic and glutamate-induced neuronal cell death, and 
identified Drp1-dependent mitochondrial fission as a potential therapeutic target in 
acute cerebrovascular diseases.  
Therefore, inhibition of Drp1 as presented here using the mdivi compound expose a 
novel therapeutic strategy for both acute and chronic neurological diseases. This is in 
line with successful approaches of Drp1 inhibitor mdiviA in other experimental models 
of ischemic tissue damage, induced by cardiac or renal ischemia and reperfusion, 
respectively. Further, inhibitors of Drp1 have a therapeutic potential for a wide array of 
chemotherapeutic drug-induced tissue damage (157;179).  
Regulation of mitochondrial dynamics in healthy cells appears to play a particularly 
critical role in neurons, because neurons have long processes, particular electrical 
properties, complex energy requirements and synaptic functions, such as 
neurotransmitter release which all require continuous supply of energy through 
mitochondrial ATP synthesis. Therefore, Drp1 regulated fission is regarded as an 
essential mechanism to allow mitochondrial transport to remote axonal and dendritic 
locations and synapses in the neurons. Mitochondrial fusion is essential for 
mitochondrial maintainence through mtDNA and protein exchange and recovery in 
fused organelles. 
Notably, in this thesis, studies elucidating the effect of Drp1 inhibition in healthy 
neurons demonstrated that high concentrations of the Drp1 inhibitor mdiviA resulted in 
enhanced fission and cell death and not the expected enhanced fusion of mitochondria. 
These toxic effects provoked by Drp1 inhibition are in line with applications of 
dominant-negative mutant of the fission protein Drp1, such as Drp1K38A. Exogenously 
expressed, Drp1K38A causes a loss of mitochondria from dendritic spines and a 
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reduction in synapse number and size, whereas enhanced mitochondrial fission 
increases synapse formation (110;180). Similarly to this, mutations in mitochondrial 
fusion proteins also cause enhanced mitochondrial fission in a number of different 
human neuropathies (97;136;181;182). In contrast, depletion of endogenous Drp1 has 
been shown to prevent mitochondria from distributing to synapses thereby causing 
synaptic dysfunction as a result of increased mitochondrial length. Further, interference 
with Drp1-mediated fission promote increased mitochondrial fusion, and this may also 
interfere with mitochondrial transport and function in neurons (82;110;115;183;184). 
For example, inhibition of Drp1 leads to persistent mitochondrial fusion that neither 
allows mitochondrial regeneration nor transport within the neurons thereby causing 
accumulation of mitochondrial DNA and protein damage and ultimately resulting in 
mitochondrial dysfunction and cell death. This is consistent with a recently described 
human mutation in Drp1 associated with severe abnormal brain development (185). 
These examples indicate that mitochondrial dynamics are tightly regulated in neurons 
and the fine-tuned balance of mitochondrial fission and fusion is of major importance 
for neuronal viability and function. Thus, future investigations are warranted to address 
whether additional inhibition of other regulators of mitochondrial fission and fusion may 
provide similar effects as observed here with the applied Drp1 inhibitors and whether 
combinatory approaches are suitable to achieve neuroprotection in models of acute 
and chronic neurodegenerative disorders.  
Regardless of the pivotal role of the outbalanced fusion and fission mechanisms in 
neurons, these data exposed Drp1 as a key factor regulating mitochondrial dysfunction 
in models of acute and chronic neurological disorders, respectively.  
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Figure 45  The pivotal role of BH3-only protein Bid and Drp1 in cell death induced by oxidative 
stress 
Mitochondrial dynamics are mainly regulated by fusion (Mfn-1, -2, Opa1) and fission proteins (Drp1, Fis-1). 
Oxidative stress, induced by different neurodegenerative diseases, cerebral ischemia and others, leads to 
dysregulation of the balanced mitochondrial dynamics towards enhanced mitochondrial fission, 
depolarization of mitochondrial outer membrane (MOMP), relocation of fragmented mitochondria to the 
nucleus, and release of mitochondrial AIF and Cytc. Mitochondrial fission and MOMP occur in parallel 
dependent on an upstream detrimental interplay between full-length Bid, activated tBid and Drp1. Inhibition 
of either factor is sufficient to block the other’s detrimental effect on mitochondria and execution of 
neuronal cell death. The Bid inhibitor BI-6c9 and siRNA prevented the translocation of both, full-length Bid 
and tBid, to the mitochondria. Down-regulation of Drp1 by siRNA or new small molecule inhibitor mdivi-1 
significantly preserved mitochondrial morphology and mitochondrial membrane potential and reduced 
glutamate toxicity in neuronal cells. Therefore, inhibition of Bid or Drp1 is a promising therapeutic target to 
prevent mitochondrial fragmentation and dysfunction, which are hallmarks of neuronal cell death in acute 
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4.6 The role of Drp1 and Bid in other models of 
oxidative stress 
4.6.1 The effects of Drp1 and Bid inhibition on neuronal 
damage by radical donors 
In addition to the glutamate-induced oxidative cell death, several also well established 
and widely accepted models of oxidative stress were tested in HT-22 cells to elucidate 
whether Drp1 activation or Bid activation were involved in neuronal cell death induced 
by different oxidative stress stimuli. Radical donors such as glucose oxidase, H2O2 and 
4-HNE were used previously in other studies of neurological disorders to increase 
formation of ROS and consequently cell death (142;143;186).  
Inhibition of Bid by BI-6c9 failed to prevent cell death induced by radical donors, H2O2 
or glucose oxidase, which showed that Bid was not involved in these models of 
oxidative cell death. Morever, these findings suggest that ROS production has a key 
role after glutamate challenge and demonstrated that the mechanism, occurring in 
HT-22 cells after glutamate challenge differ from those after treatment with radical 
donors. To this date, the applied model systems of radical donors are under debate 
concerning their suitability for research on mechanism in neurodegeneration, because 
treatment with H2O2 does not reflect the physiological H2O2 formation, but leads to 
rapid increases in ROS levels, whereas glucose oxidase may induce a more 
continuous production of H2O2. 
Further, the widely accepted model of oxidative stress by adding the highly reactive 
4-HNE was used to induce cellular damage in HT-22 cells. 4-HNE is a toxic second 
messenger of free radical formation after peroxidation of cellular lipids or circulating 
lipid proteins and is used as marker in several neurodegenerative diseases such as 
Alzheimer`s disease and arteriosclerosis (145;187). This thesis studied the effect of 
4-HNE in HT-22 cells and analyzed the role of Bid after exposure to 4-HNE. The 
inhibition of Bid by BI-6c9 could not prevent 4-HNE-induced damage, indicating, that 
glutamate toxicity does not involve the formation of large amounts of highly reactive, 
toxic 4-HNE, and Bid is not primarily activated in the 4-HNE-mediated oxidative stress 
in HT-22 cells. Thus, these results suggest that 4-HNE induces different apoptotic 
pathway in HT-22 compared to the pathways of glutamate-induced oxytosis that were 
delineated in the present thesis.  
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4.6.2 The role of NO toxicity in HT-22 cells 
NO is a gas which mediates physiological functions such as blood vessel dilation, 
neurotransmission and immune cell response, and contributes to various pathological 
actions through formation of reactive nitrogen species (RNS). Excess RNS may disturb 
protein function and induce mitochondrial fragmentation in numerous neurological 
diseases including Alzheimer`s disease, Parkinson`s disease, Huntington’s disease 
and cerebral ischemia. NO mediates neuronal cell death by interacting with various 
reactive oxygen species, DNA, enzymes, NMDA receptors and through nitrosylation of 
proteins like caspases, metalloproteinases and proteins regulating mitochondrial 
integrity such as Drp1 (116;120;148-150). Thus, RNS may be a leading cause for 
oxidative stress in different neurodegenerative processes (32;116;151;188-191). 
A recent study showed, that nitrosative stress triggers persistent mitochondrial 
fragmentation prior to neuronal cell death in isolated neurons in vitro and in an 
experimental model of ischemic stroke in vivo, where NO-induced ultrastructure 
changes of mitochondria, increased ROS and reduced intracellular ATP levels (95). 
The particular role of Drp1 S-nitrosylation by NO for the regulation of Drp1 activity and 
subsequent mitochondrial fragmentation in AD pathology, however, is a matter of 
controversy. The authors proposed an increase in GTPase activity upon S-nitrosylation 
and formation of dimers to play a significant role in neuronal cell death in AD brain 
tissue but not in PD. In contrast to these findings, Bossy et al. recently reported that S-
nitrosylation has no significant impact on Drp1 oligomerization and is not required for 
Drp1 activation (192). Thus, the mechanisms and the importance of Drp1-nitrosylation 
for Drp1-mediated mitochondrial fission remain controversial.  
To analyze the relevance of NO-toxicity for Drp1 regulation in the glutamate toxicity 
model, HT-22 cells were challanged by the NO-donors DEANONOate and sodium 
nitropusside. Both NO-donors induced NO release as well as the formation of CN-, and 
Fe2+. Inhibition of Bid and Drp1 failed to protect HT-22 cells against NO-toxicity induced 
by DEANONOate. Further, DEANONOate led to a fast, but short term increase of 
NO-concentration while SNP induces a continuous, endogenous level of NO, CN- and 
Fe2+. The Bid inhibitor BI-6c9 significantly reduced cell death induced by SNP. Thus, 
Bid seems somehow to be involved in the SNP-induced neuronal cell death in HT-22 
cells however this has to be revealed in further detail.  
In addition, these results suggest that SNP and DEANONOate induced different 
mechanisms after fast and short NO production compared to the proposed continuous 
NO production during cell death in neurodegenerative diseases. Further in comparison 
with DEANONOate, cell death induced by SNP seems to be more complex regarding 
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the involvment of NFkB activation and glutathione depletion, as well as the release 
activities of CN- and Fe2+ (193). To examine the SNP-toxicity in further detail and with 
regard to post-translational modification of Drp1 by nitrosylation, total protein lysates of 
HT-22 cells were analyzed by western blotting to evaluate the tyrosine nitrosylation 
after exposure to SNP. The NO-donor DEANONOate was used as a positive control to 
confirm the function of the antibody. Tyrosine nitrosylation was not detectable in cells 
exposed to SNP, suggesting that the formation of NO and subsequent tyrosine 
nitrosylation is not the dominant trigger in neuronal cell death and does not modify the 
Drp1 protein and his activity in HT-22 cells exposed to glutamate and SNP. 
The question if NO toxicity is relevant in glutamate-induced cell death can also be 
answered by recent work from Tobaben, 2011 (144). Experiments with neuronal 
(nNOS) and endothelial (eNOS) nitrite oxide synthase inhibitors failed to prevent 
neuronal HT-22 cell death after glutamate treatment. Analysis of total protein lysates of 
the tyrosine nitrosylation of proteins after glutamate was not detectable. The analyses 
confirmed the result that enhanced NO formation and the resulting nitrosylation of 
proteins appeared to be less important, since inhibitors of NO synthases, targeting 
iNOS and nNOS did not attenuate mitochondrial fission and cell death after exposure 
of HT-22 cells to glutamate. Further, nitrosylation of Drp1 could not be detected in this 
model system of glutamate-induced oxytosis.  
In summary the results obtained from the different models of oxidative stress 
demonstrated, that glutamate-induced a very particular form of oxidative stress, that is 
not comparable to cell death induced by radical donors like GO or H2O2 or oxidative 
toxicity induced by 4-HNE. The activation and the key mediator role of Bid and Drp1 
were linked specifically to glutamate-induced cell death and did not occur in the other 
applied models of oxidative stress. A further conclusion derived from these data was, 
that the HT-22 cells served as a suitable model system for oxidative stress to 
investigate neurodegenerative processes in vitro. Which further post-translational 
modifications of Drp1 are relevant in this model system of neuronal cell death have to 
be elucidated in further ongoing studies. As mentioned before, phosphorylation of 
Drp1, could be a potential modification by calcineurin and PKA, which are activated by 
increased Ca2+ levels. 
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4.7 Mdivi-1, the first inhibitor of mitochondrial 
dynamin-related protein 1 
The identification of mdivi-1 as a potent small molecule inhibitor is remarkable, 
because of the following properties: mdivi-1 acts as an inhibitor to attenuate the early 
stages of mitochondiral division, mediated by dynamin-related proteins (Drps) by 
preventing the polymerization of higher order structures of Drp1. Mdivi-1 compounds 
(derivatives mdiviA, B, C and E) display a high degree of selectivity of targeting the 
unassembled pool of the mitochondrial division dynamin proteins and its binding 
creates and/or stabilizes an assembly-deficient conformation. The assembly of 
mitochondrial Drp1 is critical for its function. Further, in regard to the conservation of 
the dynamin-related protein super family members, mdivi-1 has no effect on other 
Drps, such as the endocytic dynamins or the mitochondrial fusion dynamins. This 
selectivity is promising for the division dynamin Drp1 as a therapeutic target (109;125).  
The identification of mdiviA and other structurally related inhibitors of the mitochondrial 
division dynamin extend to the resolution of genetic, cytological and biochemical 
approaches by selective, rapid and reversible modulations in mitochondrial division or 
Drp1 activities. This modulation can be induced in a wild-type background without 
depletion of protein levels by complex techniques such as RNAi or the need for the 
generation of mutant or knockout cell lines. In addition, the effects of increased or 
decreased Drp1 activity can be monitored immediately in combination with biochemical 
assays to identify the biochemical activity and the role of Drp1 in cellular function (109). 
As demonstrated in this study, mdiviA is a useful tool to identify the role of Drp1 in 
intrinsic apoptosis. Additionally, in earlier studies of cell-free MOMP assays where 
mitochondrial division does not occur it was shown that mdiviA blocked Cytc release 
(125). Thus, Drp1 played a significant regulatory role in MOMP that is independent of 
its role in mitochondrial division, demonstrating that Drp1 possesses multiple 
independent roles in mammalian cells beyond the control of mitochondrial dynamics 
(109). In addition, the approach of mdiviA in cultured mammalian cells to inhbit Drp1 
activity has revealed a regulatory role for a hyperfused mitochondrial state in the 
regulation of cyclin E levels and consequently in cell cycle progression (194). 
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4.8 The therapeutic potential of small molecule 
inhibitors of Drp1  
The high therapeutic potential of small molecule inhibitors of mitochondrial division is 
not only demonstrated in the results obtained from the present thesis, but was also 
obtained with dominant negative forms of Drp1 in cell culture models of Parkinson’s, 
Alzheimer’s and Huntington’s disease, where inhibition of Drp1 activity attenuated 
disease associated phenotypes of mitochondria (95;116;195;196). The role of Drp1 to 
facilitate apoptosis has also been exploited for its therapeutic potential. Small molecule 
inhibitors of Drp1 might protect impressively against apoptotic cell death in model 
systems of re-exposure of cells to oxygen after cerebral ischemia and reperfusion or 
after myocardial infarction induced apoptotic cell death, which led to severe tissue and 
organ damage. In fact, this approach appears highly promising since Drp1 inhibition 
through genetic approaches and mdiviA compound were also applied successfully in 
experimental models of cardiac and renal ischemia/reperfusion, respectively (157;179). 
In addition, it has been shown that mdiviA is efficacious in rodent models of cisplatin-
induced renal damage (157), and thus, inhibitors of Drp1 might also have a therapeutic 
potential for a wider array of chemotherapeutic drug-induced tissue damage (109). 
Although not yet investigated, it seems likely that mdivi-1 compounds or other inhibitors 
of mitochondrial division would prove beneficial for mitochondrial fusion-linked 
neuropathies CMT2A and DOA, where the detrimental effects of ongoing division in the 
absence or attenuation of mitochondrial fusion are clearly evident (181;182). 
Interestingly, recent work had shown that partial restoration of mitochondrial fusion in 
mammalian cells can rescue the long term defects associated with loss of fusion 
proteins such as, for example, decreased respiratory capacity, reduction in mtDNA 
levels, and increased rates of mtDNA (197;198). Thus, small molecule inhibitors of 
mitochondrial division, which could serve to restore the connectivity of the 
mitochondrial network, might also rescue the defects associated with loss/attenuation 
of mitochondrial fusion (109). 
Further, in cases of human diseases caused by heteroplasmic mtDNA mutations, 
inhibitors of Drp1 may also serve as potential therapeutics. Inhibition of mitochondrial 
division would increase connectivity of mitochondria and enhance access to products 
of wild type mtDNA genes to allow for complementation of respiratory chain or other 
dysfunctional mitochondrial proteins (109). It is important to note, however, that 
mitochondrial division is an essential event in cells for mitochondrial quality control and 
transport (185;199;200). In this context, mdivi-1 compounds may cause increasing 
mitochondrial connectivity, more frequently. On the other hand, although not yet 
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validated in the according model systems, small molecule activators of Drp1 and 
inhibitors of mitochondrial fusion proteins might serve as anti-cancer therapies, 
because of their potential to stimulate apoptotic cell death at high doses or after 
prolonged inhibition of mitochondrial fragmentation (109). 
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5 Summary 
The most prominent role for mitochondria is to supply the cell with metabolic energy in 
form of ATP. Furthermore, mitochondria are involved in many catabolic and anabolic 
reactions of different metabolites, e.g. phospholipids, the regulation of ROS metabolism 
and calcium homeostasis. In addition to their central role in various biochemical 
pathways, mitochondria are key regulators of neuronal apoptosis, in development and 
aging. Beside this, mitochondria are highly dynamic organelles which build, dependent 
on physiological conditions, large interconnected networks or appear as spherical, 
small rounded organelles. Impaired regulation of mitochondrial dynamics that shifts the 
balance towards fission is associated with neuronal death in delayed neuronal cell 
death after acute brain injury by ischemic stroke or brain trauma, and in age-related 
neurodegenerative diseases, such as Alzheimer’s disease or Parkinson’s disease. 
Emerging evidence suggests that oxidative stress disturbs mitochondrial morphology 
dynamics, resulting in detrimental mitochondrial fragmentation and dysfunction. In 
particular, such fatal mitochondrial fission has been detected in neurons exposed to 
oxidative stress, suggesting mitochondrial dysfunction is a key feature in the intrinsic 
death pathway.  
Major parts of the study were performed in a model of glutamate toxicity in 
immortalized hippocampal HT-22 neurons, since glutamate selectively induced 
oxidative stress through glutathione depletion in these cells. To verify the relevance of 
the findings in HT-22 cells for post-mitotic neurons, further experiments included 
models of glutamate-induced excitotoxicity and oxygen glucose deprivation primary 
embryonic neurons in vitro and in a mouse model of cerebral ischemia in vivo.  
The first part of this study investigated, whether enhanced mitochondrial fission 
accompanied by glutamate-induced neuronal cell death. The present study 
demonstrated that glutamate-induced apoptosis was associated with enhanced 
mitochondrial fission, loss of mitochondrial membrane potential and relocation of 
fragmented mitochondria to the nucleus. Further, the results obtained here provided 
evidence for a key role of the BH3-only protein Bid in mitochondrial fragmentation of 
neuronal apoptosis caused by oxidative stress. The mitochondrial fragmentation, the 
associated loss of the mitochondrial membrane potential, and consequent neuronal cell 
death were prevented by BI-6c9, a highly specific Bid inhibitor.  
The second part of this study explored whether Drp1 played a major role in neuronal 
cell death after glutamate-toxicity in HT-22 cells and primary cortical neurons. To verify 
the role of Drp1 in glutamate-induced cell death, highly specific small molecule 
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inhibitors of Drp1 and siRNA approaches in neurons were applied in this model-system 
of oxidative stress in neurons. Data obtained from the present study demonstrated a 
significant neuroprotective effect through inhibition of Drp1, suggesting that this 
regulator of mitochondrial fission played a major role in delayed neuronal cell death. 
This conclusion is based on findings showing that down-regulation of Drp1 by siRNA or 
by small molecule inhibitors significantly preserved mitochondrial morphology and 
mitochondrial membrane potential, and reduced glutamate toxicity in neuronal cells. In 
addition, the Drp1 inhibitors protected primary cortical neurons against oxygen glucose 
deprivation in vitro, and preserved brain tissue after cerebral ischemia in vivo. These 
data expose Drp1 as a key factor in ischemic and glutamate-induced neuronal cell 
death and identify Drp1-dependent mitochondrial fission as a potential therapeutic 
target in acute cerebrovascular diseases.  
Finally, studies on the potential interaction between Bid and Drp1 revealed for the first 
time that both factors cooperate during neuronal apoptosis to mediate mitochondrial 
fragmentation, loss of mitochondrial membrane integrity and intrinsic apoptosis. 
Inhibition of either factor was sufficient to block the other’s detrimental effect on 
mitochondria and execution of neuronal cell death. 
Overall, data obtained from the present study demonstrate for the first time Bid and 
Drp1 as the key regulators of mitochondrial neuronal cell death pathways associated 
with enhanced oxidative stress in HT-22 cells and primary neuronal cells as well as in 
the mouse model of cerebral ischemia, respectively. Bid-mediated neuronal cell death 
involves Drp1-dependent mitochondrial fission, mitochondrial relocation to the nucleus, 
mitochondrial membrane permeabilization, and release of mitochondrial cell death 
regulators such as AIF. Therefore, the presented data expose the inhibition of Bid by 
BI-6c9 and Drp1 using mdivi-1 compounds as a promising therapeutic target to prevent 
mitochondrial fragmentation and dysfunction which are hallmarks of neuronal cell death 
in acute and chronic neurodegenerative diseases, where glutamate toxicity and 
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6 Zusammenfassung 
Die bekannteste Rolle von Mitochondrien ist, die Zelle mit Energie in Form von ATP zu 
versorgen. Des Weiteren sind Mitochondrien an einer Vielzahl von anabolen und 
katabolen Reaktionen von verschiedenen Zwischenprodukten wie Phospholipiden, 
sowie an der Regulation des ROS-Metabolismus und der Calcium-Homöostase 
beteiligt. Zusätzlich zu ihrer zentralen Rolle in den verschiedenen biochemischen 
Signalwegen, sind Mitochondrien Schlüsselorganelle in Signalwegen der neuronalen 
Apoptose und in Entwicklungs- und Alterungsprozessen der Zelle. Mitochondrien sind 
hoch dynamische Organelle, welche sich abhängig der physiologischen Bedingungen 
als lange miteinander verbundene Netzwerke oder als kleine, runde Organelle 
darstellen. Unter pathologischen Bedingungen und im neuronalen Zelltod ist die 
Regulation der Mitochondrienmorphologie deutlich verändert, wobei das Gleichgewicht 
der mitochondrialen Dynamik in Richtung Fragmentierung verschoben wird. 
Entsprechende Veränderungen der Mitochondrien treten z. B. im verzögerten 
neuronalen Zelltod nach Schlaganfall oder Schädel-Hirn-Trauma auf und vermehrt 
fragmentierte Mitochondrien sind auch in geschädigtem Hirngewebe bei alters-
bedingten neurodegenerativen Erkrankungen, wie Morbus Alzheimer und Morbus 
Parkinson nachgewiesen worden. 
Vorarbeiten zu dieser Studie und neuere Publikationen weisen darauf hin, dass 
oxidativer Stress die mitochondriale Struktur zerstört, was in einer nachträglicher 
mitochondrialen Fragmentierung und Dysfunktion resultiert. Im Besonderen ist solch 
fatale mitochondriale Fragmentierung in Neuronen unter oxidativem Stress 
nachgewiesen worden, die Schlussfolgerung nahe legt, dass mitochondriale 
Dysfunktion eine wichtige Eigenschaft des intrinsischen Apoptosewegs ist. Im Rahmen 
dieser Arbeit wurde vor allem eine neuronale hippokampale Zelllinie (HT-22 Zellen) 
verwendet, um die Regulation und die Bedeutung der vermehrten 
Mitochondrienfragmentierung im oxidativen neuronalen Zelltod zu untersuchen. In 
diesen Zellen führt eine Behandlung mit Glutamat zu einem kontinuierlichen Abfall der 
intrazellulären Glutathionspiegel und induziert somit oxidativen Stress. Zusätzlich 
wurden primäre neuronale Zellkulturen und ein in vivo-Modell der zerebralen Ischämie 
eingesetzt, um die in HT-22 Zellen erhaltenen Ergebnisse zu bestätigen und 
auszubauen. 
Der erste Teil dieser Arbeit untersucht, ob verstärkte mitochondriale Fragmentierung 
den Glutamat-induzierten Zelltod begleitet. Die Ergebnisse zeigen eindeutig, dass 
Glutamat-induzierte Apoptose mit einer verstärkten Fragmentierung von Mitochondrien, 
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dem Verlust von mitochondrialen Membranpotential und einer Umverteilung von 
fragmentierten Mitochondrien um den Zellkern verbunden ist. Weiter zeigen die hier 
dargestellten Ergebnisse eine Schlüsselrolle für das BH3-Protein Bid in der 
mitochondrialen Fragmentierung auf, die durch den oxidativen Stress ausgelöst wurde. 
Durch einen spezifischen Bid Inhibitor (BI-6c9) konnten die mitochondriale 
Fragmentierung und der Verlust des mitochondrialen Membranpotentials in HT-22 
Zellen verhindert werden.  
Der zweite Teil der Arbeit untersucht die Rolle des Dynamin Proteins Drp1 im 
neuronalen Zelltod nach Glutamat-Schädigung in HT-22 Zellen und in primären 
kortikalen Neuronen.Um die Rolle von Drp1 im Glutamat-induzierten Zelltod 
nachzuweisen, wurde in dem hier angewendeten Modellsystem des oxidativen Stress 
zum ersten Mal hoch spezifische Drp1 Inhibitoren und Drp1 siRNA angewendet. Die 
Ergebnisse dieser Untersuchungen zeigten einen signifikanten neuroprotektiven Effekt 
durch die Inhibition von Drp1, was darauf hinweist, dass Drp1 ein wichtiger Regulator 
der mitochondrialen Fragmentierung im verzögerten neuronalen Zelltod ist. Diese 
Schlussfolgerung basierte auf Befunden, die zeigten, dass die Deletion von Drp1 durch 
siRNA oder durch den Drp1 Inhibitor die mitochondriale Morphologie, das 
mitochondriale Membranpotential und die Glutamat-induzierte Schädigung sowohl in 
HT-22, als auch in primären Neuronen verhindert werden. Der Drp1 Inhibitor blockierte 
zudem den neuronalen Zelltod nach Sauerstoff-Glukose-Entzug in primären Neuronen 
und verringerte auch signifikant das Infarktvolumen in einem Schlaganfallmodell in 
Mäusen. Diese Daten heben Drp1 als einen Schlüsselfaktor bei ischämisch- und 
Glutamat-induziertem neuronalen Zelltod hervor und identifizierten Drp1-abhängige 
mitochondriale Fragmentierung als eine mögliche therapeutischen Zielstruktur für die 
Therapie von akuten zerebrovaskulären Erkrankungen. Weitere Untersuchungen zu 
einer möglichen Wechselwirkung zwischen Bid und Drp1 im neuronalen Zelltod zeigten 
zudem erstmalig, dass offenbar beide Proteine nach oxidativem Stress zusammen an 
der Mitochondrienmembran agieren, um intrinsische Signalkaskaden der Apoptose zu 
induzieren. Die Hemmung eines der Proteine war ausreichend, um die mitochondriale 
Translokation bzw. die toxischen Effekte des Partners an den Mitochondrien zu 
hemmen und so den neuronalen Zelltod zu verhindern.  
Insgesamt konnte in dieser Arbeit zum ersten Mal gezeigt werden, dass Bid und Drp1 
zusammen als Schlüsselregulatoren des mitochondrialen neuronalen Zelltodes in 
HT-22 Zellen agieren und das die Hemmung von Drp1 auch in primären Neuronen, 
und auch in einem Schlaganfallmodell in Mäusen eine protektive Wirkung vermittelt. 
Der Bid-vermittelte neuronale Zelltod umfasst Drp1-abhängige mitochondriale 
Fragmentierung, mitochondriale Umverteilung um den Zellkern, mitochondriale 
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Membranschädigung und die Freisetzung von mitochondrialen Apoptose-Mediatoren 
wie AIF. Aus diesem Grund sind Bid und Drp1 vielversprechende therapeutische 
Zielstrukturen, die durch neuartige Inhibitor-Moleküle blockiert werden können, um 
mitochondriale Fragmentierung und Dysfunktion, als Kennzeichen des neuronalen 
Zelltodes bei akuten und chronischen neurodegenerativen Erkrankungen zu 
verhindern, in denen Glutamatschädigung bzw. oxidativer Stress zu den wesentlichen 
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7 Abbreviations 
Abbreviation Full text 
°C Grad Celcius 
µ Micro 
µM Micromolar 
AD Alzheimer`s disease 
AIF  Apotosis inducing factor 
ALS Amyotrophic lateral sclerosis  
AMPA 2-amin-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate  
AMR ATP monitoring reagent 
ANOVA Analysis of variance 
Apaf-1 Apoptosis protease activating factor  
ATP  Adenosinetriphosphate 
Bad Bcl-2 antagonist of cell death  
Bak  Bcl-2 antagonist/killer 1 
Bax Bcl-2 associated protein X  
BCA Bicinchoninic acid 
Bcl-2 B-cell lymphoma- 2 
Bcl-xl Bcl-2 related long isoform 
BH Bcl-2 homology 
Bid Bcl-2 interacting domain death antagonist  
Bim Bcl-2 interacting mediator of cell death 
Bodipy 4,4-diflouro-5-(4-phenyl1,3-butadienyl)-4-bora-3a,4a-diaza-s-
indacene-3-undecanoic acid 
Bp Base pairs 
Ca2+ Calcium 
CAD Caspase-activated deoxyribonuclease  
CARD Caspase recruitment domain  
CCCP Carbonylcyanide-3-chlorophenylhydrazone 
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Abbreviation Full text 
CMT2A Charcot Marie Tooth 2A  
CNS Central nervous system 
CO2 Carbon dioxide 
COX Cylooxygenase 
Cu1+ Copper 
CypD Cyclophilin D 
CysA Cyclosporine A 
Cytc Cytochrome c 
DAPI 4`, 6-diamidino-2-phenylindole dihydrochloride 
DCF Dichloro-dihydroflouresceine-diacetate 
DD Death domain 
DEANONOate DEA/NO, 2-(N,N-Diethylamino)-diazenolate-2-oxide 
diaethylammonium salt 
DED Death effector domain  
DMEM Dulbecco`s modified eagle medium 
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic acid 
DOA Dominant optic atrophy  
Drp Dynamin-related protein 
Drp1 Dynamin-related protein 1 
DTT DL-Dithiotreitol 
EBSS Earl`s balanced salt solution 
EBSS w/o 
glucose 
Earls balanced salt solution without glucose 
EDTA Ethylenediaminetetraacetic acid 
EGTA Ethylene glycol-bis(2-aminoethylether)-N,N,N`,N´-tetraacetic acid 
EndoG Endonuclease G 
FACS Flourescence activated cell sorting 
FCS Fetal calf seum 
FRET Förster resonance energy transfer 
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Abbreviation Full text 
GAPDH Glyceraldehyde-3-phosphate-dehydrogenase  
GDAP Ganglioside-induced differentiation associated protein 1 
GDNF Glial cell line derived neurotrophic factor  
GFP Green flourescence protein 
GO Glucose oxidase  
GSH Gluthatione 
h Hour 
H2O2 Hydrogen peroxide 
HBSS Hank`s balanced medium 
HCl Hydrochloric acid 
HEPES 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
HNE 4-Hydroxynonenal-dimethylacetat  
HRP Horse reddish peroxidase  
IAP Inhibitors of apoptosis  
ICAD Inactive caspase-activated deoxyribonuclease 
IMM Inner mitochondrial membrane  
JC-1 5,5´,6,6´-tetrachloro-1,1´,3,3´-tetraethyl-benzimidazolylcarbocyanine 
iodide 
JNK c-Jun N-terminal kinases 
kDa Kilo Dalton 
MCA Middle carotid artery 
MCAO Middle carotid artery occlusion  
Mcl-1 Myeloid cell leukemia 1  
mdivi  Mitochondrial division inhibitor 
MEM+ Eagle’s minimum essential medium 
Mff Miochondrial fission factor 
Mfn-1, -2 Mitofusin-1, -2 
Mg2+ Magnesium 
mGFP Mitochondiral targeting green fluorescent protein 
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Abbreviation Full text 
mM Millimolar 
MMP Mitochondrial membrane permeability  
MOMP Mitochondrial outer membrane permeabilization  
MPT Mitochondrial membrane transition 
mtDNA Mitochondrial DNA 
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
mU Milli unit 
N2 Nitrogen  
NaHCO3 Sodium hydrogen carbonate 
NaOH Sodium hydroxide 
nM Nanomolar 
NMDA N-methyl-D-aspartic acid 
NNR Nucleotide releasing reagent 
NO Nitrogen monoxide  
NOS Nitrogen monoxide synthase 
OG Glucose oxidase  
OGD Oxygen glucose deprivation 
OMM Outer mitochondrial membrane 
Opa1 Optic atrophy 1 
PBS Phosphate bufferd saline 
PCD Programmed cell death 
PD Parkinson`s disease 
PEI Polyethylenimine 
PFA Paraformaldeyde 
pH Potentia hydrogenii 
PI Propidium iodide 
PLL Poly-L -ornithine  
PTP Permeability transition pore 
PTPC Permeability transition pore complex 
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Abbreviation Full text 
PVDF Polyvinylidenfluorid 
RNS Reactive nitrogen species 
ROS Reactive oxygen species 
RT Room temperature 
SD Standard deviation 
SDS Sodium dodecyl sulfate 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis  
SEM Standard deviation of the mean  
SNP Sodium nitropusside 
tBid Truncated Bid 
TBS Tris-bufferd solution 
TBST Tris-bufferd solution with Tween 20 
TE Trypsin-EDTA 
TEMED Tetramethylenethylendiamin 
TNF Tumor necrosis factor 
tPa Tissue plasminogen activator  
TRAIL Tumor necrosis factor related apoptosis inducing ligand 
wt Wild type 
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